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Mycobacteria belong to the family Mycobacteriaceae and are members of the CMN group 
(Corynebacteria, Mycobacteria and Nocardia). The family Mycobacteriaceae are Gram-
positive, nonmotile, catalase-positive, have a rodlike to filamentous morphology and can be 
pleomorphic. As a group, they produce characteristic long chain fatty acids termed mycolic 
acids. Mycobacteria are acid-fast rods of variable appearance, approximately 0.2-0.6 by 1-
10 micrometer.  
The genus Mycobacterium consists of 127 species (excluding subspecies) according to the 
latest approved list of bacterial species (1). Mycobacteria other than Mycobacterium 
tuberculosis are commonly referred to as atypical or non-tuberculous mycobacteria (NTM). 
Two of these cause disease in normal hosts and are thus primary pathogenic: M. leprae, M. 
ulcerans. They are often not regarded as NTM. The remaining species are considered 
nonpathogenic or opportunistic pathogens and cause disease when host-defences are 
compromised. Mycobacteria can be arranged into four groups according to the Runyon 
classification:  
• Group 1 – Photochromogens: slow growers and form pigment when exposed to light 
(eg, M. kansasii, M. marinum, M. simiae)  
• Group 2 – Scotochromogens: slow growers and form pigment in the dark (eg, M. 
scrofulaceum, M. szulgai, M. gordonae)  
• Group 3 – Nonphotochromogens: slow growers and not pigmented (eg, M. 
malmoense, M. xenopi, M. avium-complex, M. ulcerans, M. haemophilum)  
• Group 4 - Rapid growers (eg, M. fortuitum, M. chelonae, M. abscessus) 
Most slow-growing species have been associated with disease in humans while only few 
species of group 4 (the ones mentioned above) are disease associated. 
Since the advent of AIDS and the application of recent developments in molecular biology 
for the detection and identification of NTM, NTM infections are increasingly detected. This in 
its turn created a higher awareness for mycobacterial involvement in a variety of clinical 
conditions and NTM diseases have been increasingly recognized in immunocompetent 





Taxonomy of the genus Mycobacterium. 
 
Unidentified species are constantly being discovered and mycobacterial taxonomy is 
continuously changing. The species belonging to a species group (sometimes referred to as 
a species-complex) can be very different in virulence or pathogenesis. 
Several previously considered species appear to consist of several closely related species, 
as biochemical and mainly genetic analyses have demonstrated in, for instance, the M. 
tuberculosis-complex. The complex species can be identified using differences in size of 
genomic sequences: Region of Difference1 (RD1), RD2, RD4, RD9 and RD12, analysed in 
PCR (2). This complex now consists of M. tuberculosis, M. africanum, M. microti and M. 
bovis, the latter of which has been further differentiated into M. bovis, M. caprae, M. 
pinnipedii and M. canetii, all named after their original host (2). A similar phenomenon can be 
found in the M. avium-complex. Originally, one species, but meanwhile divided into the 
species M. avium, M. intracellulare and M. scrofulaceum. Previous serovars belonging to 
this complex have been re-arranged (3, 4, 5) and several subspecies of M. avium have been 
identified: M. avium subsp. paratuberculosis, subsp. silvaticum and subsp. avium. This 
identification was based on molecular and biochemical criteria, that is High Performance 
Liquid Chromatography (HPLC) of mycolic acids and sequencing of, for instance, Internal 
Transcribed ribosomal Regions (ITS). M. avium subsp. avium, has recently been divided in 
subsp. avium and subsp. hominissuis using Restriction Fragment Length Polymorphism 
(RFLP) of a insertion sequence IS1245 (6). The majority of human infections is caused by M. 
hominissuis (6). 
 
The identification of a new species was conventionally based on the description of the 
Runyon classification, the biochemical properties of the strain(s) and the degree of DNA-
DNA hybridization. With the growing amount of species and subspecies with various 
biochemical properties, new methods were developed and this created a new standard for 
species differentiation (7). For the acceptance of a new species, the old and new ways of 
identification are all included: biochemical characteristics, growth and pigmentation 
characteristics, HPLC analysis and a unique genetic composition determined by the 
sequence of genes that allow species differentiation, such as the 16S rRNA gene, the hsp65 
gene and the ITS region, as applied and subsequently published in the International Journal 
of systematic Bacteriology (1, 8, 9). Sequencing of at least two targets as mentioned above 
must be included, but the choice of targets is not specified.  From 1990 to 1999, 28 new 
species have been recognized (9) and from 2000 to September 2007, 41 more species have 
been identified (Table 1). Of the latter 41, at least 26 were the cause of disease in humans, 
and at least six new species of clinical origin were rapid growers not belonging to one of the 




Table 1: New NTM determined from January 2000 to September 2007. 
 
year species name source runyon group additional info 
      
2000 M. botniense water 2 M. xenopi-like  
2000 M. kubicae human 2 between slow / rapid growers 
2000 M. septicum human 4   
2000 M. elephantis elephant 4   
2001 M. heckeshornense human 2 M. xenopi-like  
2001 M. doricum human 2   
2001 M. immunogenum human 4 M. abscessus group 
2001 M. frederiksbergense contaminated soil 4   
2002 M. palustre human / other 2   
2002 M. lacus human 3   
2002 M. vanbaalenii contaminated soil 4   
2002 M. holsaticum human 4   
2003 M. pinnipedii seal  M. tuberculosis-complex  
2003 M. shottsii striped bass 3 no growth >30 0C 
2003 M. montefiorense eels 3 no growth >30 0C 
2004 M. saskatchewanense human 2   
2004 M. parascrofulaceum human 2   
2004 M. parmense human 2   
2004 M. nebraskense human 2   
2004 M. chimaera human 3 MAC group  
2004 M. psychrotolerans pond water 4   
2004 M. canariasense human 4   
2004 M. cosmeticum human 4   
2004 M. pyrenivorans contaminated soil unknown   
2004 M. massiliense human 4 M. abscessus group 
2005 M. florentinum human unknown slow growing pigment forming 
2005 M. pseudoshottsii striped bass 1   
2006 M. arupense human 3 rapid growing at 30 0C 
2006 M. phocaicum human 4   
2006 M. neworleansense unknown 4 M. fortuitum group 
2006 M. houstonense unknown 4 M. fortuitum group 
2006 M. aubagnense human 4 M. mucogenicum group 
2006 M. bolletii human 4 M. abscessus group 
2006 M. boenickei unknown 4 M. fortuitum group 
2006 M. conceptionense human 4 M. fortuitum group 
2006 M. fluoranthenivorans soil unknown  
2006 M. kumamotonense human 3 M. terrae group 
2006 M. colombiense human 3 MAC group 
2006 M. monacense human 4  
2006 M. brisbanense unknown 4 M. fortuitum group 





Disease caused by NTM. 
 
The most common sites where mycobacterial disease occurs are the lungs, the lymph nodes 
and skin. However, as M. tuberculosis is mostly known to cause the well-established 
pulmonary manifestation but is capable of infecting virtually all tissue types, the NTM 
species follow the same behaviour: the range of clinical manifestations is extensive (10). 
 
Pulmonary infections. 
Pulmonary involvement is most common in immunocompromised patients. M. avium or M. 
kansasii infection are the predominant species known in AIDS patients (11), but nowadays 
M. avium is frequently encountered in immunocompetent patients, probably due to the 
improved diagnostic tools and clinical awareness. While NTM infection in immuno competent 
patients is increasingly common, a high bacterial burden or a damaged epithelial are usually 
cofactors for infection in these patients (12).  
Studies at the reference laboratories in Australia revealed 80% of clinical NTM isolates to be 
derived from pulmonary sources. However, as stated by the reference laboratories, the 
significance of an isolate is often doubtful when isolated from pulmonary sources and in 
Australia only 10% of all pulmonary isolates are associated with disease (clinically 
significant). In contrast, almost all NTM isolates (91-98%) from lymphatic, bone or soft tissue 
(skin and joint) origin were clinically significant. Because many NTM species are ubiquitous, 
the detection of NTM in clinical materials is not per sé proof of the identification of the cause 
of disease. This is especially true for the detection in non-sterile materials. The criteria for 
the clinical significance of positive NTM diagnostics have been described by the American 
Thoracic Society (ATS) (13). 
Still, pulmonary infection with NTM can take several forms which are evidently associated 
with disease (13, 14). The first, or classical, form is radiographically indistinguishable from 
tuberculosis. It is characterized by nodular opacities in the apices, cavitation and/or apical 
pleural thickening (12). 80%-90% of the patients are elderly Caucasian males and it is often 
found secondary to other lung disease. The most common species are M. avium, M. 
kansasii and M. malmoense (12). Risk factors include smoking, alcoholism, cardiovascular 
disease, chronic liver disease, and previous gastrectomy. Symptoms include coughing (60-
100%), weight loss, fever (10-13%), weakness, and hemoptysis (15-25%), but are often mild 
or completely absent (15). The second form is non-classical, does not resemble tuberculosis 
and M. avium is primarily the species involved. This infection is characterized by an 
interstitial and/or nodular pattern instead of a cavitary pattern involving mostly the lingula or 
middle lobe of the right lung. Risk factors are poorly understood. It is not necessarily related 
to smoking or any underlying chronic lung disease and is found most often in middle-aged or 
elderly women (Lady Windermere syndrome) (16, 17, 15). The third form of mycobacterial 
pulmonary disease is the “hot-tub lung” affecting middle-aged patients, male and female. It is 
mostly caused by species belonging to the M. avium-complex and is often recognized in 
metal-fluid workers and indoor swimming pool staff. Primary differences to other forms of 
pulmonary mycobacterial disease are the diffuse nodular presentation and the acute 
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manifestation instead of chronic manifestation (18, 19, 20). Already the most common 
species involved in pulmonary tract infections in immunocompromised patients, the 
incidence proportion of M. avium in immunocompetent patients is increasing rapidly (21). 
 
Skin infections. 
Cutaneous NTM infections result from external inoculation at sites of trauma, the spread of a 
deeper infection from the joints or other tissues, or haematogenous spread of a 
disseminated infection. There are a few species-specific infections (fish tank or swimming 
pool granuloma, due to M. marinum, Buruli ulcer, caused by M. ulcerans and Leprosy, 
caused by M. leprae). Most species, however, produce a nonspecific clinical picture, like M. 
haemophilum or M. abscessus and are mostly encountered in industrialised countries. 
Lesions occur in various forms as suppurative nodules, ulcers, abscesses, sporotrichoid 
lesions, folliculitis, furunculosis and indurated plaques. In immunocompetent patients the 
infection is normally localized, superficial and limited to the extremities. In 
immunosuppressed patients the number of lesions is often multiple and cutaneous 
involvement is often accompanied by disseminated disease (22). Abscesses and ulceration 
are also more frequently observed in immunosuppressed patients.  
The risk factors for NTM infection include: 1) HIV infection, lymphoma, leukemia or 
immunosuppressive therapy. Immunosuppression is responsible for the increase of 
cutaneous infections by a large variety of species, particularly in industrialized countries.  2) 
The natural environment is directly responsible for the emergence of cutaneous infections 
caused by a small number of species including M. avium and M. marinum in Europe and 
North America, and M. ulcerans in the tropics.  3) The medical environment when 
sterilization is inadequate is also not uncommonly responsible (23). 
Different histopathological patterns can be noted in biopsy specimens from cutaneous 
nontuberculous mycobacterial infections. The evolution of the disease and the immunologic 
status of the host may explain this spectrum of morphological changes. Tuberculoid, 
palisading and sarcoid-like granulomas, a diffuse infiltrate of histiocytic foamy cells, acute 
and chronic panniculitis, non-specific chronic inflammation, cutaneous abscesses, 
suppurative granulomas and necrotizing folliculitis can be detected. Suppurative granulomas 
are the most characteristic feature in skin biopsy specimens from cutaneous NTM infections. 
A marked granulomatous inflammatory reaction is more common in immunocompetent than 
in immunosuppressed patients (24). Both sexes are equally affected but males predominate 
in M. marinum infection and females predominate in rapid growers. All ages can be affected, 
but most cases involve middle-aged people. Cervical lymphadenitis and cutaneous 
abscesses are the common manifestations of rapid-grower infections. Hyperkeratotic 
verrucous plaques (tuberculosis verrucosa cutis-like) and sporotrichoid lesions are the 
common manifestations of slow-grower infection (25). 
 
Lymphadenitis. 
NTM lymphadenitis is seen in immunocompromised patients, but is mostly known as the 
most common manifestation of NTM disease in immunocompetent patients and usually 
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affects children under the age of 12 as chronic cervicofacial lymphadenitis. It is more 
common in industrialized countries and is suggested to be a “prosperity disease” (26). This 
age group may also be more susceptible because of a lack of a fully-developed immune 
system (27).  
Occurrence of lymphadenitis in immunocompromised patients is often accompanied by 
disseminated mycobacterial disease (28) and affects lymph nodes at different body sites. In 
lymphadenitis in “healthy” children, involvement of only one single lymph node is common 
except in M. haemophilum infection, where the involvement of multiple lymph nodes is more 
common (56%) (29). Involvement of submandibular lymph nodes are seen in 75% of the 
patients, while preauricular or periparotid sites of infection account for 12% to 25% of NTM 
adenitis cases. The clinical features include non-tender enlargement of the lymph node and 
violaceous skin discoloration of the overlying skin. After several weeks to months, caseous 
necrosis develops and when untreated, spontaneous drainage can occur leaving scars. The 
ports of entry are the pharyngeal mucosa, tonsils, conjunctiva, gingiva, and salivary glands. 
Ingestion of contaminated soil or water is speculated to be the source of infection. In salivary 
gland infection, the possibility of retrograde passage of the mycobacteria along the duct 
exists, thumb sucking being a possible risk factor in children (30, 31).  
Studies reported an annual incidence varying from 1,21 to 1.78 cases per 100.000 children 
which is increasing (32, 33, 34, 35). In the Netherlands, the estimated annual incidence of 
NTM cervicofacial infections is 0.77 per 100.000 children (36). Earlier publications describe a 
higher incidence of cervical lymphadenitis in winter and spring (37, 38), but this is 
contradicted by Lindeboom et al who did not observe a seasonal difference in the 
Netherlands: autumn (29% of patients), winter (25%), spring (25%), and summer (21%) (29). 
The number of mycobacterial species is increasing and several newly identified species 
have first been encountered in lymphadenitis patients (39, 40). However, approximately 70% 
of the cervicofacial lymphadenitis cases are caused by M. avium (41). Other frequently 
involved species depend on the geographical distribution of mycobacterial species. In India 
M. scrofulaceum is commonly involved, and it used to be the most prevalent species in the 
United States. In Israel, Australia and The Netherlands, M. haemophilum is the second most 
common species (14, 32, 42, this thesis chapters 3 and 4). In the rest of Europe this is M. 
malmoense (12). The switch in species prevalence is thought to be caused by variability in 
their presence in natural sources (21, 43). 
 
Disseminated disease. 
Disseminated NTM infection in HIV or otherwise immunodeficient patients appears to 
originate from a primary infection of either the skin or respiratory or gastrointestinal tracts. 
These infections may involve any organ, but most commonly occur in the lungs, liver, 
spleen, lymph nodes or bone marrow. Common symptoms include prolonged fevers (often 
accompanied by night sweats), weight loss and occasional abdominal pain or diarrhea. This 
disease is most commonly seen in patients with less than 50 CD4 cells (13). The primary 
Mycobacterium species associated with disseminated infections in HIV infected patients is 
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M. avium. However, M. chelonae, M. abscessus, M. kansasii, M. haemophilum, M. 
genavense and sporadically M. scrofulaceum have also been implicated (44). 
 
Skeletal infections. 
NTM (usually slow-growing species) can cause skeletal infections as well, which often affect 
the synovium or osteoarticular components of the extremities, but may occur at other 
skeletal sites (i.e. osteomyelitis), particularly when there is underlying immunosuppression. 




Both slow-growing and rapid-growing species, have been isolated from intestinal specimens 
from patients with Inflammatory bowel disease (Crohn's disease), ulcerative colitis, and non-
inflammatory bowel diseases (50). It is still controversial which role mycobacterial infections 
have in the etiology of Crohn's disease. Several studies suggested M. avium spp 
paratuberculosis (MAP) as the primary cause in the etiology of Crohn’s disease and reported 
positive cultures for MAP and PCRs or high specific immune responses (51, 52, 53, 54, 55). A 
significant correlation between Crohn’s disease and MAP has even been established (56), 
but the exact role of the mycobacterium remains to be defined (56). One of the popular 
theories on Crohn’s disease is the autoimmune theory which suggests that the disease 
results from inappropriate ongoing activation of the mucosal immune system driven by the 
presence of normal luminal flora (57). This would place the infectious agent in a secondary 
position but, nevertheless, in an active role. 
 
Foreign body related and nosocomial infections. 
Keratitis is another manifestation of NTM disease. This eye infection, usually caused by 
rapid growers, can cause significant damage when not treated properly. The typical clinical 
features consist of irregular corneal infiltrates with radiating projections, indistinct fluffy lesion 
margins, satellite lesions and associated epithelial defect (58). More than 150 cases have 
been reported to date, the majority of which in Asian countries. The major risk factor is injury 
to and the presence of foreign bodies in the cornea, frequent use of lens fluid and surgical 
trauma (58, 59, 60, 61). Infection following laser-assisted in situ keratomileusis (LASIK) has 
been more commonly described in recent years (62, 63, 64, 65). 
Other infections with NTM subsequent to surgical or other invasive medical procedures have 
been reported as well, predominantly caused by rapid-growing species. (66, 67, 68, 69). 
Postsurgical inflammatory complications with NTM present a difficult challenge because of 
the resistant nature of mycobacteria against disinfectants used in the cleaning of hospital 
equipment. NTM have been encountered in hospital water supplies (70, 71) and have in 




Table 2: clinical manifestations and the most commonly encountered NTM species. Adapted from 
Wagner et al. 2004) (12, 14, 74, RIVM personal correspondence) 
 
clinical manifestation common species less common species 
      
pulmonary disease M. avium-complex M. simiae M. asiaticum 
  M. kansasii M. szulgai M. shimodii 
  M. abscessus M. fortuitum M. smegmatis 
  M. chelonae M. celatum M. haemophilum 
  M. xenopi M. gordonae  
 M. malmoense   
      
lymphadenitis M. avium-complex M. fortuitum M. interjectum 
  M. malmoense M. kansasii M. heidelbergense 
  M. haemophilum M. abscessus M. scrofulaceum 
   M. chelonae M. bohemicum 
   M. lentiflavum   
      
skin and soft-tissue disease M. ulcerans M. kansasii   
  M. marinum M. malmoense   
  M. haemophilum M. chelonae  
  M. abscessus M. smegmatis   
  M. avium-complex M. fortuitum   
    
disseminated disease M. avium-complex M. celatum M. scrofulaceum 
  M. kansasii M. conspicuum M. abscessus 
  M. haemophilum M. malmoense M. simiae 
  M. fortuitum M. genavense   
  M. chelonae M. xenopi   
      
skeletal infection M. avium-complex M. chelonae M. marinum 
  M. abscessus M. kansasii M. smegmatis 
  M. fortuitum M. scrofulaceum M. nonchromogenicum 
   M. haemophilum M. malmoense 
  M. xenopi M. szulgai 
    
Gastrointestinal infection M. avium-complex M. mucogenicum  
   M. kansasii  
    
foreign body-related  M. fortuitum M. mucogenicum M. smegmatis 
infections and nosocomial M. abscessus M. neoaurum M. avium-complex 
infections M. chelonae M. aurum   
   M. gordonae   







NTM are saprophytes and ubiquitous and can exist in soil, dust, food (eggs, raw milk, 
vegetables) and water (43, 75). Animal reservoirs are also proposed to be involved in the 
etiology of human disease (46): M. avium has been recovered from the lymph nodes of 
swine and domestic fowl; M. genavense, M. fortuitum, and M. avium from birds; M. chelonae 
from fish and frogs (12) M. haemophilum from cockroaches (76) and M. ulcerans from 
mosquitoes (77). Many species have been isolated from natural water and drinking water 
systems and appear highly capable of forming biofilms, are able to sustain disinfecting 
treatment and are present in aerosols (78). 
 
 
Pathogenesis and host defences. 
 
Mycobacteria are thermoresistant, endure most disinfectants and have the ability to form 
biofilms. This is due to their thick acid-fast cell wall. No human-to–human transmission has 
been recognised for mycobacteria other than M. tuberculosis and M. leprae. Humans are 
thought to get infected through the inhalation of aerosols (showering, swimming) or direct 
contact with the bacteria by skin or mucosa with affected integrity (79). Pulmonary infections 
can occur in patients with impaired ventilation systems but without specific immunity 
problems. Children with cervical lymphadenitis also are considered healthy. Therefore, the 
mycobacteria need to possess ingenious mechanisms to evade the host defences. 
Mycobacteria have the capacity to thrive inside macrophages. As part of the immune 
system, macrophages are capable of destroying a wide variety of bacterial pathogens. 
Mycobacteria, however, are one of the few types of bacteria that are not only able to survive 
the antibacterial effects of macrophages, but actually grow and multiply inside them. 
Considerable research has been done to try and understand how mycobacteria flourish in -
what is thought to be- the hostile intracellular environment of macrophages. Two properties 
of mycobacteria explain their resistance to being killed by macrophages: The first is the cord 
factor that can neutralize the antibacterial chemicals produced inside macrophages and 
inactivate mitochondrial membranes of phagocyts (80). Cord factor (trehalose 6, 6’-
dimycolate) is a glycolipid in the cell wall of mycobacteria. They are mostly known as the 
molecules responsible for the serpentine cord-forming growth characteristics of M. 
tuberculosis, but comparable growth phenomena are encountered in non-tuberculous 
species caused by variable forms of cord factor in the cell wall as well. The glycolipid is 
widely distributed as a potent immunomodifier among non-tuberculous mycobacteria and 
related micro-organisms such as Corynebacterium (81).  
The second is the chemically unique mycobacterial cell wall that is resistant to destruction or 
penetration. The cell wall of mycobacteria is composed of a mixture of lipids and 
polysaccharides. The lipids in the cell wall inhibit the migration of macrophages, have the 
capacity to disrupt phagosomal membranes of alveolar macrophages and disrupt normal 
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cytokine signalling that is responsible for the ineffective cell-mediated immune respons (82, 
83, 84, 85). 
Pathological properties of NTM might vary greatly between species. This is illustrated by 
three closely related species, M. marinum, M. ulcerans and M. haemophilum: All three cause 
necrotizing skin disease, are taxonomically related (86) and share common reservoirs 
(stagnant or slow-flowing water) (87), but pathogenic differences are noted. M. ulcerans is 
highly pathogenic for humans and causes specific large necrotic ulcers, while M. marinum 
and M. haemophilum are responsible for mostly self-limiting and slowly progressing 
granulomatous lesions (87). M. marinum causes disease- but seldom death- in fish, while M. 
haemophilum infection in fish results readily in death (88). Infections with M. marinum and M. 
ulcerans are almost always restricted to the skin, but M. haemophilum often causes disease 
in deeper tissues. This is in contrast with the in vitro growth charachteristics of the three 
species: M. haemophilum has great difficulties to grow at higher temperatures, M. marinum 
and M. ulcerans grow at normal culture temperatures of 35-37˚C but faster at lower 
temperatures (30-32 ˚C). Deep tissue infections would logically be restricted to species able 
to grow at higher temperatures.  
Iron uptake of mycobacterial species also differs. Because mycobacteria require iron in 
pathogenesis and the iron levels in inflammation processes are elevated, the strong cellular 
immune response of the host is induced by mycobacteria (89, 90). M. haemophilum however, 
is the only species that requires iron-additives added to the culture and this demonstrates 
the differences in iron-management between NTM. 
 
Pathogenic properties of NTM can be transferred between species. An example of a 
potentially hazardous change is the transfer of the toxin produced by M. ulcerans. This 
mycolactone causes the destructing properties of this pathogenic species. Previously, only 
M. ulcerans was known to harbour a virulence plasmid with the gene for mycolactone (91). 
Recently, in strains of M. marinum and M. pseudoshottsii, responsible for death in fish, a 
mycolactone variant has been identified. This gene is suspected to have been spread by 
horizontal transfer (92, 93). 
 
Secundary to the pathogenic properties of the mycobacteria themselves, impaired host 
defences are thought to be responsible for the susceptibility of healthy patients to NTM 
because, due to the environmental presence, humans are continuously exposed to the 
bacteria in low levels (50-500 bacilli per day) (43, 85). Acquired human resistance is cell-
mediated, antibodies do not have a protective role. T lymphocytes lyse infected 
macrophages directly or activate them via soluble mediators to destroy intracellular bacteria. 
Mutations in the genes responsible for this mechanism create resistance disorders. 
Mutations in the interferon-gamma receptor ligand-binding chain (IFN gamma R1), 
interferon-gamma receptor signalling chain (IFN gamma R2), Signal Transducer and 
Activator of Transcription-1 (STAT-1), interleukin-12 p40 subunit (IL-12 p40), and interleukin-
12 receptor beta 1 chain (IL-12R beta 1) genes have all been identified as predisposing 
factors for NTM infections (94, 85). Dominant or recessive alleles causing complete or partial 
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cellular defects have been found to define nine different inheritable disorders for the 
susceptibility of patients for opportunistic pathogens (95, 96, 97). 
 
 
Treatment of NTM. 
 
Guidelines for diagnosis and treatment have been produced for NTM by the British Thoracic 
Society (BTS) and the American Thoracic Society (ATS) (13, 98). Diagnosis is addressed in 
chapter 2 of this thesis. Criteria for the treatment of NTM infection is based on the species 
involved, the immune characteristics of the patient and the clinical manifestation of the 
infection. 
Two basic rules apply to mycobacterial disease: 1) For all mycobacterial infections long 
therapy is necessary (2-24 months), which is a direct consequence of the slow-growing 
properties of the genus. 2) Mycobacteria rapidly obtain resistance to the most common 
antibiotics and therefore dual or multiple combinations of antibiotic groups are common 
regimens (99, 100). 
Side effects to antituberculous drugs and NTM regimens are common due to the toxicity of 
the agents and include hepatitis, cutaneous reactions, gastrointestinal intolerance, 
haematological reactions and renal failure (101, 102). This results in modification or 
discontinuing of the therapy (103). The only alternative for antibiotic regimens is surgical 
excision in some cases. Treatment with steroids is not a safe alternative therapy (104). 
Mycobacteria are intrinsically resistant to most common antibiotics and while M. tuberculosis 
is resistant to macrolides, NTM are often resistant to first-line antituberculous drugs which 
emphasises the importance of species identification in mycobacterial disease (99). 
NTM infection with slow growing species in immunocompetent patients is often treated by a 
three-component or dual therapy of oral clarithromycin, rifabutin, ciprofloxacin, rifampicin 
and ethambutol (105). The normal duration of the therapy  is 4-24 months depending on the 
clinical manifestation (e.g. 4-6 months in lymphadenitis, 24 months in bone-infections) (13, 
98). In children with lymphadenitis in the Netherlands, surgical excision of the affected lymph 
nodes was the treatment with the highest cure rate. A combination of clarithromycin and 
rifabutin appeared less effective in these patients (106). In other countries, the same 
treatment for lymphadenitis is recommended (107, 108). For cutaneous or localised lung 
disease, surgical treatment is preferred in many cases as well, taking scarring and other 
complications into account. However, for M. marinum infection medical therapy is the 
treatment of choice (25). 
Treatment in immunocompromised patients is often given for a longer duration than in 
immunocompetent patients: most treatments are administered for many years. Also, 
sometimes profylaxis is given in AIDS patients: lifelong azithromycin, clarithromycin or 
azithromycin + rifabutin (13). Drawbacks of antimycobacterial therapy in AIDS patients are 
the interactions with antiretroviral therapy, which need to be closely monitored (13, 98).  
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2  Diagnosis of NTM disease. 
 
 
Diagnosing mycobacterial infections quite often is a challenge, in which several medical 
disciplines are involved. Clinical suspicion will often be the starting point of subsequent 
specific diagnostic procedures including careful pathological, immunological and 
microbiological testing, based on appropriate specimens en techniques. The path leading to 
a definitive diagnosis used to be long and complicated and therefore new approaches are 





Mycobacterial disease is often aspecific in clinical appearance and the disease usually 
progresses slowly. Clinical diagnosis starts with the exclusion of other possible diseases. In 
cutaneous infection, these include viral involvement, fungal involvement, auto-immune 
disease, tumors or other bacterial pathogens. Clinical appearance differs from subcutaneous 
nodules (in immunosuppressed patients lesions tend to be less superficial) to superficial 
plaques. Sporotrichoid lesions are usually caused by M. marinum but other species have 
been reported (1). In lymphadenitis, the differential diagnosis is often extensive: It includes 
acute pyogenic infections, tuberculosis, fungal infections, toxoplasmosis, cat-scratch 
disease, infectious mononucleosis, brucellosis, tularemia, foreign body reaction, sarcoidosis, 
and malignancy. In addition, congenital lesions such as cystic hygroma, thyroglossal cyst, 
dermoid cyst and branchial cyst should be considered (2). Up to 12 years of age, a positive 
reaction to skin-tests, few to no complaints, unilateral presence of the involved lymph nodes 
and several weeks/months duration of swelling are all clinical clues to NTM lymphadenitis. 
In pulmonary disease, symptoms other than coughing (60-100%) are often mild or 
completely absent (3). Differential diagnosis often includes fungal infection and tuberculosis, 
especially in the classical form of NTM infection which mimics M. tuberculosis infection. 
Infections that present in the classical form are often secondary to underlying lung disease 
(COPD, prior TB infection, or interstitial lung disease). Caucasian males predominate in the 
sixth or seventh decade of life. Other risk factors include smoking, alcoholism, 
cardiovascular disease, chronic liver disease, previous mycobacterial disease and previous 
gastrectomy (4). In a radiograph, the classical form of NTM (mimics M. tuberculosis infection) 
is characterized by nodular opacities in the apices, cavitation, apical pleural thickening, and 
bronchogenic spread. Pleural effusion and adenopathy are uncommon (5). Bronchiectasis is 
the primary finding in the middle lobe on high resolution computed tomography. The second 
form (atypical) is characterized by a single pulmonary nodule or multiple bilateral nodular 
and irregular interstitial opacities (<1 cm) (6). It is not necessarily related to any underlying 







For over a century, purified protein derivatives (PPD) of M. avium, M. kansasii, M. 
scrofulaceum and M. marinum, M intracellulare, M gordonae and M fortuitum have been 
used for diagnosing NTM infections in humans (7- 9). The most commonly known PPD test is 
the tuberculin test for the diagnosis of M. tuberculosis infection. A few years ago, the PPD of 
NTM were no longer commercially available. No substitution for this antigenic skin-test 
exists. The PPD tuberculin test itself, however, does appear useful in the diagnosis of NTM 
infection in children. Because of the cross-reactivity between immune reactions to different 
species, the tuberculin test often shows false-positive reactions due to previous encounters 
with NTM (10). Therefore, the diameter of the skin-reactions is considered for a definite 
diagnosis of M. tuberculosis. Previous NTM encounters are not expected in young children 
and can therefore be indicative for NTM disease in this patient group (10). The tuberculin 
tests can be applied in initial diagnosis of NTM lymphadenitis with an optimal cut-off value of 
5 mm for a positive skin-induration. However, the sensitivity of M. avium specific PPD was 
93% compared to 70% for the M. tuberculosis specific PPD and, therefore, species-specific 
sensitins would be preferable (10). 
 
The QuantiFERON-TB test, which is significantly more specific in M. tuberculosis infection 
than the tuberculin PPD (11), is built on a principle applicable to all mycobacterial species.  
This assay is based on a specific elevation in the interferon-gamma concentration that 
occurs as T cells respond to early-secreted antigenic target 6-kDa protein (ESAT-6) and 
culture filtrate protein 10 (CFP-10) and is, therefore, directed at a more recent contact 
phenomenon than tuberculin-PPD, which detects a memory respons (12). It would also be 
able to overcome the problems of a prior NTM encounter in adults. ESAT-6 and CFP-10 are 
specifically expressed by M. tuberculosis but not by most other species, including M. bovis 
BCG (cross-reactivity is for instance known for M. kansasii: 13). The specificity of this test 
has been evaluated for M. tuberculosis compared to NTM disease in children, and showed a 
95% specificity for M. tuberculosis (14). ESAT-6 and CFP-10 are also the two proteins to 
which an enzyme-linked immunospot assay (ELISPOT) is directed (15). 
 
Detection of IgG and IgM directed against mycobacterial A60 is another principle with the 
same advantages -and therefore great possibilities- in NTM diagnostics (16, 17). So far, the 
principle has shown promising results in diagnosing M. leprae, M. abscessus and M. 
tuberculosis (16, 17). Various other antigens of considerable serologic value for M. 
tuberculosis, are antigen 85A, 38-kDa protein, alpha-crystallin (16 kDa), MTB48, and PGL-
Tb1 (18). Some of these antigens are secreted or are present in the cell wall of the bacillus. 
A starting point in the identification of suitable antigens for NTM serology would be protein 
profiling (19). An especially interesting protein group for the antigen tests would be the cord 
factors (Trehalose dimycolate). The cord factors are glycolipids which are associated with 
hydrophobicity and virulence. Because of the variation in the cord factors of different NTM 
species and their direct involvement in antibody respons, they could be suitable antigens in 
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NTM serology (20). It should be noted that, in patients suffering from AIDS, in whom the 
number of T cells is low, determining the humoral response can be an invaluable tool (18). 
 
A point of discussion is whether these immunological tests (serological or interferon assays) 
are cost-effective. After all, the NTM-PPD skin-tests were no longer produced because they 
were unprofitable. However, as stated that molecular assays encounter considerable 
problems for the diagnosis of NTM infections, these immunological approaches might be 





The gross pathology of NTM-infected material frequently show necrotizing granulomas, 
caseating necrosis and masses containing purulent material (21). The pathologist 
investigates the biopsies further using thin (4-10 µm) sections from the material imbedded in 
paraffin and fixated with formalin. Microscopic investigation includes direct light microscopy 
and staining procedures. 
Acid-fast staining is applied on imbedded sections with Kinyoun, auramine or Ziehl-Neelsen 
stains (see further in text). Auramine is considered the most sensitive, but this is correlated 
to the easy microscopic recognition and not related to the staining procedure. It is also much 
faster than other staining methods due to the use of a lower microscopic magnification while 
a high visual contrast is present because of the fluorescent colouring of the mycobacteria. 
The drawback of auramine staining is that the rapid-growing species occasionally stain 
poorly and some other bacteria belonging to the family Mycobacteriaceae (Corynebacterium 
and Nocardia) can be positive in auramine staining as well. The overall sensitivity of staining 
of histopathological sections is poor: cutting of the sections includes partial destruction of 
many cells which causes the loss of bacteria and the staining procedure is more difficult to 
apply on tissue specimens than on “free” bacteria (22). Pathology caused by mycobacteria is 
often abundant while bacteria are present in low copies. However, the histological 
manifestation is highly variable. Therefore, the histopathological diagnosis of NTM infection 
is as difficult as the clinical diagnosis.  
 
Microscopic examination without staining shows necrotizing granulomas of various forms 
with or without caseating properties in NTM-affected tissue. Only few exceptions exist: the 
granulomatous reactions were only found in a minority of NTM infected patients with Cystic 
fibrosis, and histological manifestations of infection with specific species sometimes exhibit 
no granulomatous reaction at all (23, 24). The granulomas include suppurative granulomas, 
tuberculoid granulomas, mixed-cell granulomas, sarcoid-like granulomas, ill-defined 
granulomas and granulomas with a perifollicular distribution (25, 26). Differences between M. 
tuberculosis and NTM infection are significant for a few histological features. 
Microabscesses, ill-defined granulomas and noncaseating granulomas are more frequently 
found in M. tuberculosis infection, while mixed-cell granulomas, caseation and multinuclear 
25
  
giant cells are more common in NTM infection (27). Also, a relationship between the chronic 
evolution of the disease and granuloma formation has been demonstrated (26). 
In pulmonary NTM infections the usual manifestations obtained after lobectomy or 
transbronchial biopsy are bronchiolar inflammation, infiltration of lymphocytes, epithelioid 
granulomas and giant cells. The wall of cavitary lesions consists of epithelioid cells with 
multinucleated giant cells, granulomas and caseation and necrosis (28). In the hot-tub lung, 
moderate to severe granulomatous inflammation is encountered, as well as numerous 
granulomas with focal caseation and necrosis, interstitial chronic inflammation, and mild and 
interstitial immature fibrosis with focal pattern (29). 
In biopsies from lymph nodes, a fairly stable histopathological picture is seen, with 
increasing presence of caseation as the infection proceeds. Histologically, the majority of 
cases show eosinophilic necrosis with nuclear debris and Langhans type giant cells. 
Different forms of lymphocyte infiltrates and granulomas are possible (30). The most variable 
histological manifestations are observed in NTM skin infections. Mixed-cell and suppurative 
granulomas are the most common in NTM skin infections (31). Other histological features 
are: a diffuse infiltrate of histiocytes with occasionally foamy appearance, acute and chronic 
panniculitis, acute suppurative folliculitis, diffuse infiltrate of histiocytic foamy cells, non-
specific chronic inflammation, cutaneous abscesses and necrotizing folliculitis (26). 
According to Tang et al, when biopsy specimens show aspecific histological features (fibrotic 
or hyalinized granulomas, nonspecific chronic inflammation, nonspecific reactive or 
reparative changes, no significant histologic abnormality or malignancy), additional 
microbiological culture will not be successful. Only necrotizing granulomas, nonnecrotizing 
granulomas, poorly-formed granulomas or acute inflammation will contain culturable 
mycobacteria (32). 
Sometimes, the skin abnormalities have different causes at the same time: fungal, 
mycobacterial, and viral pathogens have concurrently been observed in skin lesions of basal 
cell carcinomas, Kaposi's sarcoma, melanoma, mycosis fungoides, and squamous cell 
carcinoma (33). Together with the poor sensitivity of staining procedures and the variable 
histopathological manifestation of NTM infection, this greatly affects the value of pathological 






Conventional microbiological diagnosis. 
 
Conventionally, the detection of NTM is performed by acid-fast staining and culture. The 
acid-fast staining is usually an auramine stain and/or a Ziehl Neelsen stain and is indicative 
for the presence of mycobacteria. Culture, with or without decontaminating pre-treatment, is 
followed by the identification of the species. 
 
Acid-fast staining. 
Staining procedures for mycobacteria are based on the acid-fast properties of the 
mycobacterial cell-wall, which is a bacterial cell wall composed of a thin, inner layer of 
peptidoglycan and large amount of glycolipids such as mycolic acid, arabinogalactan-lipid 
complex, and lipoarabinomannan. During the acid-fast staining procedure, the acid-fast cell 
wall enables the bacterium to resist decolorization with acid alcohol and retain the original 
stain. Mycobacteria are 1-10 µm in length and 0.2-0.6 µm in diameter and visible in different 
colors depending on the dye (22). In the modified Kinyoun and the Ziehl-Neelsen (ZN) stain 
this dye is carbol fuchsin and is directly visible with light microscopy. The Auramine stain 
uses auramine and rhodamine which both fluoresce at short wavelength as green or orange. 
The different staining methods can be performed either on direct material or on 
decontaminated material, which can therefore be more concentrated. Sensitivity rates of the 
ZN and auramine stain are higher than those of the Kinyoun stain (34, 35) and are estimated 
between 60 and 90% compared to culture (34, 36). Low sensitivity of fluorescence 
microscopy and ZN staining is also negatively influenced by formalin fixation as applied in 
histopathological examinations (37). The acid-fast staining procedures are not fully specific 
for mycobacteria, since Nocardia species, some Legionella species and some 
corynebacteria are also (partially) stained acid fast (38). The positive predictive value is 96% 
for M. tuberculosis (36). However, no speciation is possible and it is considered a pre-
screening of clinical materials. 
 
Decontamination. 
Before culture, most clinical specimens are decontaminated because of the possible 
contaminating commensals present in the non-sterile clinical materials. Several methods are 
known for this purpose: The Petroff method, N-acetyl-L-cysteine-sodium hydroxide, NaOH-
N-acetyl-L-cysteine, Sulphuric acid, Zephiran, Papain-Zephiran, Papain-Pentane-Zephiran, 
sulphuric acid, chlorhexidine and oxalic acid and the newer method: hypertonic saline with 
sodium hydroxide (HS-SH) (39-41). While the NaOH-N-acetyl-L-cysteine method is currently 
recommended for the recovery of NTM, other methods appear to be more efficient like the 
sulphuric acid, oxalic acid and the chlorhexidine methods (41- 43). They yield a higher 
recovery rate and less contamination and should be considered as the method of choice. A 
secondary effect of decontaminating pre-treatment is the property to dissolve clinical 
materials which clears bacilli from intracellular containment. Therefore, decontamination of 
specimens is also useful in sterile specimens and should be applied to all clinical specimens 




Culturing of mycobacteria is most frequently applied with a radiometric system measuring 
the assimilation of mycobacteria in Broth medium. Previously, mycobacteria were mainly 
cultured on solid medium slants (less susceptible to drying during long growth periods). Agar 
with egg yolk was, and still is, a popular culturing medium. Various commercially available 
media are possible, of which the Middlebrook media are the most widely used. Guidelines 
for the culturing of NTM include that samples should be inoculated onto at least one solid 
medium (Lowenstein-Jensen or Middlebrook variant) and into a liquid medium culture 
system (BACTEC (Beckton-Dickenson Diagnostics), MB Redox (Heipha Diagnostika), 
MB/BacT (Organon-Teknika), MGIT (BD Diagnostics) and Septi-check (BD Diagnostics)) (44, 
45). Normal growth temperature for mycobacteria is 35-37 ˚C. Most media require additives 
like Mycobactin and OADC to increase the growth rate (containing oleic acid, albumin, 
dextrose, catalase and NaCl). Antibiotics are often added to inhibit the growth of 
contaminants: Panta, containing polymyxin, amphotericin B, nalidixic acid, trimethoprim and 
azlocillin, and/or PACT, containing polymyxin B, amphotericin B, carbenicillin, and 
trimethoprim (46, 47). Additives can also inhibit growth of several species, like M. kansasii 
and M. haemophilum (47, 48). Media and additives have been extensively evaluated for M. 
tuberculosis but other (less evaluated) species might require different media for optimal 
growth. A good example is M. haemophilum. Liquid media are preferred for this species and 
it requires iron supplements such as hemin or ferric ammonium citrate for growth as well as 
a lower incubation temperature of 30-32˚C (49). This lower temperature is also preferred by 
M. marinum and M. genavense. Recommendations of the American Thoracic Society (ATS) 
include culture in liquid medium as well as on solid medium. Lowenstein-Jensen is an 
excellent medium for the recovery of M. tuberculosis, but is generally inferior to Middlebrook 
agar as an all-purpose medium for both M. tuberculosis and NTM. Incubation periods for 
liquid media stay within 6 weeks, but cultures on lower temperatures and on solid media 
might require incubations up to 10 weeks (3). It is recommended by the ATS that skin 
samples should be incubated at normal and low temperatures. This should be applied to 
lymphadenitis and soft-tissue specimens as well! 
 
Species identification. 
Species cannot be differentiated by colony morphology and further analysis subsequent to 
culture is necessary. The conventional identification of species consisted of biochemical 
tests, colony characteristics and growth temperature. Biochemical species differentiation 
includes niacin secretion, reduction of nitrate, reduction of tellurite, Tween 80 hydrolysis, 
growth on MacConkey agar without crystal violet, urease activity, caratogenesis, catalase 
activity at 68˚C, semi-quantitative catalase activity, growth activity with arylsulfatase, acid 
fosfatase, pyrazinamidase and ß-glucocidase. 
The addition of specific growth inhibitors as nitrobenzoic acid (PNB), and nitro-alpha-acetyl-
amino-beta-hydroxypropiophenone (NAP), inhibit only species belonging to the M. 




Molecular identification of NTM species. 
 
DNA-DNA hybridization as a tool for the identification of mycobacterial species was first 
described in 1978 by Baess et al (50). DNA of reference strains is denaturated and sheared 
to radiolabeled single strand fragments of approximately 500 bp (probe-DNA). Reannealing 
is allowed in the presence of genomic DNA of the test strain. All single stranded DNA left 
after hybridization is cut into mononucleotides by S1 nuclease. The proportion of 
hybridization is detected by the level of radioactivity which represents the double stranded 
DNA (51). Variations on this method are based on the same hybridization technique but 
measurements are performed by fluorescence instead of radioactivity or heat stability 
measurements of the hybrids (52). Nowadays, DNA-DNA hybridization is considered very 
laborious and many easier techniques have become available for the identification of NTM. 
High performance liquid chromatography (HPLC), completely different from all other 
methods, is a biochemical method and identifies mycobacteria by analysis of mycolic acids. 
A suspension of acid-fast bacteria is saponified to cleave the mycolic acids bound to the cell 
wall. Mycolic acids are then converted to esters and separated from all other cell compounds 
using a microprocessor-controlled pump and are subsequently detected with a UV 
spectrophotometer. Reproducible chromatographic patterns containing combinations of 
different diagnostic peaks are formed. Pattern recognition is performed by visual comparison 
of sample results with mycolic acid patterns from reference species of known mycobacteria 
(53- 55). This method, as well as DNA-DNA hybridization, is still applied in the identification 
and the proposal of a new species. HPLC is even still gaining ground in mycobacteriology 
and new applications for M. tuberculosis have recently been described (56). Quantitation of 
total mycolid acids peaks appear to correlate to susceptibility for ethambutol, isoniazid, 
pyrazinamide and rifampin (56). 
Essentially, all other techniques are based on Mycobacterium-specific amplification with 
subsequent detection and identification of the species-specific amplicons. This analysis can 
be performed by direct sequencing of amplified fragments, digestion of amplicons with 
restriction enzymes (PRA) or probe hybridisation methods: micro-array technology (57, 58), 
blotting (i.e. the commercial hybridization assays) or real-time PCR (59-61). 
PCR-based sequencing has become the gold standard for the identification of mycobacterial 
species. The method consists of PCR amplification of mycobacterial DNA with genus-
specific primers and sequencing of the amplicons. The organism is identified by comparison 
of the nucleotide sequence with publicly available reference sequences. An additional 
advantage of this method is the recognition of potentially new species. The target most 
commonly used is the last 500 basepairs of the gene coding for the 16S ribosomal RNA, 
present in all bacterial species and containing both conserved and variable regions. It is thus 
a valuable target for taxonomic purposes (59). The sequence of the 16S regions of many 
species is known at this time. Several other target genes have been found suitable for the 
differentiation of mycobacterial species: the genes coding for the 32 kDa protein, the 65 kDa 
heat shock protein, the  rpoB (RNA polymerase beta-subunit), secA1 (essential protein), 
dnaJ (heat shock induced protein), sodA (superoxide dismutase), recA (recombination 
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protein), gyrA, gyrB (DNA gyrase) and the 16S–23S ribosomal RNA internal transcribed 
spacer (ITS) contain sufficient sequence diversity to distinguish most species (53, chapter 3). 
For the dnaJ, sodA, secA1, recA, gyrA and gyrB targets, however, few sequences are 
publicly available. The panel of possible targets for the differentiation of mycobacterial 
species is still expanding; the elongation factor Tu encoding gene (tuf) and transfer mRNA 
(ssrA) gene region have recently been described for the same purpose (62). Both targets 
have been evaluated with 127 reference strains and the tuf gene yielded comparable levels 
of differentiation with the hsp65 gene while the ssrA gene yields comparable discriminatory 
power to that of the 16S gene. For both targets, it must be noted that only the sequences 
obtained in this study are available for comparison. 
For a single pan-mycobacterial PCR, conserved regions flanking the variable target 
sequence are necessary. For a real-time PCR, the amplified fragment should not exceed 
200 bp. In the rpoB and hsp65 genes, conserved regions are hard to find for at least short 
fragments. The 16S does not provide differential sequences within species groups. This 
leaves -as yet- the ITS as the target with the most potential for a genus-specific (real-time 
PCR) assay. 
 
The ITS region has also been applied in an assay described by Xiong and colleagues (63). 
These authors describe a genus specific PCR followed by a reverse line blot (as applied in a 
commercial assay i.e. InnoLipa, which is further described in this text). The target of choice 
is able to differentiate 34 species, commonly encountered in de microbiological laboratory. 
The method is based on the hybridization of a biotin-labelled PCR-product to a membrane 
with species-specific probes. Binding of the product is visualised by chemiluminescence. A 
variation on this principle is the assay recently described by Wu and colleagues (64). This 
assay uses dot blots for the identification of 22 species and targets the 16S gene. Positive 
dots are visualised using colorimetric hybridization. 
The microarray technique uses species-specific probes attached to a glass slide on which 
the PCR product can hybridize (59, 64, 65). Different sequence targets can be used for this 
application. Tobler et al, described a real-time PCR assay for the identification of the genus 
mycobacterium and targeted the hsp65 gene. Two primer-pairs were used for the 
amplification of sequences from the 37 species (and subspecies) tested. NTM species 
identification was performed separately with an extra amplification on the hsp65 gene and 
subsequent analysis with microarray technology (58). The hybridised PCR product is 
visualised by a computer via fluorophore measurements. The main advantage of the method 
is the possibility to use extensive probe panels, which may also include probes for different 
targets like resistant markers (57), and are readily equipped with extra probes. 
PCR following restriction pattern analysis (PRA) has been described several times for the 
differentiation of mycobacteria. As a PRA assay, ribotyping was described by Tsitko. The 
method (PCR of a single unknown ribosomal segment and subsequent cutting with 
restriction enzymes) could differentiate 32 species, all with individual restriction patterns with 
the enzymes pfuII and ecoRI (66). Roth and colleagues, described an PRA assay targeting 
the ITS region (67). This assay has been extended recently with a database of restriction 
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patterns for the automated analysis of 31 species with 10 different restriction enzymes (68). 
Most assays have chosen the hsp65 gene as a target with a combination of two different 
restriction enzymes (69-75). The PRA technique enables identification with limited and 
inexpensive laboratory equipment. However, while the assays are all evaluated with an 
extended panel of species, all new or un-evaluated species create undetermined patterns. 
A recently described assay from Lim and colleagues used a fluorescent probe real-time PCR 
approach: a real-time PCR with 21 probe combinations located in the rpoB gene which were 
able to differentiate 18 species and species-complexes from cultured strains (76). 
 
Based on a reverse line probe hybridisation principle, one of the four commercially available 
tests for the identification of clinically relevant NTM has been developed within the Genotype 
series (Hain). The test allows identification of 15 species in the main test and an additional 
17 in the AS (additional species) test based on 23S sequence differences (77). The second 
commercial test for the identification of mycobacterial species is the InnoLipa V2 
(Innogenetics), also a reverse line probe hybridisation assay based on the ITS region. This 
test identifies 16 species (78). The third test consists of separate ribosomal DNA probes 
(AccuProbe, Gen-Probe inc) specific to the species M. avium, M. intracellulare, M. kansasii 
and M. gordonae (79). Comparison of the InnoLipa test with the Accuprobe test shows the 
InnoLipa assay to be better internally controlled and more accurate in species identification 
than the Accuprobe assay, since Accuprobe misidentified 4 M. tuberculosis and M. avium 
strains (79). The last commercially available test contains a 16S sequencing kit (MicroSeq 
500 system, Applied Biosystems) which includes pan-bacterial primers for the amplification 
and sequencing reactions and software with sequence database for the recognition of 
obtained sequences (80). All four commercial assays are only applicable on cultured 
isolates, which is also the case for most in-house assays. 
Moreover, almost all of the methodologies described above lack the ability to identify new or 
unevaluated species. Direct sequencing and HPLC (to a lesser extent) are the only methods 





Molecular detection of NTM in clinical specimens. 
 
The main advantage of molecular detection of mycobacteria directly from clinical materials is 
that the time otherwise required for culture is greatly reduced. Rapid differentiation between 
M. tuberculosis and NTM decrease the time that patients spend in isolation and many of the 
antibiotic regimens for M. tuberculosis differ from those suitable for NTM (73). In several 
publications, the simultaneous amplification of M. tuberculosis-specific and pan-
mycobacterial fragments has been applied directly to clinical specimens (81-84). These 
methods all used the presence of multiple bands as a confirmation of M. tuberculosis, while 
a single band represented NTM. The hsp65 gene was the target used in all assays for the 
pan-mycobacterial amplification. However, the visualisation of pan-mycobacterial amplicons 
in clinical materials was performed by agarose gel electroforese, which has a poor specificity 
and sensitivity. PRA technique includes the differentiation of the amplified PCR product. 
Three published PRA assays, all targeting the hsp65 gene, have been evaluated on paraffin-
embedded materials and thus offer greater potential in various clinical specimens (74, 84, 
85). Staining methods have poor sensitivity in paraffin embedded materials and these assays 
yield either similar or higher sensitivities for the detection of mycobacteria compared to acid 
fast staining. 
 
In total, however, only a few molecular detection methods allow detection from clinical 
materials. A high sensitivity is necessary and often not reached. This is emphasised by the 
commercially available assays which are almost always exclusively for the identification of 
NTM from cultured isolates. (Almost) no commercial assays other than for the detection of 
M. tuberculosis are sensitive enough for application on clinical materials, while for these 
assays the performances are often poor as well. The overall sensitivity of the DR. MTBC 
Screen assay (DR. Chip Corporation) is 56.6% and the BD ProbeTec ET Mycobacterium 
tuberculosis Complex Direct Detection (DTB) assay (Becton Dickinson) has a sensitivity of 
57-63%. Both assays produced considerable amounts of false-positive results: 13 of 494 
patients in the DTB assay and 11 of 494 patients in the DR. MTBC assay (86, 87). The 
Mycobacterium tuberculosis Amplified Direct Test (AMTDII) (Gen-probe) yields sensitivity 
rates of 74-92% but has problems with inhibition due to the lack of internal control (88-90). 
The LCx Mycobacterium tuberculosis assay (Abbott) yields sensitivity rates of 54-88% (89, 
91). The COBAS AMPLICOR Mycobacterium tuberculosis Assay (Roche) reaches published 
sensitivities of 59-94% (90, 91). The overall sensitivity of the RAPID BAP-MTB assay 
(AsiaGen) was 57-66% and produced significant amounts of false-positive results (86). 
Recently, a test has been developed for the detection of M. tuberculosis and four clinically 
relevant NTM (M. avium, M. intracellulare, M. kansasii and M. malmoense) directly in clinical 
specimens. The GenoType Mycobacteria Direct (GTMD) (Hain) yielded 77% negative 
predictive value and a sensitivity of 90% in the only evaluation published so far (92). This is 




For the direct detection of pathogens in clinical materials, real-time PCR has claimed a 
prominent position. It yields a higher sensitivity and specificity than other detection methods, 
mainly because of the addition of specific probes to the primers. The technique allows rapid 
detection and in most assays is a closed single tube test which decreases the risk of 
contaminating DNA.  
Several detection systems are available for this purpose, of which the ABI Taqman (Applied 
Biosystems) and the Light-Cycler (Roche Diagnostics) are the most commonly used in the 
Netherlands. The ICycler IQ4 system (Bio-rad) was one of the first systems to enable 
multiplex detection by employing halogen light absorption and multiple filters for 
simultaneous detection of different fluorescent labels.  
 
For the direct detection of M. avium-complex or M. paratuberculosis many real-time PCR 
assays have been developed in veterinary medicine, but these are restricted to the detection 
of M. avium only (93-98). Another real-time PCR assay for application on FF/PE materials 
has been recently published by Beqai and colleagues (99). The assay, however, only detects 
M. tuberculosis and M. avium complex. More useful in clinical application are PCR assays 
that enable NTM detection as a group. 
In table 3, four published methods, designed for the real-time detection of the genus 
Mycobacterium, have been summarised. For pan-mycobacterial detection without culture, 
only a few assays have previously been described (100-103). Of these few, only two (102, 
103) have been evaluated on clinical materials, the assays of Khan and Kawai were 
developed for fluidic samples, but might be applicable on clinical materials. 
The assay described by Khan and colleagues has been evaluated for metal-working fluids 
(100). This assay targets the hsp65 gene. However, while the assay was designed to be 
“genus-specific”, no panel of species was tested. Moreover, the detection was performed 
using sybr-green, which essentially means a normal PCR without the extra specificity of 
additional probes. Theoretically, the amplicons could be analysed by melting-curve analysis, 
but this requires an extensive analysis of a species panel.  
The assay developed by Kawai and colleagues, a real-time PCR targeting the 16S gene, 
was only evaluated on water samples for the quantitative detection of bacterial water flora. 
The assay successfully detected mycobacterial DNA in three samples and enabled 
quantification (101). 
Shrestha and colleagues described a real-time PCR assay for the detection of mycobacteria 
with the light-cycler system (Roche) (102). The assay uses melting point analysis to identify 
NTM species by means of mismatches in the M. tuberculosis specific probe. Only the 
species M. gordonae was not detected because of too many mismatches and the species M. 
kansasii and M. marinum were not differentiated from one another due to overlapping 
melting points. The assay proved to have the same sensitivity as the Cobas amplicor for M. 
tuberculosis and yielded 96% of positive clinical samples positive for M. tuberculosis. Only 
three clinical samples were positive for NTM which were all detected. 
Garcia and colleagues described an assay with simultaneous detection of M. tuberculosis 
and the genus (103). Using three primers for a heminested PCR, amplicons of 475 basepairs 
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of the 16S gene were formed. This assay was validated on 167 clinical materials, 127 of 
which were culture positive and 40 were control samples. 12 samples yielded NTM in 
culture, 8 (66%) of which were detected by real-time PCR. The sensitivity of this assay was 
probably slightly compromised by the length of the amplicon and no NTM identification was 
performed. 
 
While a pubmed search for the combined terms “real-time PCR” and “mycobacteria”,  yields 
210 publications (until November 2007), only four real-time PCR assays are genus-specific 
and allow detection in direct materials as summarised in table 3 (our own assay described in 
chapters 3, 4 and 5 is not included). The most extensive clinical validation included 12 NTM 
positive samples, 8 of which were detected by real-time PCR (103). 
This emphasises the need for the development of a sensitive real-time PCR as described 









































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Due to the variable susceptibility patterns between and within species the susceptibility 
testing is an important part of mycobacterial diagnostics. 
The conventional methods of susceptibility testing in mycobacteria consist of culture in the 
presence of a panel of antimycobacterial agents. Resistance is measured in the Minimal 
inhibitory concentration (MIC). Three methods are used for this purpose: the E-test, the broth 
or agar microdillution and the disc diffusion methods. 
The agar and broth microdillution method are based on a two-fold dilution series of agents on 
solid medium or liquid medium and the MIC is recorded as the lowest concentration of a drug 
that inhibited “reasonable” growth (either 10% or 50% growth efficiency) (104). The E-test is a 
method for MIC determinations for antimicrobial agents that is based on a predefined 
antibiotic gradient on a plastic strip calibrated with a continuous logarithmic MIC scale 
covering 15 two-fold dilutions (105). Growth occurs only around parts of the strip with 
concentrations lower than the resistance of the isolate. The disk diffusion method is based on 
an agar plate with a tablet containing an agent which releases this into the agar. The 
concentration of the antibiotic then exists in a decreasing gradient from the tablet. The 
method allows bacterial growth in a radius around the tablet of a concentration within the 
resistance range of the isolate (106). For all methods, specific growth rates for mycobacteria 
apply. In rapid-growing species the result is read after 3 days depending on the inoculums 
used. Slow-growing species need several weeks for trustworthy readings. To help 
standardize the methods used in the clinical microbiology laboratory for testing the 
susceptibility of mycobacteria, the Clinical and Laboratory Standards Institute (CLSI, formerly 
NCCLS) published an updated NCCLS document M24-A: the tentative standard for 
antimycobacterial susceptibility testing of Mycobacterium tuberculosis and NTM (107, 108). 
The major drawbacks are similar for all these conventional methods: 1) due to the slow 
growth of mycobacteria, a high risk of contamination of the plates with other micro-organisms 
exists; 2) readings are subjective to the observing, but hardly standardised, eye of the 
technician; 3) for difficult-to-grow or non-culturable mycobacteria, these methods are not 
applicable or need alternative media/methods; and 4) the accordance of treatment failure 
with MIC values is unsure. For these reasons, mycobacterial diagnostics will benefit from 
new methods. However, genetic background of resistance appears to be complicated. For 
several different antimycobacterial agents, more than one responsible genetic markers have 
been identified. 
 
Molecular approaches for susceptibility testing. 
Due to the emerging of multidrug- and extremedrug-resistant M. tuberculosis strains, there is 
a growing need for molecular identification of drug resistance in M. tuberculosis isolates. 
Resistance in mycobacteria is linked to the same genetic mechanisms in different species 
(Table 5). Therefore, research into M. tuberculosis give clues to the resistance mechanisms 
existing in NTM for at least pyraminazine, isoniazin, rifamycins, macrolides, quinolones and 
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streptamycin (109-112). For rifamycin resistance (rifampin, rifabutin, rifapentine, and KRM-
1648), 23 mutations have been identified in the rpoB gene of M. tuberculosis of which the 4 
most common ones coding for approximately 96% of the resistance M. tuberculosis cases 
are located in the 81 bp long rifamycin hotspot: the "rifampin resistance-determining region" 
(113). Cross-reactivity for resistance to different rifamycins is recorded in subsets of the 
known mutations (114). Mutations in codons 513, 526, and 531 of the rpoB gene, have been 
identified in rifampin resistant strains of M. kansasii (115). Several molecular tests have been 
developed for the detection of rifamycin resistance in M. tuberculosis, either in cultured or 
clinical materials (111, 116-120). Two of these are commercially available: the InnoLipa Rif TB 
and the MTBDR (111). The usefulness of these tests for NTM is variable. The biggest 
drawback of the use of the assays developed for M. tuberculosis is the high sequence 
variability within the rpoB gene. Development of primers specific for all NTM in one assay will 
be very difficult. In a micro-array assay, developed by Vernet and colleagues, the mutations 
–accounting for rifamycin resistance- in the rpoB gene are probed in the same slide with 
panmycobacterial 16S sequences. However, while suitable for the mutations identified for 
both rifampin and rifabutin resistance and possibly applicable to NTM, the authors were only 
interested in identifying and characterising M. tuberculosis (57). 
Genetic alterations in the inhA and katG genes account for 70-85% of the Isoniazid (INH) 
resistant M. tuberculosis strains (111, 121). Loss of the catalase-peroxidase KatG activity has 
been shown to be the major resistance mechanism for intrinsic INH resistant M. avium 
strains as well (122). Several assays have been developed for the detection of INH 
resistance in M. tuberculosis (109, 111, 116, 119, 121) and might be useful in NTM that are not 
intrinsically resistant to INH. However, so far, no sequence information has been obtained for 
aquired INH resistance in NTM. 
Ethambutol (EMB) is widely used in the treatment of NTM infections. Mutations in the embB 
gene have been associated to EMB resistance in NTM. In the “EMB resistance determining 
region”, several mutations appear to be responsible for resistance in NTM, but seem variable 
in different species as research of Alcaide and colleagues show (123). Gene transfer of 
different alleles to M. smegmatis results in other MIC values than in the original species 
(Table 4). Therefore, more research has to be performed to elucidate the EMB resistance 
mechanisms in NTM.  
Fluoroquinolone resistance is related to mutations in de gyrase A and B genes (124). While 
different resistant mutations occur in different species, species-specific sequences seem 
conserved (125). These regions might therefore be useful in a molecular assay where a 
species can be identified with simultaneous detection of quinolone resistance. However, the 
variability in this gene is too extensive to cover all possible variations in a single PCR unless 
a hybridisation principle with a large panel of probes is used.  
Intrinsic macrolide (clarithromycin, azithromycin) resistance is correlated with the presence of 
erm genes, and is, for instance, found in M. smegmatis, M. tuberculosis and isolates of M. 
fortuitum (126, 127). However, acquired resistance is related to a mutation in the 23S gene. 
Erm genes are responsible for the methylation of 23S-RNA, but direct mutation in the 23S –
RNA gene results in the same secondary structure alteration of the ribosomes (128). 
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Development of molecular tests for the detection of these 23S mutations, might be fairly 
simple for all NTM, because to date, no other mutations have been identified except in bp 
2057-2058 and the sequence variation in this region between mycobacterial species is not 
extensive.  
Overall, since not all genetic markers responsible for antimycobacterial agents are known, 
and several mechanisms appear complicated, the molecular approach for the detection of 










Table 4: from Alcaide et al 1997 (123): TABLE 2 Correlation between EMB phenotype and genotype at 
the ERDR fragment in EmbBa .  Alignment homology of the EmbB region is represented by stripes. Displayed in 
the last column are MICs for M. smegmatis mc2155 transformed with various emb alleles. 
b A, alanine; R, arginine; N, asparagine; D, aspartic acid; E, glutamic acid; Q, glutamine; G, glycine; H, histidine; I, 
isoleucine; L, leucine; M, methionine; F, phenylalanine; S, serine; T, threonine; Y, tyrosine; V, valine. 
 
species (phenotype)   ERDRb MIC (mg/ml) or phenotype MIC (mg/ml) after gene transfer to M. smegmatis 
    
M. tuberculosis SDDGY ILGM ARVADHAGYMSN 2.5   
M. gordonae ----- ---- ------------ 2.5   
M. nonchromogenicum ----- ---- ------------ 2.5   
M. marinum  ----- ---- ------------ 4   
M. malmoense  ----- ---- ------------ 4–8   
M. genavense  ----- ---- ------------ S?   
M. kansasii  ----- ---- -----R------ 8   
M. avium ----- ---- -----R------ 8   
M. smegmatis  ----- --Q- -T-E-----A-- 0.5  10 
M. peregrinum  ----- --Q ------------- 8   
M. fortuitum ----- --Q ------------- 8–16 64 
M. chelonae ----- QM-- --T-E-----A- 64   
M. abscessus  ----- QM-- --T-E-----A- 64 254 
M. leprae  ----- QMQ- --T---S---A- R   
M. smegmatis (R)  ----- F-Q- --T-E-----A- 100 254 
M. tuberculosis (R)  ----- ---I ------------ 20   
M. tuberculosis (R)  ----- ---L ------------ 40   
































































































































































































































































































































































































































































































































































































































































































































































































































































































































Typing of NTM. 
 
Molecular genotyping studies on mycobacterial species provide insights into epidemiological 
behaviour, evolution and transmission of the bacteria. Evolutionary speed was elucidated by 
typing studies (138, 139) and taxonomical relations have been established between species 
and subspecies (140, 141). Geno-(sub)typing can follow one of two principles: genome-wide 
comparisons and comparison of small genome segments (Table 6).  
Methods targeting the whole genome have often been applied in mycobacteriology. The 
methods described most often are Pulse Field Gel Electroforese (PFGE) and Random 
Amplified Polymorphic DNA (RAPD). These two and Amplified Fragment Length 
Polymorphism (AFLP), are based on the restriction and/or hybridisation of standard primers 
over the whole genome in which variation in band patterns can be created either by one 
single nucleotide polymorphism or the insertion/deletion of larger fragments (142). No 
sequence information is necessary for these whole genome approaches and they are, 
therefore, easy to use for less prevalent species. Because of the often applied automated 
analysis of AFLP, while the other two methods generally depend on visual analysis, the 
AFLP method is more suitable for large collections of isolates. RAPD is easy to perform and 
is therefore often applied in the investigation of, for instance, pseudo-outbreaks. 
One of the earliest methods for typing mycobacteria was plasmid profiling. In this method the 
sizes of the plasmids present are compared between strains. However, because this method 
focuses on extrachromosomal DNA, it does not provide conclusive evidence about the 
relatedness of strains. In fact, isolates with similar plasmid profiles may belong to different 
biovariant groups and vice versa. The method has other drawbacks: not all isolates contain 
plasmids and profiles may change over time, whereas completely different plasmids may 
have an identical size (59). Other genome segments used in genotyping are repetitive 
elements like insertion sequences (IS). The fact that many IS elements are limited to a 
narrow range of species, and their random distribution within the chromosome, make them 
useful clinical tools for diagnosis and typing. Thus far, more than 37 different IS elements 
have been described for mycobacterial species (145). IS6110 has been widely used as a 
standard epidemiological tool for identifying and typing M. tuberculosis complex isolates 
(143). The use of insertion sequences for genotyping and identification of NTM has also been 
reported. IS900 and IS901 have been used for the identification of M. paratuberculosis and 
M. avium strains. IS1245 has been standardized for the typing of M. avium  (144). IS1407 
was applied for the characterization of M. celatum, IS1395 for M. xenopi and both IS2404 
and IS2606 for M. ulcerans. However, the recent detection of IS1245, defined as a genetic 
marker for M. avium, in a clinical strain of M. malmoense and IS2404, an M. ulcerans 
defining element in an M. marinum subspecies, seems to indicate that insertion elements 
may have spread through horizontal transfer to environmental NTM (145). 
Mycobacterial Intergenic Repetitive Units (MIRUs) are another group of genetic elements 
used in genotyping (146). These relatively short (approx. 80 bp) repetitive elements are 
located throughout the mycobacterial genome and because of their variable number and 
direct repeats they have recently been applied in typing studies of M. tuberculosis, M. avium-
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complex, M. marinum and M. ulcerans (147-149). In the research of Stragier and collegues, 
the 15 MIRU’s, applied for typing of M. marinum and the related species M. ulcerans, 
revealed evolutionary information for these species. The 15 MIRU’s found in M. tuberculosis 
were also able to differentiate between phylogenetic lineages (148). In M. avium, 22 MIRU’s 
were identified (149). 
Other repetitive sequences, not identified as IS elements, which are species-specific can 
also act as probes in mycobacterial typing studies (150). Variable Number of Tandem 
Repeats (VNTR) or microsatellite analyses are methods that are only applicable in species 
with a (largely) known genomic sequence (M. tuberculosis, M. leprae, M. ulcerans and M. 
avium). Tandem repeats or microsatellites are short repetitive sequences which are readily 
incorporated or deleted by DNA polymerase and therefore highly variable in length between 
strains (151-154). Ribotyping is applied as a sub-typing method in other bacterial taxa like 
Clostridia and Vibrios (155, 156) but is not very useful in mycobacteriology. Most 
mycobacteria contain only one copy of the ribosomal operon and ribotyping is based on the 
comparison of length, sequence variation and copy numbers of this target. 
Sequencing is also included in typing studies as a possible approach. When sequencing is 
applied in subtyping, multiple targets are required. Recent guidelines for Multilocus sequence 
typing (MLST) describe the use of at least 7 housekeeping genes as sufficient for application 
in molecular epidemiological studies (157). The method however, has hardly ever been 




Table 6: subtyping methodology applied on NTM species for epidemiological purposes. 
 
method: 
sequence knowlegde necessary discriminatory power laborious species applied 
year of 
publication reference 
      
MIRU's ++ some M. ulcerans 2006 160 
     (known sensitive for horizontal    M. marinum 2006 160 
      transfer)   M. avium-complex 2005 149 
microsattelites /short tandem  ++ some M. avium-complex 2004 158 
      repeats   M. lepra 2004/2005 159 / 153 
    M. ulcerans 2006 151 
IS elements / multi copy elements +++ no M. avium-complex 2006 163 
      (known sensitive for horizontal    M. ulcerans 1999 161 
       ransfer)   M. marinum 2002 162 
    M. celatum 1997 164 
    M. xenopi 1996 165 
    M. haemophilum 1994 150 
    M. absessus 2002 166 
    M. kansasii 1993 167 
    M. smegmatis 1998 168 
PRA of hsp65 + no M. kansasii 2006 169 
    M. gordonae 2002 170 
    M. terrae 2002 170 
    M. fortuitum 2002 170 
    M. avium-complex 2004 171 
MLST ++ yes M. marinum 1999 161 
    M. ulcerans 1999 161 
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Table 6 part 2. 
 
method: 
random genomic approach discriminatory power laborious species applied 
year of 
publication reference 
      
AFLP +++ yes M. kansasii 2003 172 
      (suitable for high troughput    M. marinum 2001 173 
       application)   M. ulcerans 2001 173 
    M. avium 2004 174 
    M. lentiflavum 2005 175 
PFGE +++ yes M. haemophilum 1994 176 
       (highly discriminatory (more    M. avium-complex 2003 177 
       so than RAPD) but difficult    M. abscessus 2003 178 
       in use and  reproducebility)   M. terrae 2006 179 
   M. chelonae 2005 180 
    M. Imunogenum 2005 180 
    M. kansasii 2004 181 
    M. goodii 2004 182 
    M. mageritense 2004 183 
    M. furunculosis 2002 184 
    M. marinum 2002 185 
    M. szulgai 2002 186 
    M. malmoense 2002 187 
    M. gordonae 2001 188 
    M. celatum 1997 164 
    M. intracellulare 1993 189 
    M. ulcerans 2000 190 
    M. jacuzzii 2003 191 
    M. fortuitum 2006 192 
    M. cosmeticum 2004 193 
    M. simiae 2000 194 
RAPD ++ no M. jacuzzii 2006 191 
       (mainly applied for small    M. fortuitum 2006 192 
       clusters of isolates to check    M. cosmeticum 2004 193 
       for clonality, easy to apply)   M. gordonae 2006 195 
    M. abscessus 2005 196 
    M. szulgai 2002 197 
    M. avium-complex 2000 198 
    M. malmoense 1999 199 
    M. chelonae 1998 200 





Conclusions and design of the thesis. 
 
Many new NTM species have been found and characterised, ranging from non-pathogenic to 
pathogenic. Molecular methods contributed significantly to the identification of these new 
species, replacing conventional laborious methods. New criteria have been formulated to 
determine whether a new species can be officially recognized. The application of these 
criteria requires that genetic information of at least two targets should be included, but the 
choice of the targets is not fixed. Therefore, we compared 6 sequence targets (chapter 8), all 
used for NTM identification in the Netherlands, for their ability in species differentiation. 
Because of the highly variable appearance of NTM infections and the large spectrum of 
species involved, a rapid diagnostic method is required to recognize as many mycobacterial 
species as possible. We therefore focused on the development of a mycobacterial genus- 
specific PCR (chapter 3) and on species-specific PCRs, enabling the identification the most 
frequently found species (chapters 3 and 4). Conventional PCRs are not practical for the 
microbiological laboratories nowadays, compared to the possibilities of real-time PCR. Since 
only 2 real-time PCRs have previously been described for the detection of the genus 
Mycobacterium in patient materials, we developed a new assay and applied it directly on 
variable clinical materials. For this real-time PCR, the ITS region was chosen because it 
enables the differentiation of all slow-growing species using a short amplicon. 
Molecular detection also enables biopsies and other histopathological materials to be 
examined for the presence of mycobacteria when culturing is not possible due to fixation of 
the tissue. This offers an excellent opportunity to investigate the presence of newly identified 
mycobacterial species in stored patient materials (chapter 5). However, the widespread 
occurrence of NTM in the environment may result in contamination of patient samples during 
processing of the materials and special precautions will be necessary.  
When an emerging mycobacterial species is found in association with a “new” clinical 
syndrome, questions arise on the epidemiology of the disease. Molecular typing methods 
play an important role in understanding the epidemiology. Based on an extensive literature 
review, we decided to develop an AFLP (chapter 6) for the genotyping of M. haemophilum 
isolates and applied a standardised RFLP on M. avium isolates (chapter 7). The aims of the 
application of these techniques were different. AFLP was chosen to compare clinical isolates 
with each other to trace a possible common source, whereas the RFLP was applied to 
investigate animals as a possible source for human M. avium infections. 
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A real-time PCR assay was developed to diagnose and identify the causative agents of 
suspected mycobacterial lymphadenitis. Primers and probes for the real-time PCR were 
designed on the basis of the internal transcribed spacer sequence, enabling the recognition 
of the genus Mycobacterium and the species Mycobacterium avium and M. tuberculosis. The 
detection limit for the assay was established at 1,100 CFU/ml of pus, and the specificity tests 
showed no false-positive reaction with other mycobacterial species and other pathogens 
causing lymphadenitis. From 67 children with suspected mycobacterial lymphadenitis based 
on a positive mycobacterial skin test, 102 samples (58 fine-needle aspirates [FNA] and 44 
tissue specimens) were obtained. The real-time PCR assay detected a mycobacterial 
infection in 48 patients (71.6%), whereas auramine staining and culturing were positive for 31 
(46.3%) and 28 (41.8%) of the patients. The addition of the real-time PCR assay to 
conventional diagnostic tests resulted in the recognition of 13 more patients with 
mycobacterial disease. These results indicate that the real-time PCR is more sensitive than 
conventional staining and culturing techniques (P = 0.006). The M. avium-specific real-time 
PCR was positive for 38 patients, and the M. tuberculosis-specific real-time PCR was positive 
for 1 patient. Analysis of 27 patients from whom FNA and tissue biopsy specimens were 
collected revealed significantly more positive real-time PCR results for FNA than for tissue 
biopsy specimens (P = 0.003). Samples from an age-matched control group of 50 patients 
with PCR-proven cat scratch disease were all found to be negative by the real-time PCR. We 
conclude that this real-time PCR assay with a sensitivity of 72% for patients with 
lymphadenitis and a specificity of 100% for the detection of atypical mycobacteria can 





Nontuberculous mycobacterial (NTM) lymphadenitis appears to be an emerging disease in 
children (6, 13). The portals of entry are the pharyngeal mucosa, tonsils, conjunctiva, gingiva, 
salivary glands, and skin (7, 14). Cervicofacial lymphadenitis, the most frequent head and 
neck manifestation of NTM infection, often presents as chronic, unilateral lymphadenopathy 
with characteristic violaceous overlying skin changes. It may be difficult to differentiate NTM 
lymphadenitis from lymphadenitis caused by other microorganisms, such as staphylococci, 
streptococci, and Bartonella species. The Mycobacterium avium complex accounts for 80% 
of NTM lymphadenitis cases, followed by M. scrofulaceum in the United States and M. 
malmoense in Europe (1, 8). The exact incidence of NTM lymphadenitis in children in The 
Netherlands is unknown but is estimated to be 0.4 patients per 100,000 inhabitants annually.  
Currently, the most commonly used treatment for NTM lymphadenitis is excision of the 
infected lymph node. Surgery is preferred because of a higher risk of sinus tract formation or 
recurrence of infection when other conservative therapies are used (1, 14, 20, 21). A number 
of recent case reports, however, suggested that effective treatment of NTM lymphadenitis is 
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possible with specific antimycobacterial agents (2, 17, 29). Since culture results for 
mycobacteria can take as long as 12 weeks, a rapid diagnostic technique is required to 
institute appropriate antimycobacterial therapy.  
Several molecular assays have been developed for the detection or identification of 
mycobacteria, but most of them are for M. tuberculosis only (5, 11, 19, 27, 31). The existing 
molecular methods for the identification of atypical mycobacteria are mainly applied on 
cultured mycobacteria and lack specificity or sensitivity when used directly on clinical 
materials (15, 18, 24). A real-time PCR technique for the detection of mycobacteria is able to 
detect a specific sequence during amplification and needs no hybridization or further 
processing time for analysis. It is easy to use and able to attain high sensitivity mainly 
because of the use of short amplicons.  
In this study, a real-time PCR assay for the genus Mycobacterium and the mycobacterial 
species M. avium and M. tuberculosis was developed for direct use on fine-needle aspirates 
(FNA) and biopsy specimens from patients with suspected mycobacterial lymphadenitis. The 
target chosen for PCR was the internal transcribed spacer (ITS) sequence between the 16S 
and the 23S rRNA genes. The ITS contains sufficient sequence variations to differentiate 
mycobacterial species (23, 24) but is still conserved enough to allow the development of a 




Material and Methods. 
 
Bacterial strains. 
The mycobacterial strains used for sensitivity and specificity testing and for optimization of 
PCR are listed in Table 1. The strains were either ATCC strains or clinical isolates, identified 
by 16S RNA sequencing and obtained from the Medical Microbiological Laboratory (Leiden 
University Medical Center, Leiden, The Netherlands), the Regional Public Health Laboratory 
(Leeuwarden, The Netherlands; supplied by G. Noordhoek), and the National Institute of 
Public Health and the Environment (Bilthoven, The Netherlands). All mycobacterial strains 
were cultured in liquid Dubos medium. Additionally, 36 strains belonging to 28 different 
species were also used in specificity tests. Some of these species are established pathogens 
causing lymphadenitis, and others are normal inhabitants of the oropharynx. The species 
belonged to the genera Streptococcus, Staphylococcus, Bordetella, Haemophilus, Neisseria, 
Chlamydia, Bartonella, Campylobacter, Legionella, and Corynebacterium and to the family 
Enterobacteriaceae. 
 
Patients and samples. 
Samples from affected lymph nodes were obtained from patients included in the CHIMED 
study. The CHIMED study is a multicenter trial in The Netherlands for studying the optimal 
treatment of children with NTM cervicofacial lymphadenitis. Surgical excision is compared to 
an antimicrobial treatment consisting of clarithromycin and rifabutin. To be eligible, patients 
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must have a positive skin test for atypical mycobacteria (29, 30). Differential skin testing with 
sensitins for M. avium, M. scrofulaceum, and M. kansasii and purified protein derivative 
(Statens Seruminstitut, Copenhagen, Denmark) consists of two simultaneous injections each 
on the middle part of the ventral surface and on the dorsal surface of the right forearm.  
From September 2001 until November 2003, 67 patients with affected lymph nodes in the 
neck were included in the study. FNA were taken from affected lymph nodes and transported 
in saline to the microbiological laboratory at Leiden University Medical Center. The lymph 
nodes removed from surgically treated patients were also investigated. Clinical samples 
arrived at the laboratory within 6 h. All samples were kept at 4°C until processing. An age-
matched control group consisted of 50 patients with affected lymph nodes. Cat scratch 
disease was diagnosed by Bartonella henselae-specific PCR of samples from these affected 
lymph nodes at the Department of Medical Microbiology, St. Elisabeth Hospital, Tilburg, The 
Netherlands (3).  
 
Conventional mycobacterial diagnostic tests. 
Patient samples were tested for contamination with rapidly growing bacteria by culturing on 
standard brain heart infusion agar. When contamination was found, the aspirates or biopsy 
specimens were decontaminated with an NaCl-NaOH decontamination protocol (12). 
Auramine staining was performed on directly obtained materials or on decontaminated 
materials for the detection of acid-fast rods. When auramine-positive rods were detected, 
Ziehl-Neelsen staining was performed to confirm the presence of acid-fast rods. Culturing 
was done at 35°C by using Bactec bottles with liquid mycobacteria growth indicator tube 
(MGIT) (Becton Dickinson Microbiology Systems) medium and on solid Löwenstein-Jensen 
medium. Positive culture results for acid-fast bacteria were further investigated by using the 
Inno-Lipa assay (InnoGenetics, Gent, Belgium), a reverse hybridization assay in which the 
mycobacterial species is identified. When no growth was detected after 12 weeks of 
incubation, the culture results were listed as negative. Samples were also investigated for the 
presence of other bacterial pathogens by conventional bacterial culturing and by PCR for B. 
henselae (3).  
 
Nucleic acid isolation for real-time PCR. 
Aliquots of the clinical samples used for PCR were first decontaminated with the NaCl-NaOH 
method. DNA from cultured strains was extracted without decontamination. Each patient 
sample was divided into three aliquots. One aliquot was spiked with 2.5 x 104 CFU of M. 
bovis and used as a control for DNA extraction and PCR inhibition. The other two aliquots 
were tested as duplicates of the patient sample. Extraction of DNA for the real-time PCR was 
performed as described by Boom et al. (4). Briefly, 90 µl of decontaminated material or 
bacterial culture was extracted, and the DNA was eluted in 100 µl of Tris-EDTA (0.1 M; pH 
8.0). The extracted DNA was stored at –20°C until used in the PCR.  
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Table 1. Reference strains and clinical isolates used in this study and results of real-time PCR. 
 
real-time PCR resultsb for: 
straina genus 
Mycobacterium M. avium M. tuberculosis 
    
M. intracellulare LUMC 5 + – – 
M. intracellulare LUMC 7 + – – 
M. intracellulare ATCC 13950 + – – 
M. avium LUMC 14 + + – 
M. avium subsp. silvaticum LUMC 18 + + – 
M. avium subsp. avium RIVM D71076 + + – 
M. avium subsp. avium RIVM 160/74 + + – 
M. avium subsp. avium RIVM R13 + + – 
M. avium subsp. paratuberculosis ATCC 19698 + + – 
M. avium subsp. paratuberculosis ATCC 43544 + + – 
M. scrofulaceum RIVM 2002-530 + – – 
M. scrofulaceum RIVM 2002-1933 + – – 
M. tuberculosis ATCC 35822 + – + 
M. bovis LUMC 1 + – + 
M. kansasii ATCC 12478 + – – 
M. kansasii LUMC 30 + – – 
M. kansasii LUMC 31 + – – 
M. kansasii LUMC 32 + – – 
M. xenopi LUMC 59 + – – 
M. xenopi LUMC 60 + – – 
M. malmoense M 2148 + – – 
M. malmoense M 2240 + – – 
M. malmoense M 1172 + – – 
M. haemophilum LUMC 201 + – – 
M. fortuitum LUMC 101 + – – 
M. gordonae ATCC 14470 + – – 
M. marinum LUMC 48 + – – 
 
a LUMC, Leiden University Medical Center; ATCC, American Type Culture Collection; RIVM, National Institute of 
Public Health and the Environment; M, Regional Public Health Laboratory. Identification of clinical strains was 
performed at RIVM.  
b +, positive; –, negative.  
c RIVM strains. 
 
Primers and probes. 
Primers were selected based on alignments of the ITS region with sequences from the 
National Center for Biotechnology Information (NCBI) database (http://www.ncbi.nlm.nih.gov) 
and the Ridom GmbH database (http://www.ridom.com) and sequences derived from clinical 
isolates. Sequence alignments were made to investigate the interspecies variations and the 
intraspecies variations. The alignments included all three subspecies of M. avium and five 
sequevars of M. avium (A, B, C, D, and E). From these alignments, conserved regions were 
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used to select primers specific for the genus Mycobacterium. The forward primer was 
selected from the ITS region; the reverse primer was selected from the 23S rRNA gene (Fig. 
1). Another small conserved sequence in the ITS region was used for the Taqman probe 
specific for the genus Mycobacterium. The larger part of the ITS region contains a high 
degree of variation; probes specific for M. avium (molecular beacon) and M. tuberculosis 
(Taqman probe) were designed from this part  (Fig. 1B). The choice of a molecular beacon or 
a Taqman probe was based on the overall stability of the secondary structures in the probe 
sequence.  
The PCR primer and probe sequences were selected by using the Primer3 program 
(http://www-genome.wi.mit.edu/cgi-bin/primer/primer3_www.cgi) (25) and were checked with 
Oligo-Analyzer 3.0 (http://biotools.idtdna.com/analyzer), an online service of IDT Biotools 
(Coralville, Iowa), to ensure minimal self-complementarity and to prevent the presence of 
secondary structures.  
The molecular beacon for M. avium was designed by using the Mfold program 
(http://biotools.idtdna.com/mfold) (IDT Biotools). Additional criteria for a good probe included 
a melting temperature at least 7°C above the melting temperatures of the primers and a 
relatively short amplicon, with a maximum of 200 nucleotides. The stem sequence of the 
molecular beacon was selected to have a melting temperature compatible with that of the 
beacon. The beacon formed a stable structure at the proposed annealing temperature of 
55°C, with no secondary structures (26). An NCBI BLAST search was performed to check the 
specificity of the DNA sequences of the primers and probes. Primers were synthesized at 
Eurogentec (Seraing, Belgium), and probes were synthesized at Biolegio (Malden, The 
Netherlands). Selected primers and probes are shown in Table 2.  
 
Table 2. Sequences of oligonucleotides used in this study.  
 
primer or probe sequence (5'-3') 
  
Forward primer GGGGTGTGGTGTTTGAG 
Reverse primer CTCCCACGTCCTTCATC 
Mycobacterium-specific Taqman probe Fam-TGGATAGTGGTTGCGAGCATC-Tamra 
M. avium-specific molecular beacon Fam-CCCACCGGCCGGCGTTCATCGAAATGGTGGG-DabCyl 




Quantified dilutions of M. avium and M. bovis were prepared by measuring optical density 
(spectrophotometry) and CFU. Aliquots of 20 µl, containing serial dilutions of 110 to 107 
CFU/ml, were added to water and pooled pus samples. The influence of decontamination on 
the sensitivity of the assay was investigated by comparing decontamination before spiking 





The real-time PCR was performed with a 50-µl reaction mixture consisting of 25 µl of 2x IQ 
Supermix (Bio-Rad, Veenendaal, The Netherlands), 3.0 mM MgCl2, 20 pmol of each primer, 
10 pmol of probe, and 10 µl of template. The PCR thermal profile consisted of an initial 
incubation for 3 min at 95°C, followed by 50 cycles of 30 s at 95°C, 40 s at 55°C, and 30 s at 
72°C (the annealing temperature for the M. tuberculosis-specific PCR was 52°C instead of 
55°C). Amplification, detection, and data analysis were performed with an iCycler IQ real-time 
detection system (Bio-Rad). The same reaction mixture and the same PCR profile were used 
for all three probes.  
Each DNA extract was tested undiluted and diluted 10-fold by the real-time PCR for detection 
of the genus Mycobacterium and the species M. avium. For the M. avium-specific PCR, M. 
avium DNA was used as a positive control instead of M. bovis DNA.  
 
Statistical analysis. 
All statistical calculations were performed with SPSS 10.0.7. The Wilcoxon signed rank test 
was used for a comparison of FNA and tissue biopsy specimens from patients from whom 





Test characteristics in vitro. Quantified dilutions of M. avium and M. bovis were tested in 
water and pooled pus samples. All three real-time PCRs reached a sensitivity of 2.7 CFU 
when spiked in water and a sensitivity of 27 CFU when spiked in pus, establishing a 
detection limit for the assay of 1,100 CFU/ml of pus. The sensitivity of the assay was not 
influenced by the decontamination protocol.  
The specificity was assessed with DNA from 11 mycobacterial species (Table 1) and 36 other 
human pathogens. Several pathogens that may cause lymphadenitis, such as 
Staphylococcus aureus, Streptococcus pyogenes, Nocardia spp., and Bartonella spp., were 
also included in this specificity testing. No nonspecific results were obtained in the genus 
Mycobacterium-specific PCR. The M. tuberculosis-specific PCR detected only M. 
tuberculosis and M. bovis. The M. avium-specific PCR recognized seven isolates belonging 
to all three subspecies of M. avium and was negative for M. scrofulaceum, M. intracellulare, 
and other species tested (Table 1).  
Patient samples. From 67 patients included in the CHIMED study, 102 samples were 
obtained (58 FNA and 44 tissue specimens) (Table 3). Auramine staining was positive for 31 
patients (46.3%). Mycobacteria could be cultured from 28 patients (41.8%) and included M. 
avium (n = 22), M. malmoense (n = 2), M. kansasii (n = 1), M. tuberculosis (n = 1), and 
Mycobacterium spp. (n = 2). The real-time PCR assay detected a mycobacterial infection in 
48 patients (71.6%). The M. avium-specific real-time PCR was positive for 38 patients, and 
the M. tuberculosis-specific real-time PCR was positive for 1 patient (Table 3). The remaining 
nine PCR-positive patients were found to be positive only by the genus-specific real-time 
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PCR. The real-time PCR assay was more sensitive for the detection of atypical mycobacteria 
in patients with lymphadenitis than were staining and culturing (P value determined by the 
chi-square test, 0.006). When all tests were combined, the diagnosis of mycobacterial 
infection could be verified for 55 (82.1%) of 67 patients. The mycobacterial species was not 
identified for 12 of these 55 patients, because the samples were found to be positive only by 
the genus Mycobacterium-specific PCR (n = 8) or only by auramine staining (n = 2) or 
because the cultured species could not be identified by the reverse line blot assay (n = 2). 
Samples from the age-matched control group of 50 patients were all found to be negative by 
the real-time PCR.  
The results indicated higher recovery from FNA than from tissue specimens from lymph 
nodes obtained during surgical excision or biopsy (Table 4). For 27 patients from whom FNA 
and tissue biopsy specimens were collected, specific real-time PCRs for the genus 
Mycobacterium and the species M. avium both yielded significantly more positive results for 
FNA than for tissue biopsy specimens (P values determined by the Wilcoxon test, 0.001 and 
0.0011, respectively). Tissue biopsy specimens never were found to be positive by the real-
time PCR when FNA were found to be negative. Although acid-fast staining and culture 
results were also more frequently positive for FNA than for surgically removed tissue (no 
statistical significance), tissue biopsy specimens yielded three more positive results when 
only conventional diagnostic tests were applied for patients from whom both materials were 
obtained (Table 4). 
Compared to a positive mycobacterial skin test as an indication of the presence of a 
mycobacterial infection, the sensitivity, specificity, positive predictive value, and negative 
predictive value of the real-time PCR assay for patients with lymphadenitis were 71.6, 100, 
100, and 72.5%, respectively. The application of the real-time PCR assay to all collected 
samples revealed 66.7% sensitivity, 100% specificity, 100% positive predictive value, and 
59.5% negative predictive value. In total, the PCR assay detected a mycobacterial infection 




Table 3. Results of real-time PCR, auramine staining, and mycobacterial culturing of FNA and tissue 
samples from 67 patients with suspected NTM lymphadenitis.  
 
total no. (%) of: 
positive diagnostic test 
patients (n = 67) smples (n = 102) 
   
Auramine staining 31 (46.3) 38 (37.3) 
Mycobacterial culturing 28 (41.8) 35 (34.3) 
Real-time PCR 48 (71.6) 68 (66.7) 
    Genus specific 45 (67.2) 59 (57.8) 
    M. tuberculosis specific 1 (1.5) 1 (1.0) 
    M. avium specific 38 (56.7) 53 (52.0) 
Any test 55 (82.1) 76 (74.5) 
 
 
Table 4. Results of diagnostic tests of materials from 27 patients from whom both FNA and tissue biopsy 
specimens were collected.  
 
no. (%) of patients with the following test results for FNA and excisional biopsy 
specimens: diagnostic test 
FNA +, biopsy + FNA +, biopsy – FNA –, biopsy + FNA –, biopsy – 
     
Auramine staining 8 (29.6) 6 (22.2) 3 (11.1) 10 (37.0) 
Mycobacterial culturing 6 (22.2) 5 (18.5) 2 (7.4) 14 (51.9) 
Real-time PCR assaya 16 (59.3) 9 (33.3) 0 2 (7.4) 
    M. avium specific 12 (44.4) 9 (33.3) 1 (3.7) 5 (18.5) 
    Genus specific 10 (37.0) 13 (48.1) 1 (3.7) 3 (11.1) 
Any positive diagnostic test 16 (59.3) 9 (33.3) 0 2 (7.4) 
 
a Significantly better performance with FNA than with tissue samples, as determined by the Wilcoxon test. P 
values for real-time PCR assay, M. avium-specific real-time PCR assay, genus-specific real-time PCR assay, and 





In the past few years, real-time PCR assays have been implemented in clinical 
microbiological laboratories. A few assays for the detection of mycobacteria have been 
described (15, 19). However, assays for mycobacterial species other than M. tuberculosis 
have not been successfully applied to clinical patient material and are mainly restricted to the 
identification of cultured isolates. In this study, we developed a real-time PCR to identify the 
causative agents of mycobacterial lymphadenitis. Primers for the real-time PCR were 
designed to amplify an amplicon in the ITS between the 16S and the 23S rRNA genes of 
mycobacteria, enabling the annealing of a genus-, M. avium-, or M. tuberculosis-specific 
probe. The detection limit of the assay was established at 1,100 CFU/ml of pus, and the 
assay was shown to be specific. For patients with suspected NTM lymphadenitis, the real-
time PCR was significantly more sensitive than conventional staining and culturing. All 
65
  
samples were also tested for the presence of inhibition of the assay by spiking portions of the 
samples and by diluting the samples 10 times. We did not encounter any inhibition, but the 
risk of inhibition will remain, considering the nature of the clinical materials (26).  
Among 67 patients with suspected NTM lymphadenitis, successful identification of the 
pathogen was achieved for 55 of the patients by acid-fast staining, culturing, or real-time 
PCR. For 48 patients, it was possible to identify the pathogen within 2 days by the real-time 
PCR, whereas culturing of the remaining mycobacteria took 4 to 8 weeks. M. avium was 
identified in 39 patients, i.e., 71% of all confirmed mycobacterial infections in this study. This 
result corresponds to those of earlier studies where the M. avium complex was found to be 
the most common species in atypical mycobacterial lymphadenitis (8, 14, 22).  
Our results also indicate that FNA have a higher recovery rate than tissue samples for 
diagnostic testing by the real-time PCR. The high recovery rate for FNA in the PCR 
diminishes the need for invasive methods for diagnosis of the involved pathogen, but a higher 
recovery rate for tissue biopsy specimens was expected. The genus-specific PCR performed 
less well with tissue biopsy specimens. The M. avium-specific PCR also performed better 
with FNA but was positive for six tissue samples for which the genus-specific PCR remained 
negative. An NCBI BLAST search of the probe sequences in the human sequence database 
showed a higher homology of the genus-specific probe than of the M. avium-specific probe 
with human chromosomal sequences. As a result, less genus-specific probe will be available, 
resulting in reduced efficiency of the real-time PCR for tissue samples or FNA. This situation 
will mainly affect weak positive samples, as demonstrated by high threshold cycle values 
(between 38 and 45) for the 6 M. avium-positive samples with negative results in the genus-
specific PCR, in contrast to low cycle threshold values (between 30 and 37) for 15 M. avium- 
and genus Mycobacterium-positive samples.  
Traditionally, culturing has been regarded as the most appropriate "gold standard." A definite 
diagnosis of mycobacterial lymphadenitis is made by recovery of the bacterium from lymph 
node material, but some causative pathogens may require a long incubation period (e.g., M. 
malmoense) or special culture conditions (M. haemophilum) (28). Skin tests may prove 
beneficial for the evaluation of mycobacterial lymphadenitis (29, 30). All children included in 
this study were investigated by one of the authors (J.A.L.), who also performed a skin test. 
Only children with a clinical syndrome suspected of being mycobacterial lymphadenitis and a 
positive skin test were further investigated. Since no other pathogens besides mycobacteria 
were detected in this study, a positive skin test can be considered indicative of mycobacterial 
infection. The skin test that we used is a well-standardized preparation from M. avium, M. 
scrofulaceum, and M. kansasii. Intradermal skin testing for the diagnosis of NTM 
lymphadenitis has been reported to have a sensitivity of 87%, but the specificity has not been 
well investigated (20). For instance, studies of asymptomatic healthy children in Sweden and 
Denmark with the same skin test that we used demonstrated that 6 to 32% had positive 
reactions (9, 16). NTM are common environmental isolates present in soil and water, and 
extensive cross-reactivity may exist among these mycobacteria. Therefore, a species-specific 
skin test is difficult to interpret, and more information on the incidence of a positive skin test in 
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healthy Dutch children is needed to determine the diagnostic value of the skin test more 
precisely.  
For staining- and culture-negative samples from eight patients, the genus-specific PCR 
results were positive, whereas the real-time PCR results for M. avium and M. tuberculosis 
were negative. In two cases, sufficient PCR product was obtained for sequence analysis, and 
M. haemophilum was identified in both cases. This species requires special culture 
conditions and was therefore not detected in routine mycobacterial cultures. Our next 
objective is to expand the real-time assay with an M. haemophilum-specific probe. 
Approximately 70% of NTM lymphadenitis cases are due to M. avium. The remaining species 
identified in this study were M. malmoense, M. kansasii, M. haemophilum, and M. 
tuberculosis. The real-time PCR assay developed in this study can be expanded with probes 
specific for other species because of the large sequence variations in the ITS region. These 
variations are much greater than those found in any other known region, including the 16S 
rRNA gene. This finding has also been demonstrated by the ability of the real-time PCR to 
distinguish M. avium from M. intracellulare, whereas several other molecular methods do not 
distinguish this difference. The M. avium-specific real-time PCR detects only M. avium subsp. 
avium, M. avium subsp. silvaticum, and M. avium subsp. paratuberculosis.  
Mycobacterial culturing is not optimal. When DNA was isolated from 12 negative MGIT 
cultures of M. avium-specific real-time PCR-positive samples, 5 samples gave a weak 
positive signal in the PCR. This result indicates that mycobacteria were present in the MGIT 
cultures. In two MGIT cultures, contamination with other bacteria was apparent and could 
have caused this growth inhibition, but in the remaining three MGIT cultures, no growth was 
detected at all. For these cultures, it is possible that the bacteria were dead or the conditions 
were not optimal.  
In summary, the 71.6% sensitivity and the 100% specificity of the real-time PCR assay for the 
detection of atypical mycobacteria in patients with lymphadenitis suggest that the real-time 
PCR is an important diagnostic test and is more sensitive than conventional acid-fast staining 
techniques and mycobacterial culturing. The development of a rapid diagnostic test for the 
identification of mycobacteria as the cause of lymphadenitis is important, since an increasing 
number of reports suggest that rapid initiation of drug therapy may be of benefit and may be 




















































































FIG. 1. (A) Alignment of ITS fragments used in the real-time PCR assay of various mycobacterial species. M. 
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Infections associated with Mycobacterium haemophilum are underdiagnosed because 
specific culture methods required for its recovery are not applied routinely. Using polymerase 
chain reaction (PCR) technology on fine needle aspirates and biopsied specimens from 89 
children with cervicofacial lymphadenitis, we assessed the importance of M. haemophilum. 
Application of a Mycobacterium genus–specific real-time PCR in combination with amplicon 
sequencing and a M. haemophilum–specific PCR resulted in the recognition of M. 
haemophilum as the causative agent in 16 (18%) children with cervicofacial lymphadenitis. 
M. avium was the most frequently found species (56%), and M. haemophilum was the 
second most commonly recognized pathogen. Real-time PCR results were superior to 






Cervicofacial lymphadenitis is the most frequently encountered manifestation of 
nontuberculous mycobacterial (NTM) disease in children. In previous studies, Mycobacterium 
avium has been identified as the cause in >80% of the patients (1). Other mycobacterial 
species isolated from patients with lymphadenitis are M. tuberculosis, M. malmoense, M. 
kansasii, M. scrofulaceum, M. intracellulare, and M. xenopi. M. haemophilum has been 
described as the causative agent of lymphadenitis as well (2–7). 
In an ongoing multicenter study in the Netherlands, the optimal treatment for NTM 
lymphadenitis is investigated. Diagnosis of mycobacterial infection is performed by using 
mycobacterial differential skin tests and fine needle aspiration biopsy. Biopsied specimens 
are subjected to acid-fast staining, mycobacterial culturing, and Mycobacterium genus–
specific real-time PCR. Of 89 patients included in the study so far, mycobacterial species 
were identified in 55 cases, of which M. avium had been found in 50 patients (8). In addition, 
a mycobacterial infection without further identification was detected in 16 patients. An 
atypical mycobacterial infection was diagnosed in these patients because either acid-fast 
staining results were positive or the Mycobacterium genus–specific real-time polymerase 
chain reaction (PCR) was positive. Cultures or species-specific real-time PCR for M. avium 
and M. tuberculosis remained negative. Previously, an attempt to characterize these 
mycobacteria by sequence analysis of the genus-specific PCR fragment was successful in 
only 2 cases and showed M. haemophilum (8). In the current study, we further analyzed 
these uncharacterized mycobacteria. 
M. haemophilum requires special growth conditions (9), and most of the diagnostic 
laboratories do not use these culture conditions. Furthermore, no molecular test is available 
to detect M. haemophilum directly in clinical materials. Therefore, M. haemophilum infection 
could be seriously underdiagnosed (4,10–12). In this study, we developed a species-specific 
real-time PCR to detect M. haemophilum directly in patient materials. This assay can show 
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the actual prevalence of M. haemophilum in patients with mycobacterial lymphadenitis, but it 




Materials and Methods. 
 
Bacterial strains. 
Five M. haemophilum reference strains (all clinical isolates) were available for 16S and 
internal transcribed spacer (ITS) sequencing. Three strains were provided by the National 
Institute for Public Health and the Environment and 2 were provided by the Institute for 
Tropical Medicine (Antwerp, Belgium). The 25 mycobacterial strains used for specificity 
testing included M. tuberculosis complex, M. kansasii, M. xenopi, M. avium, M. intracellulare, 
M. gordonae, M. chelonae, M. fortuitum, M. marinum, M. scrofulaceum, and M. malmoense. 
A complete list of all strains (species and subspecies) has been published in Bruijnesteijn et 
al. (8). The strains were cultured in liquid Dubos medium at 35°C. The M. haemophilum 
strains were cultured at 30°C on solid Löwenstein-Jensen (LJ) medium with added iron 
citrate or in liquid Mycobacteria Growth Index Tube (MGIT) medium with X-factor-strip added 
(Becton-Dickinson, Alphen a/d Rijn, the Netherlands). 
 
Patients and samples. 
Clinical materials were obtained from patients included in the CHIMED-study. In CHIMED (a 
multicenter nationwide study on the optimal treatment for children with lymphadenitis), 
treatment is randomized between surgical and medical treatment. Pediatric patients were 
included on the basis of clinical appearance of atypical mycobacterial lymphadenitis and a 
positive skin test (13,14). Fine needle aspirates were taken from affected lymph nodes. In 
patients who underwent surgical treatment, the removed lymph nodes were also submitted 
for investigation. A control group to assess the specificity of the assay was assembled from 
50 patients with lymphadenitis caused by Bartonella henselae. 
 
Mycobacterial diagnostics. 
Clinical materials were decontaminated with a Nalc-NaOH decontamination protocol (15). 
Auramine staining was performed on the decontaminated materials for detection of acid-fast 
rods. Standard mycobacterial culturing was performed at 35°C in liquid MGIT medium and on 
solid LJ medium. M. haemophilum–specific culturing was performed at 30°C on LJ medium 
with added iron citrate and in MGIT medium with X-factor-strip added. Mycobacterial species 
were identified by using the Inno-Lipa and more recently using the Inno-Lipa V2 assay 
(InnoGenetics, Gent, Belgium) (16). When no growth was detected after 12 weeks of 
incubation, the culture results were listed as negative. Samples were also investigated for the 





Nucleic Acid Isolation. 
All clinical materials were processed as described in Bruijnesteijn et al. (8). DNA was 
extracted from bacterial strains and clinical materials according to the method of Boom et al. 
(18) with an overnight incubation with proteinase K. 
 
Primers and probes. 
Genus-specific primers for sequencing the total ITS region of mycobacteria were described 
by Frothingham et al. (19). Primers described previously for a genus-specific real-time PCR 
(8) were also used for sequencing a part of the ITS region directly from clinical materials. 
Using these primer sets combined, we applied a seminested PCR approach to increase the 
amount of amplicon. The part of the ITS region used in this real-time PCR shows 
considerable variation between mycobacterial species (20) (Figure). The primers used in the 
real-time PCR are genus-specific, and for the design of the M. haemophilum–specific minor 
groove binding (MGB) probe, the intraspecies and interspecies variation in the amplified ITS 
region was investigated. Alignments were made of the sequences of the M. haemophilum 
strains and of different mycobacterial species. The Mycobacterium genus–specific probe is 
described in Bruijnesteijn et al. (8). 
The M. haemophilum–specific probe sequence was checked by using the primer 3 program 
(http://www-genome.wi.mit.edu/cgi-bin/primer/primer3_www.cgi/) (21) and oligo-analyzer 3.0 
(http://biotools.idtdna.com/analyzer/) (IDT Biotools, Coralville, IA), to ensure minimal self-
complementary binding and to prevent the presence of secondary structures. By using the 
unique features of the MGB group (22), a short and highly specific probe could be designed. 
The probe was designed on the antisense strand to ensure an A/T rich MGB-site. An NCBI 
BLAST search was performed to check the specificity of the probe. The primers were 
prepared by Biolegio (Biolegio, Malden, the Netherlands), and the MGB probe was 
generated by ABI (Applied Biosystems Inc, Nieuwekerk a/d IJssel, The Netherlands). The 
broad range primers P1 and P4 were used for 16S sequencing. Primers and probes are 
listed in Table 1, and their positioning in the genome is illustrated in the Figure. 
 
Sensitivity testing. 
A plasmid with the ITS sequence of M. haemophilum was prepared by cloning the PCR 
product in a vector and was subsequently quantified (IQ corporation, Groningen, the 
Netherlands). Dilution series of this plasmid were tested in duplicate in the genus-specific 
and the M. haemophilum–specific real-time PCR. 
 
Sequence analysis. 
After amplification, PCR products were subjected to a cycle sequencing reaction with the Big 
Dye Terminator Cycle Sequencing ready reaction kit (Applied Biosystems). Samples 
underwent electrophoresis and sequences were detected and analyzed on ABI model 310 





Real-time PCR was performed in 50 µL of reaction mixture consisting of 25 µL of 2x IQ 
supermix (Bio-Rad, Veenendaal, the Netherlands), 20 pmol of each primer, 12.5 pmol of the 
genus-specific probe or 10 pmol of the M. haemophilum–specific probe, and 10 µL template. 
The PCR thermal profile consisted of an initial incubation of 3 min at 95°C for activation of 
the enzyme, followed by 50 cycles of 30 s at 95°C, 40 s at 55°C, and 30 s at 72°C. 
Amplification, detection, and data analysis were performed with an iCycler IQ real-time 
detection system (Bio-Rad). The reaction mix and PCR profile were similar for both the 
genus-specific probe and the M. haemophilum probe. 
Each DNA extract was tested by real-time PCR for the detection of the genus Mycobacterium 
and species M. haemophilum. As positive control for the genus-specific real-time PCR and 
extraction protocol, a dilution of M. bovis was used. 
Table 1. Sequences of oligonucleotides used in this study* 
primer  probe sequence (5´–3´) target sequence 
   
ITS a forward primer real-time PCR GGGGTGTGGTGTTTGAG partial ITS 
ITS reverse primer real-time PCR CTCCCACGTCCTTCATC partial ITS 
Forward primer Ec16S.1390p b TTGTACACACCGCCCGTCA total ITS 
Reverse primer Mb23S.44n b TCTCGATGCCAAGGCATCCACC total ITS 
16S forward primer P1 c TAACACATGCAAGTCGAACG 16S 
16S reverse primer P4 c TCGTTGCGGGACTTAACCCAAC 16S 
Mycobacterium genus–specific TaqMan probe Fam-TGGATAGTGGTTGCGAGCATC-Tamra ITS 
Mycobacterium haemophilum–specific MGB-probe VIC–ACGCCACCATTACT-MGB ITS 
 






Identification of M. haemophilum in patient material. 
In 16 (18%) of 89 patients from the CHIMED study, a mycobacterial infection was suspected, 
but initially no species identification could be established. After a positive signal was 
generated by the genus-specific real-time PCR and negative results from the cultures, the 
amplicons generated in real-time PCR were sequenced to determine the species. 
Sequencing of the ITS fragment formed in the real-time PCR was difficult, owing to the small 
amount of amplicon, but eventually the sequences of 4 patient samples were successfully 
derived. On 4 more samples, a seminested PCR was performed to increase the amount of 
specific amplicon. This enhancement of PCR resulted in the successful amplification and 
sequencing of all fragments. No variation was encountered between the ITS sequences of all 
8 strains analyzed here. Because no M. haemophilum ITS sequences were available in the 
public databases, 3 complete ITS sequences from M. haemophilum strains isolated from 
different CHIMED patients were determined and submitted to the NCBI database (accession 
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no. AY579398, AY579399, and AY579400). After specific culturing, the identity of the strains 
was confirmed by comparing partial 16S-gene sequences to the sequences in the NCBI 
(http://www.ncbi.nlm.nih.gov/) and the RIDOM database (http://www.ridom.com/). A variable 
part of the 16S gene of 330 base pairs was analyzed, and a 100% agreement was obtained 
with 16S sequences of 7 available M. haemophilum strains, including ATCC 29548. The M. 
haemophilum strains had at least 4 mismatches in the analyzed 16S PCR fragment in 
comparison to other mycobacterial species; therefore, all these strains were M. 
haemophilum. The identity was also confirmed because of a minimum of 4 mismatches in the 
16S fragment between the M. haemophilum sequence and other mycobacterial species. 
 
Application of real-time PCR for the recognition of M. haemophilum. 
The real-time PCR was designed to the ITS region. The same conserved primers were used 
as described previously. The obtained ITS sequences were used to select an M. 
haemophilum–specific probe. 
The detection limit of the M. haemophilum–specific real-time PCR was assessed at 1 copy 
per reaction by using a dilution series of the plasmid standard. The mycobacterial genus–
specific PCR was tested simultaneously with the M. haemophilum–specific PCR and resulted 
in the same analytical sensitivity. As determined previously, the sensitivity of the primer set in 
clinical materials was estimated to be 1,100 CFU in pus (8). Specificity testing of the M. 
haemophilum–specific real-time PCR with 25 other species and subspecies showed no 
aspecific reactions. All 50 Bartonella-positive samples from the control group remained 
negative in the real-time PCR assay as well. 
Of 16 patients with evidence for M. haemophilum infection, 9 (56%) were positive on 
auramine staining, and 9 (56%) were positive in M. haemophilum–specific cultures. In 
addition, in 1 patient (6%), the pathogen was able to grow on and in normal mycobacterial 
cultures. Thirteen patients (81%) had positive specimens in mycobacterial genus–specific 
real-time PCR, 11 of which were also positive in the M. haemophilum–specific real-time PCR 
(Table 2). In contrast, 2 genus-specific M. haemophilum–negative specimens were positive 
in the M. haemophilum–specific real-time PCR. Thus, the 2 PCRs combined yielded 15 
positive (94%) patients. These 4 samples with inconsistent results all had high threshold 
cycle values, indicating that the amount of bacterial DNA present was close to the detection 
limit of the assays. This finding was confirmed by retesting the samples 5 times in both 
PCRs, which yielded 2 or 3 positive reactions in the genus-specific PCR and in the M. 
haemophilum–specific PCR. No correlation was found between the threshold cycle values in 
the real-time PCR assay and the culture or auramine-staining results. All 9 patients with 
positive specimens by auramine staining also had positive results in the real-time PCR 
assay. Three patients' conditions were diagnosed by real-time PCR only. Only 1 patient had 
a positive culture while results of the real-time PCR or auramine staining remained negative. 
Real-time PCR on the isolate cultured from this patient resulted in a positive signal. 
The M. haemophilum–specific culturing method was less sensitive than the real-time PCR 
assay. The materials from the first 6 patients were cultured specifically for M. haemophilum 
after negative results were obtained from conventional culturing methods. The stored 
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decontaminated materials were thawed and incubated at 30°C on enriched media. From 
these 6 patients, 2 samples (33%) yielded positive cultures. The materials from the 10 other 
patients were cultured directly and yielded positive results from 7 (70%) patients. M. 
haemophilum–specific real-time PCR was performed additionally on all positive cultures to 
confirm the specific growth of M. haemophilum. 
From the 16 patients positive for M. haemophilum, 22 samples were collected: 9 tissue 
biopsy specimens and 13 fine needle aspirates. Of these samples, 19 (86%) were positive in 
the real-time PCR assay, while 11 (50%) samples yielded positive results in auramine 
staining and 9 (36%) were positive in culture. No discrepancies were encountered in the real-
time PCR assay when all samples instead of patients were considered. Application of the 




Table 2. Results of diagnostics tests of 16 Mycobacterium haemophilum–positive patients. 
M. haemophilum–positive 
patient acid-fast staining culture 30°C
a genus-specific        
real-time PCR 
M. haemophilum     
real-time PCR 
     1 + – + + 
     2 – + – – 
     3 + – + + 
     4 – – + + 
     5 – – + + 
     6 + + + + 
     7 + – + + 
     8 + + b + + 
     9 + + + c –c 
   10 + + – c + c 
   11 + – + c – c 
   12 – + – c + c 
   13 – + + + 
   14 – – + + 
   15 – + + + 
   16 + + + + 
   Total positive patients 9 9 13 13 
 
a  Löwenstein-Jensen (LJ) medium with added iron citrate or liquid MGIT medium with X-factor-strip added. 
Cultures at 30°C were performed after storage for patients 1 to 6. 
b  Patient material was also culture positive at 35°C. 
c  Because of discrepant polymerase chain reaction (PCR) results with high threshold cycle values, the PCR was 
performed 5 times on these samples, which resulted in at least 2 specific positive signals for both PCRs on every 
sample. Therefore. the amount of mycobacterial DNA is estimated at the detection limit of the assay. The first 





M. haemophilum was found to be the causative agent of lymphadenitis in 16 (18%) of the 
children included in this study. Despite the use of specific enriched culture mediums, only 9 
(56%) of the 16 M. haemophilum infections were culture-positive. In contrast, the real-time 
PCR assay was positive in 15 (94%) patients. 
M. haemophilum infection is not diagnosed frequently and is therefore not considered a 
common cause of lymphadenitis. However, most studies on children with mycobacterial 
lymphadenitis have not used optimized cultures for M. haemophilum, and infection with this 
species is therefore likely underdiagnosed. Nevertheless, differences in geographic 
distribution may also contribute to the variable prevalence of M. haemophilum. For instance, 
no M. haemophilum was found in children with atypical mycobacterial lymphadenitis in a 
study in Ohio (24), whereas in a study in Israel, M. haemophilum was found in 12 of 29 
patients (5). Both studies used appropriate culture conditions for M. haemophilum. Another 
reason for an underestimation of the occurrence of M. haemophilum infections is the 
misleading positive skin test. M. haemophilum can induce similar reactions in the Mantoux 
test as M. tuberculosis and could be misdiagnosed when no positive cultures are obtained (4, 
5). 
The natural source of M. haemophilum infection is unknown. Its geographic distribution 
appears to be related to the occurrence of large bodies of water (6). A few natural reservoirs 
have been suggested (25–27), but studies focusing on the environmental reservoirs of NTM 
tend to culture without optimized conditions for M. haemophilum, which may be the reason 
the organism is rarely found. The temperature for culture is often too high (28, 29), cultures 
do not contain hemin or iron citrate, or the incubation time is too short (30). Only 1 study 
detected M. haemophilum in water distribution systems, although the culture method was not 
optimal (26). Therefore, M. haemophilum may be widely distributed and present in several 
natural reservoirs; water is the most likely one (12). 
M. haemophilum is slow growing, iron dependent, and has an optimal growth temperature 
from 30°C to 32°C. It is unable to grow on routine media such as LJ Middlebrook 7H9 and 
7H10, or BACTEC broth. Media used to recover M. haemophilum on primary isolation 
include commercially available solid media or broth enriched with ferric ammonium citrate or 
hemin (31). Chocolate agar and lysed blood agar are mentioned as inexpensive and suitable 
alternatives (32,33). Little is known about the sensitivities of direct culturing of clinical 
materials for the recovery of M. haemophilum, and not all media have equal capacity for 
stimulating the growth (34). 
Because application of culture conditions specific for M. haemophilum are not likely to 
become standard in clinical microbiologic laboratories, including this specific diagnosis might 
be useful for molecular methods. A species-specific real-time PCR was developed to identify 
M. haemophilum directly in patient materials. Because M. haemophilum was not expected to 
be an important pathogen, no specific culturing was applied initially. After the recognition of 
M. haemophilum by molecular methods, the culture methods were optimized, which resulted 
in 70% positive cultures. Additionally, all stored decontaminated materials from culture-
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negative specimens were recultured under M. haemophilum–specific conditions. Most likely 
because of these additional freezing and thawing steps, cultures were less sensitive for 
these materials and resulted in 33% positive cultures. 
Identification of M. haemophilum in patient materials was performed by 16S sequencing (of 
cultures) and ITS sequencing. Two versions of a commercial reverse line hybridization assay 
(the Inno-Lipa assay and the V2 Inno-Lipa assay) were also used for the recognition of M. 
haemophilum, but these tests can only be applied on cultured isolates. The V2 Inno-Lipa can 
identify M. haemophilum by a specific probe, which was absent in the previous version of the 
Inno-Lipa assay. The reactions were uniformly positive only for M. haemophilum in the V2 
Inno-Lipa. 
The design of the real-time PCR MGB probe was based on the ITS sequences that were 
obtained from the patient materials and reference strains. An MGB probe enables specific 
detection of the target by using a shorter sequence than that of a TaqMan probe or a 
molecular beacon. 
Sequencing of the ITS amplicons from the genus-specific real-time PCR on patient samples 
was difficult because of the small amounts of target sequence. To enhance the specific 
amplification, a seminested PCR was applied. Of the 8 clinical samples from which 
sequences were obtained, 4 samples also yielded positive cultures once the culture protocol 
was optimized. The ITS and 16S sequences derived from the cultured isolates confirmed the 
authenticity of the identified pathogen. 
In this study, both fine needle aspiration and excisional biopsy were not applied as treatment 
options but as diagnostic procedures. Complete surgical excision of the affected lymph 
nodes is considered as the treatment of choice for atypical mycobacterial lymphadenitis (1, 
35, 36). However, surgical excision leaves scarring and carries the risk of damaging 
branches of the peripheral facial nerves (37, 38). Antimicrobial therapy as a conservative 
treatment is currently the topic of our study. Incision and drainage increase the risk for sinus 
tract formation or recurrence of infection (33,35). This risk also applies to fine needle 
aspiration, but the usage of fine needle aspirate for PCR will provide a rapid diagnosis and 
thereby allow treatment to begin earlier and thus lower the risk for complications. 
In conclusion, for detecting and identifying M. haemophilum, real-time PCR is a sensitive and 
specific assay suitable for direct application on clinical materials. In this study, by using the 
real-time PCR, M. haemophilum was shown to be an important pathogen involved in 
lymphadenitis. Because of special growth requirements, the clinical spectrum of diseases 
associated with M. haemophilum is largely unknown. Real-time PCR may be particularly 
useful for testing clinical samples such as sputum, cerebrospinal fluid, and synovial fluid for 











































Figure 1. Alignment of internal transcribed spacers (ITS) and partial 23S sequences with primers and 
probes used for real-time polymerase chain (PCR) reaction. (nucleotides [nt] 1 to 301 make up the total ITS 
region; nt 302 to 367 are coding for partial 23S gene). The Mycobacterium haemophilum sequence was derived 
from 3 different patients, but no variation was found. A, forward primer for real-time PCR; B, Mycobacterium 
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Atypical mycobacterial skin infections are difficult to diagnose owing to their aspecific 
histopathologic presentations and to the presence of few bacteria. Therefore, these 
infections are often not recognized. Molecular detection of mycobacterial DNA has proven to 
be useful in clinical samples. The aim of this study was to investigate the incidence of 
mycobacterial involvement in skin biopsies showing granulomatous inflammation, using real-
time polymerase chain reaction (PCR). 
Real-time PCR specific for the genus Mycobacterium and the species Mycobacterium avium 
and Mycobacterium haemophilum was performed on formalin-fixed/paraffin-embedded 
biopsies from patients with granulomatous inflammation of the skin, from the period 1984 to 
2004. A control group was assembled from patients with proven basal cell carcinoma. 
Amplicons of all positive reactions were sequenced to confirm or identify the mycobacterial 
species. 
Of 30 patients, 13 (43%) were found to be positive for mycobacterial infection, of whom only 
5 patients had been previously diagnosed with a mycobacterial disease. M. haemophilum 
was identified as the most common species (n=7). The other identified species were 
Mycobacterium malmoense, Mycobacterium gordonae, and Mycobacterium marinum. The 
results show that real-time PCR is useful in detecting mycobacterial infections in 
undiagnosed formalin-fixed / paraffin-embedded skin samples and that the application of 





Nontuberculous mycobacteria (NTM) cause a variety of diseases mostly in 
immunocompromised patients in lungs, skin, lymph nodes, bone, joints, and intestines. The 
incidence of NTM-infections has increased over the last few years, mainly in 
immunocompromised patients but also in immunocompetent. The increase may be related to 
the development of new diagnostic technologies (1). However, the true incidence is still 
probably many times higher than that clinically diagnosed. 
Mycobacterium leprae (leprosy) and Mycobacterium ulcerans (Buruli ulcer) are the most 
notorious pathogens causing specific cutaneous infections, but other NTM like 
Mycobacterium marinum, Mycobacterium avium, and Mycobacterium haemophilum have 
highly variable clinical presentations. They can manifest as pustuls, hyperkeratotic papels, 
suppurative noduli, ulcerations, cellulitis, or erythematous plaques. The histologic picture is 
often a granulomatous lesion that can show variable forms of cellular infiltration (2,3). Owing 
to the aspecific presentation, clinical and histologic recognition of mycobacterial involvement 
is difficult. The conventional diagnostics for a mycobacterial infection in formalin-
fixed/paraffin-embedded (FF/PE) materials is mostly restricted to acid-fast staining but this 
has an unsatisfying sensitivity. Therefore, a molecular approach is considered to be a 
valuable alternative method. 
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Recently, a real-time polymerase chain reaction (PCR) assay, specific for the genus 
Mycobacterium, which could detect the slow-growing species and the species M. avium and 
M. haemophilum, was developed in our hospital. Application of this test on cervical lymph 
node biopsies in comparison with acid-fast stain and culture revealed that the molecular 
approach had a significantly higher sensitivity (4). This assay helped to elucidate the 
incidence of slow-growing mycobacterial species-associated lymphadenitis in The 
Netherlands (5). 
The aim of this study was to retrospectively apply the real-time PCR assay on FF/PE skin 
biopsies with histologic evidences of granulomatous inflammation and to compare the results 
with the earlier diagnostic examinations and clinical information. 
 
 
Materials and Methods. 
 
Patient materials. 
A digital search was performed in the database of the department of pathology from our 
hospital. The database was searched from 1984 to 2004 for cases that consisted of a 
histologic diagnosis of granulomatous inflammation of the skin. Forty-two cases were 
identified; 12 of the 42 were excluded as either there was insufficient material or they could 
not be found in the archives. The clinical and histologic specifications of the remaining 30 
patients who were included are listed in Table 2. The collection included materials from 14 
male and 16 female patients. The patients’ ages ranged from 14 to 81 with a medium age of 
47 years. A control group was assembled from archival skin biopsies of 30 patients with 
diagnosed basal cell carcinoma (BCC). The patients were matched for age and the biopsies 
were matched for year of investigation and body location. 
 
Conventional mycobacterial diagnostics. 
In 5 cases, mycobacterial diagnostics had been requested at the time of the case 
presentations (Table 2). On the original biopsy materials, Ziehl-Neelsen (Zn) staining was 
performed and a culture at 35°C on solid Löwenstein-Jensen (LJ) medium, and, after the 
year 2000, also in liquid MGIT medium (Mycobacterial Growth Indicator Tube, Becton 
Dickinson). No M. haemophilum specific culture conditions were applied until 2004. 
 
DNA-extraction. 
The FF/PE biopsies were at least 1 mm2 in size. Five to 10 sections of 10 µm were collected 
in sterile tubes for DNA extraction. The sections were cut after removal of the outer parts of 
the paraffin blocks. To avoid cross contamination, the microtome block was wiped with 
xylene and the blade was shifted or discarded with each new block. With every 8 samples, a 
negative control was added, which consisted of a paraffin block without tissue. 
Deparaffinization and tissue digestion was performed according to an in-house method using 
an overnight incubation at 56°C with proteinase K (Invitrogen, Breda, The Netherlands) (add 
per sample: 0.5 mg proteinase K, dissolved in 400 µL buffer solution with 0.01M Tris-HCl and 
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0.45% Tween 20). Then the paraffin was separated from the tissue cells by increasing the 
temperature to 95°C for 5 minutes, centrifuging, cooling at 4°C for 5 minutes. This allows the 
paraffin to coagulate and the transfer of the approximately 350 µL of the liquid volume to a 
clean tube. Subsequently, a second incubation with fresh proteinase K (add per sample: 0.2 
mg proteinase K, dissolved in 50 µL buffer solution with 0.01M Tris-HCl and 0.45% Tween 
20) was performed for 1 hour at 60°C for an extra rigorous digestion of the acid-fast wall of 
the intracellular bacilli. The total volume of 400 µL tissue cells and buffer was then used for 
DNA extraction. For 1 patient (patient 30), only sections on glass slides were available. 
These were scraped off the glass slide and were processed similarly for DNA extraction. The 
DNA-extraction protocol described by Boom et al (6) was followed. DNA was eluted in 50 µL 
TE and stored at 4°C before using in the PCR. 
 
Table 1: sequences of primers and probes. 
 
oligo 




   
16S forward primer a TAACACATGCAAGTCGAACG ca 323 bp 
16S reverse primer a CCCATTGTGCAATATTCCCC  
ITS forward primer b GGGGTGTGGTGTTTGAG ca 170 bp 
ITS reverse primer b CTCCCACGTCCTTCATC  
genus-specific Taqman-probe c FAM -TGGATAGTGGTTGCGAGCATC- Tamra  
M. avium specific molecular beacon c FAM-CCCACCGGCCGGCGTTCATCGAAATGGTGGG-DabCyl  
M. haemophilum specific 
MinorGrooveBinder-probe c 
VIC –ACGCCACCATTACT- MGB 
 
 
a 16S PCR used in early molecular identification of culture in patient 10. 
b Genus and species specific real-time PCR retrospectively used for all specimens. 
c Probes applied in combination with ITS forward and reverse primer. 
 
Real-time PCR and nucleotide sequence analysis. 
Real-time PCR was performed as described previously (4,7). Oligos used for real-time PCRs 
and for the sequencing of the internal transcribed spacer (ITS) and 16S rRNA gene are 
described in Table 1. The genus-specific PCR was performed twice for each sample, the M. 
avium and M. haemophilum-specific PCRs only once because of the limited amount of DNA 
extract. 
When a positive signal was found in the real-time PCR, the amplicon was sequenced to 
determine the involved species or to confirm a species-specific signal. All positive PCR 
reactions were analyzed with gel-electrophoresis. Bands between 150 and 200 bp were 
subsequently cut out and purified with the Qiagen gel-extraction kit (Qiagen, Venlo, The 
Netherlands). These bands represent the amplified region of the mycobacterial ITS. 
Sequence reactions have been performed with the PCR primers using the Qiagen Big Dye 
terminator ready reaction kit (Applied Biosystems, Nieuwerkerk a/d IJssel, The Netherlands) 







Archival FF-PE materials from 30 patients were collected from the archives of the pathology 
department. All the available clinical and histologic information on these patients was 
collected and the data revealed 14/30 immunocompromised patients (Table 1). Overall, the 
materials from 13 of the 30 (43%) patients contained mycobacteria (or mycobacterial DNA), 
diagnosed by conventional methods or by real-time PCR. Table 3 describes the diagnostic 
results of 15 samples from the 13 positive patients. Fourteen samples from 12 patients 
showed a positive signal in the genus-specific PCR. 
Amplicons formed in real-time PCR were sequenced to confirm or determine the species. All 
the amplicons but 1 (patient 3) were successfully sequenced and were recognizable as 
mycobacteria. The materials of 7 patients were positive for M. haemophilum, of which 3 were 
also directly identified in the M. haemophilum-specific PCR. No variation was found between 
the M. haemophilum sequences and 100% concordance was found with M. haemophilum-
specific sequences in the NCBI BLAST database. The latter differentiated this species clearly 
from others. Other identified species were Mycobacterium malmoense (n=1), Mycobacterium 
gordonae (n=2), and M. marinum (n=1). Two sequences did not match any known 
sequences. 
For several samples only 1 of the duplicate genus-specific reactions was positive. All of 
these samples had high Threshold cycle (Ct) values (Ct between 40 and 47). For the 
samples for which duplicate positive reactions were obtained, the Ct-values were lower (Ct 
between 32 and 41). The sequences of the positive duplicate reactions were identical. 
Conventional mycobacterial diagnostics was requested for only 5 patient materials. All the 5 
patients were subsequently diagnosed with a mycobacterial infection. Two were only positive 
in Zn staining (patients 8 and 28) and 3 were both Zn stain and culture positive (patients 7, 9, 
and 10). Discrepancies to the current molecular identification were found in the latter 3 
patients: 2 patients (patients 7 and 10) were previously diagnosed with a M. marinum 
infection, but the real-time PCR assay identified M. haemophilum in both cases. One patient 
(patient 9) previously had a positive culture for M. marinum but yielded no positive signal in 
real-time PCR. Fresh sections were cut from the materials from these 3 patients and 
processed again. The new PCR results confirmed our initial PCR results. From 1 patient, 3 
different materials were collected. The first sample dated from 1987 and 2 dated from 1993 
but were from different locations of the body. All the 3 samples yielded positive signals in 
PCR but all with different sequences. The sample from 1987 yielded a M. haemophilum, 1 
from 1993 resembled an M. gordonae and 1 sequence did not match any known sequence 
(Table 3). 
A control group was assembled from the biopsies of 30 patients with histologic proven BCC. 
Of these, 2 materials yielded positive signals for the genus Mycobacterium (Ct values: 42.1 
and 39.0) in one of the duplicate tests. From these 2 materials paraffin sections were 
prepared again and tested a second time in the real-time PCRs. Now only 1 sample yielded 
positive signals, twice in the genus-PCR and once in the M. haemophilum-specific PCR (Ct 
values: genus-specific PCR: 38.9 and 39.3, M. haemophilum-specific PCR: 41.1). The other 
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sample now remained consequently negative in all PCRs performed and could not be 
confirmed. However, it was only weakly positive the first time round (Ct value: 42.1). No 
positive reactions were obtained in the M. avium-specific PCR. Negative controls (paraffin 





In the last few years, several molecular assays for the detection of mycobacteria in clinical 
materials have been developed. Especially, the diagnosis of Mycobacterium tuberculosis 
infection has improved considerably, mainly because of the ability of PCR to deliver results in 
a clinically relevant timeframe and the resulting improved sensitivity (8–12). For the detection 
of atypical mycobacteria, several PCR assays have been developed (4,13–17). Also for the 
detection of mycobacteria in FF/PE materials, molecular assays have been applied to 
improve the sensitivity of the diagnostics. However, a real-time PCR assay for the direct 
recognition of nontuberculous mycobacteria in FF/PE specimens has not been evaluated, as 
described previously. 
From the 14 materials that yielded positive real-time PCR signals, 13 were successfully 
identified as mycobacteria by sequencing of the PCR amplicon. The obtained sequences of 
M. haemophilum, M. malmoense, and M. marinum were 100% identical to sequences in the 
NCBI database and were, therefore, clearly identifiable. The sequences of M. gordonae 
showed 99% and 97% homology to known sequences. Because the variability of the ITS 
sequences in this species is considerable, the obtained sequences can be considered 
representative for M. gordonae. For 2 patient materials, however, the obtained ITS 
sequences did not yield species identification. Both were recognizable as mycobacteria but 
could not be ascribed to 1 species. They both resembled the species M. tuberculosis and 
Mycobacterium asiaticum with 90% to 94% homology. Probably, as there were few bacteria 
available to be detected in the samples, several of the cases were on the detection limit of 
the assay (shown by the high Ct-values) and hence only positive in 1 PCR. However, 
comparison with the results from the control group shows that these results are associated 
with granulomatous inflammation. Moreover, a more sensitive assay would require a multi-
copy target, which is not available for the detection and differentiation of slow-growing 
mycobacteria. 
The risk of PCR inhibition has not been completely excluded. An internal control could be of 
benefit, but it could also affect the sensitivity of the assay and has, therefore, not been 
applied here. The sensitivity of the assay (both genus and species specific) has been 
determined previously to be 27 CFU per reaction in spiked pus (4). This explains the high Ct 
values encountered in several samples for which a more sensitive assay would provide 
stronger PCR reactions. 
As the diagnosis of rapid-growers is less difficult, the assay applied here is mainly designed 
for slow-growers. The detection limit for several rapid-growing species like Mycobacterium 
chelonae can be completely different owing to sequence variability. 
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Several discrepancies were examined in more detail. In 2 patients M. haemophilum was 
identified by ITS sequencing; whereas, previously M. marinum infection had been diagnosed 
using conventional cultures not suitable for the recovery of M. haemophilum. In the first 
patient (patient 7), the species M. marinum was identified biochemically. For the second 
patient (patient 10) 16S sequencing of the cultured isolate revealed M. marinum. Both 16S 
and ITS are sufficiently discriminative. A possible explanation for these discrepancies is the 
presence of a mixed infection. Dual infections have been described before and it is 
suggested that superinfections of previously established granulomas can occur (18–21). For 
another patient a positive culture for M. marinum had originally been obtained but real-time 
PCR remained repeatedly negative, although it was suitable for the detection of this species. 
This could be caused by the degrading of DNA, a sensitivity problem or nonhomogenous 
distribution of the bacteria in the sample. 
The prevention of laboratory contamination with mycobacterial bacilli or DNA has been 
carefully taken into account and precautionary measures have been applied as much as 
possible. Although it cannot be excluded, it is not expected that positive reactions, obtained 
during this study, are the result of previous contaminating handling of the materials because 
the sections that were cut out of the paraffin blocks had all been cleared from the outer parts. 
However, as no other diagnostic tool can distinguish between contaminant and true positive 
sample, this assay cannot either. 
The control group was assembled from patients with diagnosed BCC. Because 
mycobacterial infections are not linked to specific histopathologic patterns (22), it is very 
difficult to exclude mycobacterial involvement in samples of a control group. Our aim of 
testing this control group was to confirm that the mycobacteria are not a contamination owing 
to the handling of the sample but are indeed present within the tissue. Two materials from 
the control group gave positive real-time PCR signals. This could indicate carriership or 
colonization. However, these patients have conclusive diagnoses of BCC, but seemed to 
have severe and variable skin disease. In the histologic description of the biopsies 
inflammatory infiltrates were found besides evidence of BCC. This could be indicative for an 
additional infection by atypical mycobacteria. 
Mycobacterial infection has often been described in immunocompetent patients although the 
pathogenic properties of most atypical mycobacteria are unclear. In this test group 6 patients 
were found positive for mycobacterial skin involvement, which had no known underlying 
disease at the time of diagnosing the skin infection, but it remains possible that they had a 
genetic disorder predisposing for mycobacterial infections (23, 24) or a yet unrecognized 
underlying disease. Interestingly, such an immunocompromising condition was recognized in 
2 patients after the onset of the skin inflammation. 
Striking is the high prevalence of M. haemophilum in these patient materials. In 7 of 14 
positive biopsies M. haemophilum was identified. This species is an important pathogen in 
cervicofacial lymphadenitis (5,7), has been described as cause of pneumonia (25,26), 
arthritis (25,26), and bacteremia (27) and is probably underestimated in skin infections as 
well. M. haemophilum was first described as the cause of skin  inflammation in 1978 (28). 
Since then approximately 100 cases of M. haemophilum associated skin infection have been 
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described worldwide. In The Netherlands the first skin infection owing to M. haemophilum 
was described in 1997 (29). Other M. haemophilum infections occurred only sporadically until 
a series of M. haemophilum-associated lymphadenitis was recently discovered (7). The 
histologic manifestation of M. haemophilum is generally granulomas with giant cells, 
lymphocytes, and histiocytes. Necrosis can be absent. The number of bacteria is mostly low. 
Several publications suggest this species to be underdiagnosed (25,30,31), which is 
confirmed by the results described here. Although increasing number of laboratories are 
applying specific culturing methods suitable for the recovery of M. haemophilum, some 
laboratories still do not. In some cases when the culture becomes positive at 30 °C, it is 
assumed that M. marinum is involved without proper species identification (32). It is shown 
here that M. haemophilum-infections were present in The Netherlands years before the first 
diagnosis. 
In conclusion, the application of molecular diagnostics can be useful to diagnose atypical 
mycobacterial skin infections in FF/PE patient materials. A higher awareness about 
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The role of the species Mycobacterium haemophilum as a pathogenic non-tuberculous 
microorganism is becoming more well-defined with the use of specific detection methods. 
However, epidemiological investigations of this species are still scarce. We analyzed the 
genetic diversity of M. haemophilum by amplified fragment length polymorphism (AFLP) 
typing and compared strains from different parts of the world. A total of 128 strains including 
41 from the United States, 51 from Australia, 28 from Europe and 8 strains from Israel were 
compared using AFLP methodology. Two restriction enzymes (MseI and EcoRI) and one 
selective primer were applied and provided a high discriminatory power. Clusters of strains 
with identical AFLP patterns were observed from the Netherlands, New York and Australia 
which could indicate a possible common source. No clear clustering based on continental 
origin was determined. However, types were restricted to geographic areas and not found on 
other continents. A high genetic stability within the species was demonstrated by the long 





Mycobacterium haemophilum was first described in 1978 following isolation from cutaneous 
lesions of a woman with Hodgkin’s disease [1]. The organism is unusual in that it has an 
optimal temperature for in vitro growth between 30° and 32° C, and a requirement for 
supplementation of growth media with iron containing compounds, including ferric 
ammonium citrate or hemin. M. haemophilum most often causes joint, cutaneous and 
pulmonary infections in immunocompromised patients and lymphadenitis in 
immunocompetent children, although infections in immunocompetent adults do occur [2, 3]. 
In recent studies, M. haemophilum was identified as the second most common mycobacterial 
pathogen causing cervicofacial lymphadenitis in children in The Netherlands [4, 5]. There is 
no evidence of patient-to-patient spread of the organism and M. haemophilum infections 
appear to be acquired from the environment, most likely water and bio-films [6-8]. Clusters of 
cases representing a variety of clinical manifestations from Australia [9], Israel [10], New 
York City [11] and The Netherlands [4] have been reported. Molecular epidemiology studies 
have suggested clonal geographical clustering [12, 13]. To analyze the molecular 
relatedness and global diversity of M. haemophilum, a collection of isolates from Australia, 
Europe, Israel and the United States were typed by amplified fragment length polymorphism 
(AFLP). The AFLP method is based on the selective amplification of genomic fragments after 
digestion by one or more restriction enzymes and visualized by band patterns. The genomic 
mutations that cause a restriction site to emerge or disappear or that change the length of 
the fragment between the restriction sites, give rise to differences in band patterns [14].  
Compared with the PFGE as a gold standard for typing, AFLP has been shown to be as 




Materials and Methods. 
  
Mycobacterial strains.  
Isolates of M. haemophilum were obtained from Leiden University Medical Center, Leiden, 
The Netherlands; Memorial Sloan-Kettering Cancer Center, New York, USA; Western 
Australian Centre for Pathology & Medical Research, Nedlands WA, Australia; Rabin Medical 
Center, Petach-Tiqva, Israel; Institute of Microbiology, University of Oslo, Oslo, Norway; and 
the Laboratory for Microbiology and Virology, Ospedale Careggi, Firenze, Italy. Isolates were 
shipped either freeze-dried or as a culture, and upon arrival in Leiden cultured on 
Lowenstein-Jensen medium with added FAC (ferric ammonium citrate) and incubated at 30 
°C. Other mycobacterial species were cultured on Lowenstein-Jensen medium with added 
PACT (polymyxin B, amphotericin B, carbenicillin, and trimethoprim) and incubated at 35 °C. 
(Bectondickinson, Alphen a/d Rijn, The Netherlands). After sufficient growth, aliquots of the 
organisms were stored at -20°C pending DNA-extraction. In total, 182 M. haemophilum 
strains were collected of which 54 failed to grow. The remaining 128 M. haemophilum strains 
(including two strains tested in duplicate) were subjected to genotyping and are described in 
Table 1.  
Seven mycobacterial species, encompassing M. haemophilum and six other mycobacterial 
species were tested for species differentiation based on the AFLP protocol. Closely related 
species to M. haemophilum, based on combined phylogenetic analysis of different genomic 
targets, were Mycobacterium malmoense and Mycobacterium heidelbergense [17]. Species 
that appeared closely related based on only 16S rRNA gene phylogeny were Mycobacterium 
szulgai and Mycobacterium bohemicum [18, 19]. Mycobacterial species with less 
phylogenetic relations to M. haemophilum were Mycobacterium interjectum and one 
unidentified species, OMS011. All of these strains were clinical isolates from the Leiden 
University Medical Center collection or provided by the National Tuberculosis Reference 
Center (RIVM) and all were identified by the RIVM by 16S rRNA gene sequencing [20].  
 
AFLP procedure optimization.  
Optimization of the procedure included 1) Different methods of DNA-extraction: QIAamp 
DNA mini kit (Qiagen Benelux, Venlo, Netherlands), MoBio® Ultraclean Microbial DNA 
isolation Kit (Sanbio, Uden, The Netherlands), ZR Genomic DNA kit and DNA II kit (Zymo 
research, Orange, CA, USA) and the Boom extraction method [21]. All DNA extraction 
methods were tested according to the manufacturers protocols, with or without sonication 
and proteinase pre-steps. 2) Variations in the AFLP protocol: incubation time and cycling 
conditions. Strains were re-cultured several times to provide fresh isolates for the different 
trials during the optimization process. During optimization of the typing procedure, DNA 
extraction was performed in triplicate.  
 
DNA-extraction.  
For DNA extraction, one or more colonies were suspended in molecular grade water and 
sonicated 3 times 5 seconds at 8 microns (amplitude) prior to an overnight incubation with 
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proteinase K (2 mg/ml) at 50 °C (Invitrogen, Breda, The Netherlands). DNA was extracted 
using the MoBio Ultraclean Microbial DNA isolation Kit (Sanbio) and eluted in 100 µl (50 µl 
elutionbuffer with 50 µl molecular grade water). Final concentration and purity of DNA was 
confirmed with the Nanodrop ND 1000 (Nanodrop technologies, Wilmington, Delaware USA), 
and for successful patterns a concentration range of 5-20 ng/µl (5 µl/reaction) and a purity 
OD range of 1.50-2.30 (260/280 coefficient) was used.  
 
Genotyping.  
The AFLP procedure was as follows: 3 hr 37 °C (digestion and simultaneous ligation of the 
adaptors). The restriction/ligation mix contained 10x T4-ligation buffer (Westburg, Leusden, 
The Netherlands), 0.5 M NaCl, 0.5 µg BSA (Westburg), 2 pmol EcoRI adaptor (Eurogentec, 
Maastricht, The Netherlands), 20 pmol MseI adaptor (Eurogentec), 80 U T4-ligase 
(Westburg), 1 U MseI (Westburg) and 1 U EcoRI (Westburg) in a 5 µl volume per reaction 
and 5 µl DNA. Subsequently, the restriction/ligation product mixture was diluted 20x in 0.1 
Tris-EDTA-buffer before amplification. PCR was carried out in 10x PCR buffer (Applied 
Biosystems, Foster City CA, USA), 15 nmol MgCl2, 2 nmol DNTP’s, 20 ng primer Eco-0 (5'-
GACTGCGTACCAATTC-3’) (Applied Biosystems), 60 ng primer Mse-C (5'-
GATGAGTCCTGAGTAAC-3') (Eurogentec) and 1 U Ampli-taq polymerase (Applied 
Biosystems). 5 µl PCR mix was added to 5 µl of diluted restriction/ligation product mixture. 
The PCR program started with an activation of 2 min at 72 °C, 35 cycles with a touchdown 
principle: 30 sec 94°C, 10 sec 65-56 °C, 1 min 72 °C (annealing first cycle at 65 °C, 12 
cycles 0.7 degrees down per cycle, followed by 23 cycles at 56 °C), and a final extension of 
10 min at 72 °C. 2.5 µl of PCR product was added directly in 22.5 µl HiDi formamide (Applied 
Biosystems) with ROX500 (Applied Biosystems) as internal marker and analyzed in an 
ABI3100 genetic analyzer (Applied Biosystems).  
 
Analyzing patterns.  
AFLP patterns were analyzed and calculations were performed with the Bionumerics 
software (Applied Maths, Sint-Martens-Latem, Belgium). During optimization of the protocol, 
the AFLP patterns (PCR fragments length distribution) were analyzed with Pearsons 
coefficient and the unweighted pair group method with mathematical averaging (UPGMA) 
cluster analysis. Application of the Pearsons coefficient resulted in intensity differences of 
bands which affected the similarity calculations for strains with identical and highly similar 
band patterns. Therefore, another approach was chosen for the study of the M. haemophilum 
strain collection. Digitized bands were assigned to the AFLP fragments and the DICE 
coefficient and UPGMA cluster analysis were applied to the band patterns. For a subset of 
three M. haemophilum strains, Pearson analysis was compared with DICE analysis (Fig 2a 
and 2b). In order to exclude subjective interpretation duplicate AFLP reactions were included 
of each strain of the M. haemophilum strain collection. The average amount of bands per 
pattern is 50. Bands between 85 and 350 nucleotides have been included in the analysis. A 
strain was considered different from another when at least 1 band is different in the DICE 
pattern, since one band difference is associated with a detectable mutational event [22]. One 
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band difference was designated a “variant type”, two or more bands difference was 
considered a “type”. Designation of types was given by continent of origin and did not yield 
information concerning the genetic distance (e.g. type-designation USA A has no correlation 





Optimization of the molecular typing procedure. 
The optimization process utilized the method as described in Materials and Methods. A panel 
of strains was used to validate the different levels of discrimination. Seven different species, 
including M. haemophilum (strain Netherlands 5) were tested in triplicate and compared 
(Figure 1). All patterns were calculated with the Pearsons coefficient. The similarity between 
species was well below 15% with this AFLP protocol. Therefore, the applied method was 
clearly capable of discriminating different mycobacterial species. The pattern homology 
between different DNA extracts of the same strain was 90% or more when calculations were 
made with Pearsons coefficient (Figure 2a). The variability between these DNA extracts after 
assignment of digitized bands for DICE calculation showed a similarity of 100% (Figure 2b).  
 
 
Figure 1. AFLP patterns of different species in triplicate, calculation with Pearsons coefficient 
Mycobacterium spp is the unidentified species OMS011, which clearly not belongs to one the species included in 



























Figure 2. AFLP patterns of 3 M. haemophilum strains in triplicate. A) calculations with pearsons 





























The AFLP procedure (including Dice analysis) was used for typing 128 clinical isolates of M. 
haemophilum representing four geographic areas; 8 were from Israel, 41 from the United 
Sates, 28 from Europe and 51 from Australia (Table 1).  
Figure 3 (supplemental data) depicts pattern comparisons of the collection of 128 M. 
haemophilum strains. The lowest similarity between all strains was 78%. No clear clustering 
based on continental origin was observed. All types were unique to their continent of origin 
and not found in other continents. However, the types from each continent were not 
necessarily the most similar to each other. For instance: Type USA A was restricted to New 
York but other USA types could be located in other clusters of the dendrogram. Only one 
band difference was observed between types Eur A and Aus A, and are therefore considered 

















USA  41 1991-2001 USA A (29) 4 
   1990-1991 USA B (5)  
   1998 USA C (1)  
   1991-1993 USA D (3)  
   2000 USA E (2)  
   1984 USA F (1)  
Israel  8 1996-2003 East A (2) 1 
   2003 East B (1)  
   1971 East C (1)  
   2003 East D (1)  
   2003-2004 East E (2) 1 
   1996 East F (1)  
Australia  51 1987-2003 Aus A (23) 3 
   1987 Aus B (1)  
   1986-2004 Aus C (16)  
   1990-1996 Aus D (2)  
   2003 Aus E (1)  
   2004 Aus F (1)  
   2000 Aus G (1)  
   1977 Aus H (1)  
   unknown Aus I (1)  
   unknown Aus J (1)  
   unknown Aus K (1)  
   unknown Aus L (2)  
Europe  28 2003-2005 Eur A (24) 1 
   2004 Eur B (1)  
   2004 Eur C (1)  
   2003 Eur D (1)  
    2000 Eur E (1)   
 
 
Forty-one strains were from the USA; 38 from 7 New York City hospitals (1989-2001), 2 from 
Seattle (2000) and 1 from Phoenix (1984). All of the patients except one were adults, and 
most had AIDS or cancer and/or were transplant patients. There were 6 AFLP types (USA A-
F). USA A, including a type variant, was the most prevalent type (29 isolates) and was only 
found at New York City hospitals. Among the New York isolates, 15 were from patients at 
one hospital. Type USA B was found in 4 patients at two New York hospitals, and all 4 
patients possibly acquired the infection outside New York City, in the late 1980’s (according 
to their physicians). Type USA C was isolated from a lung nodule of a patient at a New York 
hospital, but the immunocompetent patient probably acquired the infection while at home in 
the Philippines [23]. Type USA D was only found in 3 AIDS patients at one New York City 
hospital early in the 1990’s. Type USA E was isolated from two patients at a hospital in 
Seattle; one patient with AIDS and the other with diabetes, in 2000. Type USA F was isolated 
from a renal transplant patient in Phoenix in 1984.  
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Of the 8 strains from Israel, 7 were isolated from lymph node specimens between 1996 and 
2003 and the other represented the first known isolate of M. haemophilum (ATCC 29548), 
from 1971. The ATCC strain from Israel clustered with other strains from Israel (94%), but 
identical patterns were not observed. The 8 isolates could be divided in two clusters of which 
one cluster forms the most distinct cluster of strains of this collection; 77% similarity with all 
others.  
Within the collection of 51 strains from Australia, two large type clusters of identical patterns, 
Aus A and Aus C and 12 strains representing 10 other types could be recognized. Type Aus 
A consisted of 23 strains, including 3 strains with type Aus A var, a type that remained 
unchanged from 1987 thru 2002. The type Aus C included 16 strains and remained 
unchanged from 1986 thru 2004. The minimum similarity between the other Australian types, 
Aus B and Aus D-L, was 85% and appears scattered throughout the dendrogram. About half 
of the Australian isolates were from immune compromised patients and isolates were 
recovered from variable sites. 
The European collection of 28 strains consisted of 26 from the Netherlands of which 22 from 
the Amsterdam region and 4 from other regions of the Netherlands, one from Norway and 
one from Italy. Twenty-three Netherlands strains yielded type Eur A of which 21 strains were 
from the Amsterdam region and all from children with cervicofacial lymphadenitis. The 
Norwegian strain differed in only one band with the Amsterdam type and is therefore 
designated type Eur A var. Four other types, Eur B-E, were identified once for each type, of 





Molecular methods play an increasingly important role in our understanding of 
epidemiological strain characteristics and patient related significance of infectious micro-
organisms. Although several species of mycobacteria have been examined extensively by 
molecular methods, there is very limited information regarding the diversity of this organism. 
Previously, two molecular methods, a Restriction Fragment Length Polymorphism (RFLP) 
assay [12] and a Pulse Field Gel Electrophoresis (PFGE) assay [13], were used to type USA 
isolates, most from the New York City area, of M. haemophilum. These two studies 
demonstrated genetic clustering within the tested strain collections which could indicate a 
common source. The RFLP showed similar discriminatory power compared to the PFGE [12, 
13]. We compared the results of 15 isolates typed by RFLP in New York in 1994 with our 
results of AFLP and found that 5 different RFLP types corresponded with 5 different AFLP 
types (data not shown) [12]. Therefore, the discriminatory power of all three methods seem 
similar. 
The main objective of the present study was to investigate the level of genetic diversity within 
and between isolates of M. haemophilum collected from several part of the world and typed 
by AFLP. Prior to comparing the different isolates of M. haemophilum, a validation procedure 
was conducted to determine the optimal discriminatory power of the AFLP method for M. 
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haemophilum at the strain and species level. The enzyme combination with one selective 
primer showed a suitable fragment distribution for this species. Because M. haemophilum 
has a strong tendency to clump, a stringent protocol was necessary to obtain high quality 
and quantity of DNA from bacterial colonies for reproducible AFLP patterns: A combination of 
sonication, enzymatic and mechanical disruption resulted in pure DNA and subsequent 
reproducible AFLP patterns. Although Pearsons analogue analysis of the AFLP patterns 
revealed similar clustering, DICE analysis enabled a clearer visualization of the true 
differential patterns of a large panel of M. haemophilum isolates. Among the 128 strains 
typed in this study, there were indications of clustering. Strains from the Amsterdam region 
(Netherlands 1-21) resulted in one identical AFLP pattern, type Eur A, while patterns of 
strains from other regions of the country varied, thus confirming the epidemiological 
relatedness of the Amsterdam strains. Most strains from the New York area yielded an 
identical pattern as well, type USA A, which was observed from 1989 to 2000. Among 
Australian strains, two clusters were observed. One of these clusters remained unchanged 
for 18 years (type Aus C), and the other for 15 years (Aus A), suggesting an extremely low 
evolutionary rate for this mycobacterium, and perhaps the ability of the organism to create a 
stable niche. Previously, the persistent colonization of the species M. avium was 
demonstrated in water distribution-systems, which illustrates the ability of mycobacteria to 
prevail long-term in a stable niche [24]. A similar water borne niche for M. haemophilum 
might exist.  
 
The variety between strains is relatively high between different types (minimal similarity of 
78%), while the types Aus A and Eur A are variant strains of each other, suggesting an 
evolutionary link between these two types. Also, type Aus A appears common in immune 
competent patients (p<0.001) and this could indicate differences in virulence between types. 
The immuno status of patients was equally distributed among the 51 isolates from Australia, 
in contrast to the isolates from other continents. Of 23 type “Aus A” and type “Aus A variant” 
strains, 19 (83%) were isolated from immuno competent patients, while only 4 strains from 
immuno competent patients yielded another type. In addition, the type “Eur A” is solely found 
in immune competent children (no background information is available for the Norwegian 
strain with type “Eur A variant”). Two Netherlands strains with other types (201: type “Eur C” 
and 200: type “Eur D”) had both been isolated from the only two Netherlands patients with 
immune compromising conditions.  
 
It is difficult to define the exact origin of a clinical isolate due to a lack of information 
regarding patient travel history, out-patient or in-patient history, precise clinical history, etc. 
Also, the incubation period for the infections is probably, in some cases, extensive, thus the 
exact origins of the strain might vary from the documented patient history. For example, 
among the Australian strains two large clusters of similar strains have been determined of 
which a few isolates have been encountered in geographically distant locations from the rest 
of the strains. Therefore, a common source or geographical linkage to type distribution 
cannot be excluded. The source and spread of M. haemophilum infections is still in question. 
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It has been difficult to recover the organism from the environment, although the scant 
literature suggests a water and/or biofilm source [6, 8]. This study and the New York studies 
suggest a clustering of cases both by geography, patient types, clinical presentations and 
time period of the cluster. For example, the New York City cases began, rather abruptly, in 
1990, were mostly found in adult, immunocompromised adults, and most with AIDS or who 
had received bone marrow transplants. The methods of diagnostics in New York had not 
been adjusted prior to this abrupt rise of M. haemophilum isolates. Investigators of the M. 
haemophilum infections in the Amsterdam region suggested a public indoor swimming pool 
or home water supplies as possible sources of the infection. The home water supply of one 
child with lymphadenitis was examined for the presence of M. haemophilum, but real-time 
PCR and culturing methods yielded only the species M. kansasii. That investigation was 
performed several months after onset of the disease and the home water supply can 
therefore not be excluded as infection source. 
 
As reported cases of M. haemophilum increase, additional epidemiologic information 
will become available, and we now have the molecular tools to further define the global 








Figure 3. AFLP typing results of clinical Mycobacterium haemophilum isolates in dendrogram calculated 
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Mycobacterium avium is the most commonly encountered mycobacterium species among 
non-Mycobacterium tuberculosis complex (NTM) isolates worldwide and frequently causes 
lymphadenitis in children. During a multi-center study in the Netherlands that was performed 
to determine the optimal treatment for mycobacterial lymphadenitis, concern was expressed 
in the media about the possible role of birds as sources of these M. avium infections, referred 
to as ‘bird-tuberculosis’. To examine the involvement of birds in mycobacterial lymphadenitis, 
34 M. avium isolates from lymphadenitis cases were subjected to IS1245 restriction fragment 
length polymorphism (RFLP) typing. This genotyping method enables the distinction of the 
sub-species M. avium subsp. hominissuis and the “bird-type” M. avium spp. avium. 
Highly variable RFLP patterns were found among the lymphadenitis M. avium isolates and all 
belonged to the M. avium hominissuis subspecies. A relation to pet-birds in the etiology of 






While the absolute number of clinical isolates of non-tuberculous mycobacteria (NTM) has 
worldwide increased gradually with the upcoming of AIDS, the number of isolates in The 
Netherlands remained stable in the last decade. In the period from 1996 to 2005, 4640 NTM 
isolates were collected at the national tuberculosis reference laboratory (RIVM), of which 
1484 (32 %) belonged to the M. avium complex. Mycobacterium avium is not only a well-
known cause of pulmonary disease, especially in immunocompromised patients, but is also 
the most commonly encountered species in mycobacterial lymphadenitis in children. The 
exact incidence of M. avium lymphadenitis is difficult to assess but is estimated at 1.15 per 
100,000 children (1-18 years) in the Netherlands [1]. 
From 2001 to 2004, a nation-wide multi-center to examine the optimal treatment of NTM 
mycobacterial cervicofacial lymphadenitis (surgery vs medical therapy) was performed [2]. In 
this study it was found that 94 (70%) of 135 diagnosed mycobacterium infections were 
caused by M. avium [3]. As a consequence of this study, numerous articles appeared in 
regional and national newspapers in the Netherlands in which the concern was expressed 
that mycobacterial lymphadenitis in children is a form of ‘bird-tuberculosis’. This is based on 
the conventional, but still widely accepted dogma that M. avium infections in humans are 
derived from birds. Moreover, many patients included in the treatment study and diagnosed 
with M. avium-associated lymphadenitis, appeared to keep pet-birds in the household or had 
an otherwise frequent contact with birds, as was demonstrated in a questionnaire for 
epidemiological purposes [3]. However, no demographic information on the presence of pet-
birds in the general population in The Netherlands is available and it therefore remains 





With the improved possibilities for the diagnosis of mycobacterial infections, new (sub-) 
species have been identified and new insights in taxonomy are being developed. Previously, 
in the M. avium- M. intracellulare complex (MAC), 28 serotypes were distinguished [4]. The 
species M. avium consists of the subspecies M. avium ssp. avium, M. avium ssp. silvaticum 
and M. avium ssp. paratuberculosis [5]. Restriction Fragment Length Polymorphism (RFLP) 
typing, using insertion sequence IS1245 as a probe is a standardised epidemiological tool for 
the molecular typing of M. avium [6, 7]. The targeted insertion element IS1245, is specific for 
the species M. avium, and is present in a highly variable number and location in the genome 
of these bacteria.  
Application of this typing method led to the recognition that M. avium isolates from birds of a 
wide variety of species exhibited one identical pattern [7, 8, 9, 10]. This three band pattern 
was designated the “bird-type” RFLP pattern. To exclude the raised confusion in the 
epidemiology of M. avium infections, the “bird-type” M. avium strains were further 
characterized and this sub-species was named M. avium avium [9]. The M. avium isolates 
from human- and porcine sources showed highly polymorphic IS1245 RFLP patterns and 
were designated “M. avium hominissuis” [9].   
In this study the contribution of the bird-type M. avium avium to lymphadenitis in children in 
The Netherlands is examined to confirm or exclude the involvement of birds in the aetiology 
of this disease. 
 
 
Materials and Methods. 
  
Strains and culturing methods. 
M. avium strains were isolated from children included in the lymphadenitis treatment study. 
Inclusion criteria for this study were an enlarged cervicofacial lymphadenitis for a period 
longer than 3 weeks, with negative serology for other infectious causes of chronic 
lymphadenitis. Excluded were patients with an immunosuppressive therapy or disease [3]. In 
addition, skin testing with M. tuberculosis complex- and 3 NTM sensitins was performed [11]. 
Diagnosis was confirmed by culture and/or specific real-time PCR, performed on lymph node 
aspirates or surgically obtained tissue biopsies [3, 12]. Culturing was performed at 35 °C in 
liquid MGIT medium enriched with PANTA and OADC or on solid Löwenstein Jensen 
medium (Becton Dickinson, Alphen a/d Rijn, The Netherlands). Strains were sent to the 
RIVM in Bilthoven and processed in IS1245 RFLP typing (Table1). 
 
Species identification. 
Real-time PCR was performed as described previously [12]. A genus-specific and a M. 
avium-specific PCR were performed on all isolated strains as well as on DNA extracts of bird 
materials. When a positive signal was found in exclusively the genus-specific real-time PCR, 
the amplicon was purified using a gel-extraction kit (Qiagen, Venlo, The Netherlands) and the 
PCR product was sequenced to determine the species the respective bacteria belonged to. 
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Sequencing was performed on basis of the PCR primers using the Big Dye Terminator ready 
reaction mix (Applied Biosystems, Nieuwerkerk a/d IJssel, The Netherlands) and analysed 
on an ABI 3100 automatic Sequencer (Applied Biosystems). A second identification was 
performed at the RIVM; either by 16S-sequencing [13] or by a reverse line blot (InnoLipa V2, 
Innogenetics, Gent, Belgium) to confirm the identity of the M. avium strains. 
 
Molecular typing. 
A database has previously been assembled by the RIVM of RFLP patterns from M. avium 
isolates from humans in the Netherlands in the period 1996-1997, or from animals and soil in 
a period of decades. IS1245 RFLP typing was performed as described previously [6, 10]. 
RFLP patterns of 34 M. avium isolates from lymphadenitis cases were analysed and 
compared with known patterns in the database using Bionumerics software (Applied Maths 
BVBA, Sint-Martens-Latem, Belgium).  
 
Bird materials. 
Materials of pet-birds from two patients diagnosed with M. avium-associated lymphadenitis 
were collected. One patient owned two parakeets and kept them inside the house. Another 
owned 8 parakeets and they were kept in an aviary in the yard. Considering the age of the 
included children it is not expected that the children were the direct care-takers of the birds. 
The parakeets had different ages, gender and breed. The birds did not show any sign of 
illness. Swabs were collected from the cloacae of the parakeets and faeces were scraped 
from the bottom of the cages (as fresh as possible). All samples were divided equally in two 
portions and examined by two different institutes (CIDC Lelystad and LUMC, Leiden, The 
Netherlands). Swabs were processed as clinical materials [12] and decontaminated once 
with the Nalc-NaOH method prior to culture. Faeces were decontaminated twice prior to 
culture, but otherwise processed identically, including the culturing. One institute also 






In the lymphadenitis treatment study, 210 lymph node biopsies of cervicofacial lymphadenitis 
patients were examined for the presence of mycobacteria by culture and real-time PCR [2, 
12]. Mycobacterial infection was diagnosed in 138 children, of which 94 (70%) were caused 
by M. avium. Sixty positive cultures were obtained in the four years period of the study. All 
positive M. avium cultures from between November 2001 and June 2004 (n=34) were sent to 
the RIVM and subjected to RFLP typing. 
Analysis of the background information of the 34 children demonstrated only one child to 
have ducks in the immediate vicinity of its house and none of the 34 children had been into 
direct contact with horses, chickens, geese, pigs, goats and pigeons. Twenty-one (62%) 
children, however, played in a sandpit, 13 (38%) children swam in a closed swimming pool 
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(none in open water) and a total of 18 (53%) children had pet animals of which in 33% of the 
cases this concerned birds (Table1). 
 
Molecular typing. 
In total 34 M. avium isolates from the patients included in the lymphadenitis treatment study 
were subjected to IS1245 RFLP typing and the results are depicted in figure 1. Among the M. 
avium isolates of the lymphadenitis patients a high variety of multi-banded IS1245 RFLP 
types was found and all belonged to the ssp. avium hominissuis and not to M. avium ssp. 
avium. The obtained IS1245 RFLP patterns were compared with the Dutch IS1245 RFLP 
database and showed similarity with the patterns of previously described genotype families in 
The Netherlands (clades 7501-7509) [14]. No association was found between the clades -to 
which the isolates were assigned to- and pet-birds or other pet-animals, time of onset of the 
disease, playing in sandpits, visiting the children’s farm, swimming or location of housing.  
Also, no geographical clustering could be found for these strains, the residence of the 
respective patients appeared to be completely random in The Netherlands. In fact, the RFLP 
patterns of several M. avium strains were 95-100% similar to that of another strain while no 
correlation was observed with any patient factor (Table 1: designation α-ε). 
 
Bird materials. 
Culture and real-time PCR performed on the bird materials revealed two faeces specimens 
positive for mycobacteria. One was only detected by culture and was identified as M. terrae. 
The other one was concordantly detected by culture and real-time PCR and identified as M. 
malmoense. Both identifications were done by sequencing the Internal Transcribed Spacer 





Atypical mycobacteria are ubiquitous present in our environment, but few clinical cases have 
so far been directly linked to their natural reservoirs [15, 16, 17]. Traditionally, lymphadenitis 
in children caused by M. avium is indicated as ‘bird tuberculosis’, because historically M. 
avium bacteria were thought to have an association with birds. Because a striking 
percentage of the lymphadenitis patients in the Netherlands were in contact with birds, the 
concern was expressed in the media that birds were the source of infection for these 
lymphadenitis cases. This was not only driven by the fact that children naturally play outside 
in sand and soil, but also by the fact that 8 of 34 children were in households where pet birds 
were present. Therefore, in this study, M. avium isolates from the lymph nodes of 34 children 
with lymphadenitis were subjected to IS1245 RFLP typing and compared. The main objective 
in this comparison was to verify the occurrence of the bird-type M. avium within this group of 
patients. Although the patient strains revealed a high degree of variation in the IS1245 RFLP 
patterns, the bird-type was not found in any of the 34 M. avium isolates which excludes the 
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possibility that bird-type strains are the source of infection. Moreover, no M. avium could be 
isolated from bird materials collected from the patients’ pet birds. 
In several studies this DNA typing method has been applied for epidemiological purposes [7, 
8, 14, 18, 19, 20] and almost all M. avium isolates from birds revealed a characteristic bird-
type 3-banded IS1245 RFLP pattern, while multi-banded RFLP types were very rarely 
encountered in bird isolates. The method has been investigated for its stability of patterns 
[21] and its specificity for the IS1245 has been discussed in several papers [7, 22].  
 
Earlier studies [partially published: 14] conducted by the RIVM demonstrated a high degree 
of similarity between human and porcine M. avium isolates. IS1245 RFLP typing of 146 
isolates from humans in The Netherlands- the total number of M. avium strains collected in 
the year 1996 and 1997- yielded highly variable DNA fingerprint patterns and a large part of 
the isolates could be assigned to nine different clades with a high degree of similarity among 
the RFLP patterns. A large part of the isolates both from human and porcine sources were 
grouped in the same clades.   
The M. avium isolates of this study were scattered over several clades as was similarly found 
for the lymphadenitis isolates from the period 1996-1997. Six strains from this study 
belonged to clade 7502 in which in previous studies the majority of strains from HIV-infected 
patients clustered (unpublished: Thesis Schneider, Bilthoven, the Netherlands). The high 
variability among the RFLP patterns may demonstrate the presence of high numbers of M. 
avium hominissuis bacteria in environmental sources and/or variability in source of infection. 
While a high degree of variation was generally observed between the typed M. avium strains 
of the lymphadenitis cases, several patient strains were identical to one-other strain. 
Comparison of the strains to the IS1245 RFLP database showed one strain from 1996 to be 
identical to one strain from 2004. This indicates the long-term genomic stability of the 
representative strains and the ability of these bacteria to prevail in a stable niche. 
The bird-type M. avium is pathogenic to birds [7, 23]. However, the birds kept in the patients’ 
home showed no signs of illness. It is, however, still possible that pet-birds are carriers of M. 
avium subsp. hominissuis strains and regularly transmit these M. avium bacteria to children 
causing lymphadenitis in a significant number of them. In this study, we were not able to 
grow M. avium from bird faeces and cloaca swabs. Therefore, this hypothetical carriership of 
birds could not be confirmed. Because the pilot experiment with bird materials was very small 
in size and the materials were not collected at time of onset of the disease, the possibility 
that non-diseased pet-birds are carriers of M. avium hominissuis cannot be completely 
excluded. The pet-birds can also be an indirect cause; because M. avium is ubiquitous in 
soil, water, animals, food and sawdust [14, 15, 19, 24], these bacteria may well spread 
directly from such sources. 
No other contact with farm animals than an occasional trip to the children’s farm (33%) was 
apparent in these patients. Therefore, pigs or other farm animals are not likely to have 
served as sources of infection [19].  
Reed and colleagues described in a random household survey conducted in Florida, the only 
apparent risk factor for M. avium infection is prolonged exposure to soil [25]. Von Reyn and 
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colleagues described that while some clinical M. avium cases could be linked to the 
household water supply by molecular typing, colonization of the water supply with M. avium 
does not increase the risk of infection [26]. 
No correlation could be found in strain distribution with any kind of behaviour or geographical 
residence of the patient. We therefore conclude that the sources of M. avium causing 
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Figure 1: Comparison of IS1245 RFLP patterns of all M. avium strains. Analysis in Bionumerics. Clade 













month pets swimming sandpit 
children's 
farm season etnicity  
Typing 
details a 
           
102014 june '01 FL 35 - - + + summer NE  
200875 feb '02 OI 20 + - - - spring NE  
201583 jun '02 NH 25 - - + + summer NE  
201584 jul '02 NH 19 - - - - summer NE  
201871 jul '02 NH 21 - - - - autumn NE  
300211 sep '02 GL 27 - - + + autumn NE  
300212 oct '02 FL 34 - - + - autumn Afghan       Clade 7502 
300987 oct '02 ZH 148 + + - - winter NE β 
300601 jan '03 FL 38 + - + + winter NE Clade 7509 
400124 may '03 ZH 31 + - - - winter NE δ 
300985 feb '03 GL 67 + + - - spring NE β 
300986 feb '03 NH 18 + - - - winter NE Clade 7501 
302015 jul '03 NH 45 - - + - summer NE  
301141 mar '03 LB 57 + + + - spring NE Clade 7509 
301142 mar '03 Dr 17 + - + + spring NE Clade 7501 
302014 jul '03 NB 15 + - - - spring NE Clade 7509 
302016 may '03 NH 50 - + + + spring NE γ 
302013 jun '03 FL 73 - + - + summer Maroccan γ 
400892 may '03 NB 47 + + + - autumn NE α 
302203 jul '03 NB 21 - - - - autumn NE Clade 7509 
302205 sep '03 ZL 58 + + + - autumn NE δ 
302204 may '03 ZL 36 + + + - spring NE Clade 7502 
302300 aug '03 UR 25 + - + - autumn NE  
400059 sep '03 GL 47 - - + + autumn NE Clade 7502 
400274 dec '03 GL 20 - - + - winter NE Clade 7501 
400819 feb '04 NB 104 + + - - autumn NE Clade 7502 
400398 nov '03 ZH 44 - + + + autumn NE Clade 7502 
400620 dec '03 NH 27 + - + - winter NE Clade 7501 
400619 feb '04 NH 26 - - - - winter NE  
400821 feb '04 NH 52 + + + + winter NE α 
400895 mar '04 NH 18 - - - - spring NE  
401217 feb '04 NB 56 - + + - spring NE Clade II / ε 
401218 feb '04 LB 19 + - + - spring NE Clade I 
300854 feb '04 FL 32 + + + + spring NE Clade II / ε 
 
a typing details include clade designation according to Komijn et al [14] and similarity (95-100%) designation 
between strains of this collection: α, β, γ, δ or ε. 
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The work presented in this chapter is part of a more extensive analysis on the diagnostic value 
of gene targets for the identification of mycobacterial species, which is currently performed by 






Sequencing of specific genomic targets like 16S and the 16S-23S spacer for the identification of 
Mycobacterium isolates is a widely used approach. However, it is not known whether the 
currently used targets are the most optimal for speciation of mycobacteria. Hence, the most 
widely used gene; the 16S rRNA, automatically remains the favourite target of choice for this 
purpose, while no independent study has been conducted to compare the utility of the other 
candidate genes.  
In this study, the performance of Important for the functionality of a target is the quality of 
sequences (practicability), availability of sequences in public databases and inter- and intra- 
species variation. 
six gene targets (16S, ITS, sodA, secA1, hsp65 and rpoB) were compared regarding the 
differentiation of 3 or 4 isolates of each of the five most frequently encountered Mycobacterium 
species; M. avium, M. kansasii, M. gordonae, M. chelonae/abscessus, and M. malmoense and 
1 isolate of M. tuberculosis. 
The results demonstrate that all targets can be used to adequately identify all mentioned 
species groups. Furthermore, 16S sequence information provided one intra-species distinction; 
between M. gordonea I and II. All five other targets revealed different levels of intra-species 
variation. Most different intra-species types among the 18 strains tested were provided by the 
secA1 (17), followed by sodA (16), hsp65 (13) and ITS (13). We conclude that apart from the 
currently used genomic targets for identification of mycobacteria, other loci contain genetic 
information to subdivide the currently recognised species. This should lead to a more detailed 
identification and eventually taxonomy, if there is a difference in the clinical relevance of 





To date, 128 species of the genus Mycobacterium have been registered in the approved list of 
bacterial species (DSMZ - Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH, 
april 2006). In fact, the correct designation of Atypical mycobacteria is ‘non-Mycobacterium 
tuberculosis complex’ (NTM). 
Infections by NTM have been increasingly recognized in the last decades, mainly due to the 
high prevalence of these infections in immune-compromised patients. However, the clinical 
significance of the isolation of these bacteria is often not clear. A part of the microbiological 
laboratories in The Netherlands are equipped to perform cultures and to identify of 
mycobacterial species by molecular tests. While several molecular assays (1, 2, 3, 4) have been 
designed for the direct detection of the genus Mycobacterium in clinical materials, culturing of 
the mycobacteria is still widely propagated to confirm the result of the molecular detection and 
to determine its susceptibility pattern.  
Commercially available molecular assays for the identification of cultured mycobacteria are 
restricted to the Accuprobe hybridization assay (Gen-Probe Inc, San Diego, CA, USA) for the 
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species M. gordonae, M. avium-complex, M. kansasii and M. tuberculosis, and and to reverse 
line hybridization assays: the GenoType Mycobacterium for a wide variety of M. tuberculosis 
complex and NTM species (Hain Lifesciences, Nehren, Germany), and the Inno-Lipa V2 
Mycobacteria for NTM species (Innogenetics, Gent, Belgium). The latter two assays identify 
respectively 16 and 13 different species and both target the Internal Transcribed Spacer (ITS) 
region between the 16S and the 23S rRNA genes. For the identification of all other NTM 
species DNA sequencing is currently the golden standard and this is mostly based on the 
analysis of the 16S rRNA. However, in principle there are multiple semi-conserved genes 
suitable for identification procedures. The hsp65 gene (encoding the 65 kDa heat shock protein) 
and the rpoB gene (encoding the ß subunit of RNA polymerase) are often used as sequence 
target for the identification of mycobacterial isolates. Other targets like the gyrase genes 
(gyrA/B), dnaJ, sodA, secA1, recA have also been reported to contain sufficient genetic 
variation for identification. Important for the utility of a target for identification at species level is 
the rate of DNA polymorphism among Mycobacterium species and between strains of the 
respective species. Suitable genes offer sufficient polymorphism to distinguish between species, 
but are so conserved in the evolution that strains of the same species have little to no variation 
in sequences.  
Genes which reveal too much intra-species variation may not be suitable for the identification 
within the currently used taxonomy, but sub-division of groupings within species may be 
important in the light of studies on the clinical relevance of the isolation of certain NTM. 
Furthermore, the performance of the sequence analysis and the interpretability of the results is 
of importance. 
The National Reference Laboratory for Mycobacteriology (RIVM) collects all M. tuberculosis 
complex, as well as the largest part of the clinical NTM isolates. In the last decade the most 
common mycobacterial species were M. tuberculosis-complex (n= 11777), M. avium-complex 
(n=1480), M. gordonae (n=468), M. kansasii (n=353), M. malmoense (n=185) and M. 
chelonae/abscessus (n=131).  
We compared 6 gene targets (16S, ITS, sodA, secA1, hsp65 and rpoB), all applied as gene 
targets for the identification of NTM isolates in diagnostic laboratories in the Netherlands, for 
their usefulness in the identification of isolates of the most commonly encountered species. 
 
 
Strains & Methods. 
 
Of each NTM species, 3 or 4 strains were included in this study. The strains were all clinical 
isolates from the Netherlands collected by the RIVM in 2003: M. chelonae/abscessus (n=4), 
M.avium-complex (n=4), M. malmoense (n=3), M. kansasii (n=3), M. gordonae (n=3) and ATCC 
control strain M. tuberculosis H37RV. The isolates were randomly selected and no background 
information was available on clinical relevance of isolation of these mycobacteria or the clinical 
picture of the respective patients. Strains were identified at the RIVM by 16S sequencing (Table 
1). This method is the current standard and has previously been described by Bottger et al. (5). 
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DNA was extracted using the QiaAmp DNA extraction kit (Qiagen, Venlo, The Netherlands) and 
diluted to a final concentration of 250 ng/µl.  
The DNA extract was divided into aliquots and send to all participating institutes which 
performed their method(s) of species identification as described below.  
For the targets 16S, ITS, sodA, hsp65 and rpoB, standard 3-step PCR protocols were used 
using the primers depicted in Table 1. The same primers were used in the PCR as for direct 
sequencing. For secA1, the protocol has been described by Zelazny et al (6). 
Both forward and reverse sequences were obtained and assembled. All sequences were sent to 
one institute for further analysing. All targets were subjected to a BLAST recognition in the NCBI 
database (http://www.ncbi.nlm.nih.gov/) and the 16S and ITS sequences in the RIDOM 
database (http://www.ridom.com/) as well. 
A phylogenetic tree was assembled for each target to visualise the variability between the 
strains using Bionumerics software 3.5 with UPMGA applied as clustering method (Applied-
Maths, Belgium). The lengths of all sequences were shortened to the shortest product per target 





The analysis of the sodA, 16S, ITS and secA1 sequences resulted in readable sequences for all 
strains. For the target hsp65 one M. kansasii strain repeatedly yielded no PCR product as was 
the case as well for the rpoB target with several M. malmoense and M. gordonae strains (table 
2). Only a part of the rpoB sequences were successful for M. malmoense isolates. For both 
targets, alignments of known target-sequences revealed mismatches in the primer regions of 
several species. 
Inter- and intraspecies diversity of the analysed NTM isolates per target is shown in figure 1.  
ITS and sodA sequences show less than 90% sequence homology for strains in different 
species groups. RpoB sequences show less than 93% homology for strains of different species 
groups and 16S, hsp65 and secA1 sequences show less than 95% homology. All targets except 
for the 16S, yielded a clear difference between M. abscessus and M. chelonae. 
Table 2 describes the amount of different sequences (subtypes) found within species groups 
and the amount of mismatches between strains of the same species group. Variability between 
isolates of the same species was significant for the ITS, SecA1, hsp65 and sodA targets. The 
sodA and secA1 targets reveal the most subtypes over all species and the largest amount of 
mismatches within species. No variability between strains of the same species group or species 
is observed for the 16S target. However, a clear differentiation between species groups is 
observed.  
As shown in table 3, the RIDOM database does not provide more information on the identity of 
the strains than given by the NCBi database. In fact, no ITS sequences of M. malmoense are 
present in the RIDOM database and are therefore not recognised. M. massiliensis and M. 
bolletii sequences are not present in the RIDOM database either. The 16S sequence of M. 
malmoense was present in both databases. The NCBI database provides identifications of all 
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strains of all targets to the species group level. However, discrepanties were seen between the 
strains belonging to the M. avium-complex. Both the rpoB and the secA1 targets identify M. 
paratuberculosis on multiple occasions while the other targets either identify M. avium or M. 
avium-complex. M. gastri is recognised twice by secA1 while all other targets yield M. kansasii. 
None of the discrepant results have a 100% concordance with the database sequences which 
indicates that the matching sequences are not available. 
 










Molecular identification of mycobacterial species provides two primary advantages to 
phenotypic (conventional) identification: it is more rapid and accurate in identification. Although 
fast and easy to perform, "sequence based" methods, like species specific real-time PCR and 
PCR-RFLP have their limitations, since they only recognise the evaluated species. Most 
laboratories are equipped with a sequencer and are therefore able to perform sequence 
identifications. Six different sequence targets have been analysed for their ability to differentiate 
the most common clinical mycobacterial species in the Netherlands. Considerations for a 
preferable protocol are: practicability (high success rate of creating identifiable sequences and 
easy to use protocol) , availability of sequences in public databases and suitable levels of 
discrimination within the target. The level of resolution for routine diagnostic application of 
species differentiation is difficult to ascertain; clinical relevance of determining subspecies or 
only group levels is not known. Trial information is lacking on this subject. 
 
The 16S rRNA gene has an advantage in its presence in all prokaryotic organisms, therefore a 
broadrange PCR would be able to detect sequences of all genera and differentiate based on 
sequence variation. Still, because this gene does not contain a high degree of variation 
compared to some of the other targets, the use of this target for the differentiation of 
mycobacteria is limited. Several species have identical 16S sequences, among which the 
species belonging to the M. tuberculosis complex, "M. kansasii and M. gastri", and the 
subspecies of M. avium. Using only the 5'part of the gene, species as "M. chelonae and M. 
abscessus" and "M. ulcerans and M. marinum" cannot be differentiated either. In other words: 
16S differentiation does not exceed the group level, as confirmed with the strains used here. An 
important advantage of the 16S gene is the abundance of sequences in the public databases. 
However, the reliability of sequence information can be questionable (11). 
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Both rpoB and hsp65 contain a higher degree of divergence between species than the 16S 
target. The additional advantage of the rpoB target is that it contains species-specific sequences 
as well as polymorphisms responsible for rifamycin resistance and can therefore be used for the 
simultaneously detection of susceptibility and species identification. rpoB and hsp65 protocols 
lack in reliability: sufficient amounts of sequences are available, but primer sequences are often 
not completely genus specific due to too much variation, which explains the unsuccessful PCR 
of several strains. 
In 1993 the Internal Transcribed Spacer (ITS) region was added as a possible target in species 
differentiation and proven useful as such (12, 13) for the recognition of virtually all known 
mycobacterial species . It is used in the commercial assays InnoLipa V2 and GenoType 
Mycobacterium. The ITS-protocol has a similar performance but with more discriminative power 
than the 16S. However, while many sequences are available for the ITS target, differentiation 
between M. kansasii and M. gastri is not possible and no clear differentiation between species 
belonging to the M. avium group can be made. Also, many short and incomplete sequences are 
a pollution to the database and might cause false identifications when analysed incautiously. 
 
In 1994 the sodA gene was proposed as possible target for differentiation (14) and since then 
sporadically applied (10, 15) SecA1 is the most recent evaluated target gene used here for 
species identification (16). Correct identifications can only be made with an extended database. 
SodA appears superior in species differentiation to secA1, probably due to the availability of 
more than 130 sequences (less species) while for secA1 42 sequences of 30 different species 
are available. Considering there are over 150 species known to date, a second sequence target 
would be necessary for the identification of uncommon (sub)species for both targets. Also, when 
the amount of interspecies variation within a target is too small, species differentiation will be 
compromised. However, if there is too much variation, the risk of mismatches in the primer 
sequences will increase as well as the occurrence of unidentifiable new sequences. In either 
way a second target will be necessary for the correct differentiation of uncommon species or 
difficult taxonomical groups. 
None of the tested targets is capable of differentiation within the M. tuberculosis-complex, but all 
targets are 100% reliable in identifying the correct species group. 
M. gordonae and M. malmoense are both clearly separated from other species by all targets 
and no complicated taxonomy intricate differentiation of these species. 
SecA1 is the only target to identify M. gastri in two cases while no other targets confirm these 
results. Both sequences are 99% similar to an ATCC strain of M. gastri, and therefore a 100% 
concordance with a M. kansasii would be optional if more sequences were available. However, 
ITS and 16S are not able to differentiate the two species, while rpoB, hsp65 and sodA have no 
100% assurance either for the identification of M. kansasii. 
The M. abscessus/chelonae group is recently divided into more species. M. massiliensis and M. 
bolletii belong to this group. They are an example of the increasing complexity of mycobacterial 
taxonomy. Not for all targets the sequences of these species are known yet, but for sodA and 
the ITS the sequence variability within this species group is probably sufficient enough to 
harbour specific differences. 
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The M. avium-complex appears to be the most difficult group to differentiate. This species-group 
is known to harbour extensive sequence variation. Still, 16S and hsp65 show no variability 
between the (sub)species of this complex. All strains yield discrepant results for the other 
targets. While one target shows two strains to have similar sequences, another target shows 
another combination of strains to be similar. Not one strain is identified consistently by different 
targets. While by two targets identified as such, the recognition of M. paratuberculosis is unlikely 
to be correct, due to the difficult growth kinetics of the species. The identification of this species 
group in particular would benefit by an extensive and quality controlled database. 
 
Concluding: When is chosen for identification to the group level, then 16S sequencing is the 
most reliable. When identification to the (sub)species level is preferred, no target will be 
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9  Discussion: diagnostics of non-tuberculous mycobacteria. 
 
 
Molecular identification of species and recognition of subspecies. 
 
Molecular techniques have replaced conventional methods for appropriate species 
identification and can be considered the new gold standard. As described in detail in chapter 
2, many gene targets have been described to be suitable for species differentiation. Of these, 
the partial genes for 65 kDa heat shock protein (hsp65), RNA polymerase beta-subunit 
(rpoB), essential protein secA1, superoxide dismutase (sodA), 16S RNA and the 16S–23S 
ribosomal RNA internal transcribed spacer (ITS) have been compared in chapter 8 for the 
species M. avium, M. kansassii, M. gordonae, M. abscessus/chelonae and M. malmoense. 
These 6 gene targets are currently applied for mycobacterial species identification in the 
Netherlands. The most obvious differences between the compared sequence targets are the 
availability of comparable sequences in public databases and the level of differentiation. The 
16S gene is the most conserved among mycobacterial species and allows only differentiation 
to the species-complex level, while the ITS and the hsp65 gene are the most variable. The 
sodA and secA1 genes are variable as well, but of these, few sequences are available in the 
public databases. 
Since the taxonomical and clinical status of subspecies or species variants are unclear, it is 
uncertain if differentiation of NTM species to the sub-levels is clinically relevant. Several 
studies have been performed to establish further insight into the clinical significance of for 
instance M. kansasii subtypes (1, 2). Some M. kansasii subtypes appear more prevalent in 
human disease, but differences in virulence or pathogenesis have not been determined. The 
only NTM species of which differences in virulence of subtypes have been determined are M. 
avium (3), M. ulcerans (4) and M. marinum (5, 6). M. marinum is often used as a model for M. 
tuberculosis research and through this species, many mutations in coding genomic regions 
related to virulence and pathogenesis have been identified (7, 8). 
Chapter 8 of this thesis represents a pilot study to examine the usefulness of gene-targets in 
the differentiation of mycobacterial species. 
While it remains unclear if differentiating NTM species variants provides relevant information 
for treatment, the identification of species is relevant from an epidemiologic point of view at 
least. Therefore, we concluded that the ITS or hsp65 sequences, which are abundant in the 
public databases and provide a sufficient level of differentiation, are the best available 
sequence targets for species identification at this moment. 
Using these results the next step is to evaluate the targets in their relation to clinical 
significance of isolates. It might be possible that these or other sequence targets harbour 







Real-time PCR for the detection of NTM in clinical materials. 
 
PCR detection in clinical materials enables rapid identification of the mycobacterial pathogen. 
A conventional PCR with agarose analysis has a low sensitivity due to the amount of 
amplicon needed for analysis. Moreover, handling PCR products after amplification is a risk 
for laboratory contamination and sequencing of amplicons (for identification) derived from 
clinical materials often fails. A possible solution to these problems is the use of real-time 
PCR. As summarized in the introduction, after a systematic review, most real-time PCR 
assays are not validated on clinical materials or only capable to detect the M. tuberculosis-
complex or M. avium-complex.  
 
In chapter 3 of this thesis, the development of a real-time PCR assay was described for the 
direct detection of mycobacterial DNA in clinical specimens. The forward primer and genus 
specific probe were located in the ITS region and the reverse primer is located in the first part 
of the conserved 23S gene. The primers yield an amplicon of approximately 175 basepairs 
(depending on the species) of the ITS region. The primers and genus specific probe for the 
real-time PCR are located in conserved sequences, but the sequence in between is highly 
variable and provides enough variation for the design of probes for any other slow-growing 
species (figure 1). However, because the oligo’s were designed on the sequences of slow-
growers, mismatches in the forward primer and genus-specific probe have been encountered 
in several rapid-growing species (i.e. M. fortuitum and M. chelonae). 
 
 




For the assay in chapters 3, 4 and 5, species-specific probes have been designed for M. 
avium, M. tuberculosis and M. haemophilum. In chapter 3, The M. tuberculosis-specific probe 
was applied to exclude the involvement of the species from the M. tuberculosis-complex. In 
chapter 3, 4 and 5, The M. avium-specific and M. haemophilum-specific probe, to enable the 
direct recognition of the most common NTM species. Clinical validation revealed that the 
assay provided a rapid diagnosis of mycobacterial disease in children with mycobacterial 
lymphadenitis. Addition of the real-time PCR assay to conventional diagnostics (culture and 
acid-fast staining) performed in 67 children with suspected mycobacterial disease, resulted in 
the recognition of 13 more children with NTM disease (chapter 3). 
While evaluating the application in lymph node specimens, several specimens only yielded a 
genus-specific signal, while culture remained negative. Sequencing of the amplicons formed 
in the real-time PCR identified M. haemophilum. Therefore, an M. haemophilum-specific 
probe was designed and added to the assay as described in chapter 4. M. haemophilum-
Forward primer 
Reverse primer        Genus specific probe 
16S gene 23S gene 
  
Variable species specific probe region 
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specific real-time PCR was superior to culture because only 9 (56%) of the 16 diagnosed M. 
haemophilum infections were positive by culture. 
Chapters 3 and 4 reflect only a part of the total study described by Lindeboom (9). In total, 
135 children with cervicofacial NTM lymphadenitis were included in the study. The addition of 
the real-time PCR assay to conventional diagnostics revealed M. avium to be present in 94 
of 135 (70%) of the diagnosed lymphadenitis cases and M. haemophilum in 32 of 135 (25%) 
cases.  
No other real-time PCR assay that has been described so far enables genus-specific 
detection and has been extensively validated for application in clinical materials. 
The publications of Shrestha and Garcia are best comparable to the assays we developed 
and tested as described in chapters 3 and 5 (10, 11). Details of these assays have been 
described in table 3 in chapter 2. Shrestha and colleagues designed a genus-specific PCR 
targeting the 16S gene with a 215 bp amplicon (10). An M. tuberculosis-specific probe 
combination (Fluorescence resonance energy transfer principle) was employed for the 
detection of all species. Because the different mycobacterial species contained variable 
mismatches in the M. tuberculosis-probe region, analysis of the melting points enabled 
species identification for 9 of the 11 species tested, which included M. avium but not M. 
haemophilum. The sensitivity of NTM detection could not be compared to the assay from 
chapters 3 and 5, because only 3 NTM positive samples were included in the validation. 
The method described by Garcia and colleagues comprised a genus-specific probe and 
targeted the 16S gene as well (11). The clinical validation included 12 NTM positive samples, 
not including M. haemophilum. No culture negative specimens were included from patients 
with a suspicion of NTM disease. Therefore, the performance of the PCR could only be 
compared with culture positive specimens. Still, the real-time PCR yielded only 8 samples 
positive for NTM (66%). This poor sensitivity might be related to the length of the amplicon, 
which was 475 basepairs. The extraction method might be another reason for the poor 
sensitivity: alkali washings combined with heating. Mycobacteria are extremely difficult to 
disrupt and are often intracellular. Therefore, vigorous methods are necessary for successful 
DNA extraction (12, 13). The assays of Shrestha and Garcia might be as valuable as our own 
assay in chapters 3 and 5, but a more extensive validation should be performed on NTM 
containing clinical materials. 
 
In chapter 5, the real-time PCR assay for the detection of mycobacteria was applied to 
formalin fixed / paraffin embedded (FF/PE) specimens. As far as we are aware, only one 
publication revealed real-time PCR to be successful in diagnosing NTM disease on FF/PE 
specimens (14). This real-time PCR assay was compared to conventional staining results. 
However, the assay by Beqaj, detected only M. tuberculosis-complex and M. avium-complex 
and not the genus. Based on our experiences described in chapter 4, we consider it very 
likely that M. haemophilum represents an underdiagnosed causative agent of granulomatous 
inflammations in other clinical manifestations than just lymphadenitis.  
Therefore, in chapter 5, the real-time PCR was applied on 30 FF/PE archival skin specimens 
with granulomatous inflammation collected over the last 25 years. A control group was 
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assembled of 30 specimens of patients with basal-cellcarcinoma. Surprisingly, DNA of M. 
haemophilum was present in 7 of 13 NTM positive specimens. The oldest M. haemophilum 
positive specimen was from a patient with panniculitis from 1984, initially suspected to be 
caused by a mycosis. These results clearly prove M. haemophilum to be underdiagnosed as  
a causative agent in granulomatous skin lesions as Sampaio and colleagues suggested 
previously (15). They are not so much “emerging” as suggested by Brown-Elliot (16), but 
appear to have been present years before the real-time PCR detection was introduced. 
Unfortunately, one sample of the control group yielded an M. haemophilum positive result as 
well and some of the real-time PCR results could not be confirmed after repeated 
examinations. The Ct-values (threshold cycles) indicated that the detection limit had been 
reached. Therefore a higher sensitivity appeared to be necessary in these materials to 
provide a definite diagnosis of NTM. The true incidence of NTM involvement in 
granulomatous skin inflammation needs further confirmation in a prospective study using 
conventional methods for comparison. 
 
 
Suggestions to improve molecular detection of NTM in clinical materials. 
 
Increasing the sensitivity. 
The target for a PCR design can influence the sensitivity in several ways: 1) a small fragment 
(100-200 bp) is less inclined to form secondary structures than a large fragment (200-1000 
bp). The target chosen for the real-time PCR in chapters 3 and 5 is approximately 175 bp; 2) 
sequence variation should be limited: mismatches in primer sequences decrease effective 
amplification, mainly in the 3’ end of the primers. All known sequences of slow-growing 
species contain identical primer sequences but the sequences of rapid-growing species 
contain too much variation; 3) multiple copies of the target sequence increases sensitive 
detection. Many of the NTM species found in humans are slow-growers. This slow growth 
rate is related to the presence of only one ribosomal operon in slow growers (and two in 
some rapid growers) (17). The variety of growth rate in different species is influenced by the 
amount of promoters at the start of the operon (17-19). Most other bacterial taxa contain 
several copies of the ribosomal operon and a higher sensitivity is reached when targeting this 
multi-copy element. Therefore, the ribosomal operon as target in a PCR reaction does not 
increase the sensitivity of the detection. While repetitive elements applied, for instance, in the 
detection of M. tuberculosis are available for several species, such an element has not yet 
been identified for all mycobacteria. Some attention might go out to Mycobacterial Intergenic 
Repetitive Units (MIRUs) (20). These relatively short (approx. 80 bp) repetitive elements are 
located throughout the mycobacterial genome and have been applied in typing studies of M. 
tuberculosis, M. avium-complex, M. marinum and M. ulcerans (21-23). As mycobacterial 
MIRU’s contain open reading frames, and are therefore fairly stable coding sequences, they 
might be useful in detecting mycobacteria. When the repeats described in Supply et al (20), 
are compared to the known genome sequences in the public database, homology is 
encountered in the genomes of the species M. paratuberculosis, M. tuberculosis, M. leprae, 
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M. bovis and M. smegmatis, which are all species of which total genomes have been 
sequenced and are publicly available. This is in accordance with the homology information 
given in the article of Supply, where southern Blot analysis yielded homology between M. 
tuberculosis, M. bovis and M. leprae. However, other genomes have not been fully 
sequenced and no knowledge about the presence of sufficient homologous sequences is 
available. Furthermore, because of the variable amount of repeats of most of the MIRU’s, the 
sensitivity of an assay based on MIRUs can vary in different strains. The identification of a 
suitable multi-copy DNA target for a diagnostic PCR assay is worth considering, but a more 
sensitive target than the ITS region we employed for the real-time PCR in chapters 3, 4 and 
5 is yet to be discovered.  
 
Optimization for molecular detection in pathological formalin fixed-paraffin embedded 
materials.  
Molecular detection methods applied on pathological formalin fixed-paraffin embedded 
(FF/PE) materials again often lack sufficient sensitivity levels for diagnostic purposes. Low 
bacterial loads are a problem in these materials as well, but this is amplified in combination 
with small paraffin sections. A second problem is encountered in histopathological materials 
due to DNA degradation by the fixation protocol. This fixation protocol is also responsible for 
low sensitivity of acid-fast staining procedures. Molecular detection of mycobacteria can yield 
significantly more positive diagnoses than acid-fast staining, as observed in the comparison 
of real-time PCR to staining by Fukunaga and collegues (24) and also observed for fresh 
specimens in chapter 3 and 4. 
Denaturating properties of formalin fixation used in tissue specimens are known to damage 
DNA. It has been suggested that the fixation method is the reason that PCR techniques are 
less successful in materials for histological examination (25). Hepes-glutamic acid buffer 
mediated Organic solvent Protection Effect (HOPE)-fixation technique provides FF/PE-like 
morphology together with good preservation of nucleic acids and antigenic structures (26). 
This fixation technique has been proven to create a higher sensitivity in normal PCR, real-
time PCR and hybridization methodology (25-27). A third problem, often encountered in the 
molecular laboratory, is that DNA from FF/PE materials is difficult to separate completely 
from the paraffin. Therefore, inhibition of PCR is a common problem in molecular diagnostics 
of these materials. The protocol used during our study, proved sufficient to eliminate this 
inhibition. 
As described in chapter 5, application of the genus-specific real-time PCR on normal FF/PE 
materials, was successful in detecting specific mycobacterial sequences, but the sensitivity 
was limited. A duplex genus specific PCR was only positive in both reactions for 5 specimens 
and only one of two reactions was positive for 8 specimens. Also, the high threshold-cycles 
indicate that the detection limit of this assay was reached in these specimens. Application of 
HOPE fixation in these samples could possibly have led to a higher positivity rate. 
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Prevention of contamination. 
The necessity to detect a low copy number of the bacilli, might compromise the specificity of 
the assays because contaminating mycobacteria are also detected. This emphasizes the 
importance of establishing clinical significance in the detection of NTM. However, there is 
another type of contamination that poses a problem in NTM detection: the components used 
in molecular assays are all dissolved in water. Experiences in our laboratory and several 
published articles demonstrate that the PCR mixes are often contaminated with bacterial 
DNA, presumably present in the water used during preparation of the mixes (28-30). 
Sensitivity of (real-time) PCR assays is increased by short amplicons and a maximum 
amount of cycles, as applied in the assay described in chapters 3 and 5. When highly 
sensitive assays are applied to clinical materials, single copies of contaminated DNA 
fragments are detected as well. We have encountered this contaminating DNA in PCR mixes 
through the use of negative controls in diagnostic runs of the assay from chapters 3 and 5. 
Contaminated batches were observed in Hotstar mastermix (Qiagen) and Platinum taq 
mastermix (Invitrogen), while batches of IQ mastermix (Biorad) and Universal mastermix 
(Applied Biosystems) appeared clean. Laboratories should be aware of this: each new batch 
of PCR mix can potentially contain mycobacterial DNA and should be tested. 
Few approaches towards overcoming this problem have been described earlier by cleaning 
strategies including treatment by 8-methoxypsoralen and different UV wavelengths (31, 32). 
However, these attempts were demonstrated to be useful in normal PCR programs with 30-
35 cycles and detection on agarose, which is less sensitive than the modern real-time 
approaches. The study of Corless et al, evaluated possible elimination strategies for 
contaminating DNA. The most effective appeared a combination of AvaI and DNaseI 
enzymes. UV radiation appeared to reduce the polymerase activity (30). However, the 
application of nucleases requires inactivation prior to the PCR cycling. Only hotstart 
polymerase, requiring 10-15 min incubation at a high temperature, will endure this treatment. 
A control PCR of each batch of mastermix and other contaminating components (i.e. TE 
buffer and water) will reduce the risk of contamination further. The last component requiring 
elimination of contaminating DNA is the clinical specimen itself. In other words, the 
specimens need to be transported in a dry state and all handling should be performed with 
DNA-free fluids: a very laborious process and difficult to control. 
 
A promising substitution for a DNA target could be an RNA target. While the RNA operon is 
only present as single copy in most mycobacterial species, the transcripts are available in 
thousands of copies in intact organisms (33, 34). The Gen-Probe Amplified Mycobacterium 
Tuberculosis Direct Test (AMTDT, Gen-probe, US California) is a commercially available test 
which employs the 16S RNA copies from M. tuberculosis in direct detection. Several RNA 
amplification techniques, like Transcription Mediated Amplification (TMA) and Nucleic Acid 
Sequence Based Amplification (NASBA), might be useful in the detection of NTM. 
Extraction of RNA is more difficult than extracting the stable DNA, but this approach might 







Susceptibility testing of NTM for some specific antimycobacterial agents may be valuable for 
an optimal therapy.  However, culture is not always successful and a mycobacterial isolate is 
required to determine its sensitivity to antimycobacterial agents. Susceptibility tests for 
mycobacteria require a growth period of several weeks. Also, cut-off values of MIC values for 
resistancy vary between slow-growing and rapid-growing species (35). For instance, for 
clarithromycin slow-growing species are considered resistant with a MIC ->32, while rapid- 
growing species are resistant with a MIC ->8 (36, 37). So far, no molecular tests have been 
evaluated for antimicrobial resistance in NTM species. The existing assays have been 
developed for M. tuberculosis and for several antibiotics the genetic trait loci have been 
identified in M. tuberculosis. However, for the NTM that have been examined, the loci 
appeared the same, which creates possibilities for molecular detection approaches.  
In general, in vitro susceptibility to clarithromycin is considered to correlate with a clinical 
response of patients treated with chlarithomycin. Therefore, we evaluated the presence of 
the 23S mutation in clarithromycin-resistant M. avium isolates. Clarithromycin resistance is 
primarily related to the secondary structure of the ribosomes. Methylation of position 
2058/2059 in the structural domain V results in conformational change of the ribosomal 
binding-site for macrolides, either by mutations in the 23S gene or by direct methylation of 
the RNA. Of the 6 highly resistant isolates (MIC value >32), all contained a mutation at 
positions 2058 or 2059 in the 23S gene. However, the intermediate resistant isolates (MIC-
value 8 or 16) did not contain the mutation and might be influenced by other resistance-
mechanisms, e.g. other known mutations (i.e. in domain II of the 23S gene), direct 
methylation of the RNA or so far unknown mechanisms (38). The relevance of this 
intermediate resistance is questionable since clinical failure has never been investigated in 
correlation to different resistance levels. The rate at which clarithromycin resistance is 
obtained by an M. avium isolate was investigated in our laboratory in a pilot experiment. 
Three initially susceptible isolates of M. avium, were grown for four weeks in Lowenstein 
media with low concentration of clarithromycin (4 mg/ml). When a colony had grown 
sufficiently, this colony was passed onto a culture medium with a slightly higher 
concentration of clarithromycin (8 mg/ml). Subsequently, a colony was transferred to new 
medium with 32 mg/ml clarithromycin. 23S sequences of the colonies from the highest 
concentration of clarithromycin were compared to the sequences from the initial strain. The 
initially susceptible strain yielded wild-type sequences, while the strains obtained in the 
presence of 32 mg/ml clarithromycin yielded mutations in the 23S sequences at positions 
2058 or 2059. These mutations were the same as described previously (39) and our results 
were in concordance with the readily acquired resistance in vivo as described by Thiermann 
and colleagues: Their research showed the same 23S mutations in clinical M. avium strains 
obtained from AIDS patients after clarithromycin monotherapy, while the strains obtained 
prior to the therapy showed wild-type sequences (40). Similar experiences were obtained in a 
retrospective study including isolates from 51 M. avium patients who failed clarithromycin 
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treatment. Many developed resistance during treatment, and 96% of the isolates showed the 
23S mutation at position 2058 or 2059 (39). 
Molecular identification of drug susceptibility patterns, preferably directly in clinical 
specimens, would enable a rapid initiation of the appropriate antimycobacterial therapy. The 
macrolide resistance mutations are especially easy to target in an assay, but for other 
important anti-NTM agents, ethambutol and rifabutin, enough knowledge is also available to 
develop molecular assays for resistance detection as described in chapter 2. These assays 
would be fairly easy to develop and could prove a valuable asset to mycobacterial 
diagnostics. 
 
Typing of NTM for taxonomic purpose and as an epidemiological tool.   
 
In chapters 6 and 7, genotyping was performed on mycobacterial species M. avium and M. 
haemophilum. M. avium was typed to investigate animals as a possible source for human 
infections and M. haemophilum was typed to elucidate the possibility of a common source. 
In chapter 6, M. haemophilum strains from lymphadenitis patients from the Netherlands were 
compared with strains from other continents and with strains from various clinical 
manifestations. An Amplified Fragment Length Polymorphism (AFLP) methodololgy was 
applied which enabled a genome-wide comparison without any sequence information. In 
total, only 3 published genotyping studies have been performed with M. haemophilum (41, 
42), including chapter 6. One article describes a Restriction Fragment Length Polymorhism 
(RFLP) method in which an M. haemophilum specific multi-copy sequence was analysed 
(41). The variable genomic distribution of this “un-named sequence” in M. haemophilum was 
visualized by the RFLP patterns. The method applied by Yakrus and colleagues was a Pulse 
Field Gel Electroforese (PFGE) (42). This method enables the separation of band patterns 
created with random priming. In both the studies of Kikuchi and Yakrus, the investigated M. 
haemophilum strains (resp. n=28 and n=19) showed clustered type distribution which might 
indicate common infection sources among the patients. The strains in these studies were 
mainly isolated in hospitals in New York. The same strains have been subjected to the AFLP 
method in chapter 6 to compare the level of discrimination of the methods. The AFLP method 
was highly discriminatory, and it showed the same clustering as the other two methods. The 
most striking finding in chapter 6 was a large cluster of 28 strains from the Amsterdam region 
with one identical pattern. During the CHIMED* study, conducted from 2001 through 2005, a 
total of 32 children were diagnosed with M. haemophilum lymphadenitis (9). Because of this 
finding, one single niche might be expected for the M. haemophilum strain. Another 
supporting fact was that some of the children included in the study appeared to be living in 
the same neighbourhood. The only environmental source for M. haemophilum described so 
far is biofilms (43). Water as a reservoir, combined with the finding of clustered cases, might 
indicate the household water system to be the environmental source of infection. However, 
we attempted to isolate M. haemophilum from one of the patient’s homes, but were only able 
to detect Mycobacterium kansasii. While this patient was the most recent case, there were 
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several months between the onset of disease and the tapping of household water samples. 
Therefore, the natural reservoir of M. haemophilum remains unknown. 
M. avium strains isolated from children with lymphadenitis were genotyped in chapter 7. The 
applied IS1245 RFLP method has previously been described to have a high discriminatory 
capacity (44). Many papers have been written about genotyping in M. avium complex in 
which a broad spectrum of methods have been applied, ranging from RFLP (44, 45), AFLP 
(46), Multilocus Variable-number Tandem Repeat Analysis (MLVA) (45) and Microarray 
technology (47). The IS1245 method was considered the preferred typing method for M. 
avium and was chosen in chapter 7. The two main objectives in chapter 7 were 1) to 
establish a correlation of human isolates with isolates from pet birds; and 2) the range of type 
distribution among human strains. In contrast to M. haemophilum, M. avium is ubiquitous and 
has been isolated from soil, animals and water sources (48). While there have been 
incidences with clustered cases of M. avium infection with identical genotypes (49) and some 
cases have been linked to environmental reservoirs (48, 50), we found a large variety of 
patterns in our typing study and no relation to types isolated from  pet birds. Another 
suggested source of the infecting M. avium strains is pig farms. Porcine isolates have been 
described to be similar to human isolates (51, 52), but no clinical cases have been linked to 
pigs so far. It should be noted, that while so many studies concentrate on the genetic 
variability and epidemiological behaviour of opportunistic pathogenic mycobacteria, no clear 
environmental sources have been determined and little research is being performed to find 
the modes of transmission and risk factors. 
Another important finding in chapter 6 is the geographical distribution of M. haemophilum 
genotypes. This phenomenon is recognised in M. ulcerans as well (53-55), while type 
distribution in the closely related species M. marinum is not related to geographical origin 
(55). In chapter 7, also no geographical clustering could be detected for M. avium genotypes. 
The recent article by Johansen and colleagues, support our findings of chapter 7, by 
determining highly variable RFLP patterns for the human isolates and no geographical 
relation (52). 
These evolutionary or epidemiological differences between mycobacterial species have not 
been elucidated yet, but should be a highly interesting topic for future research. 
 
* CHIMED: multicenter study to determine the optimal treatment for children with mycobacterial 
lymphadenitis: medical versus surgical treatment. 
 
A new typing method: Protein profiling.  
Previously applied geno(sub)typing methods all have one or more drawbacks: 1) They 
require sequence information; 2) they have poor reproducibility; 3) they are laborious, as are 
the methods applied in chapters 6 and 7; and/or 4) they represent only an unknown fraction 
of the total genomic variation.  
New protein profiling methods, the MALDI-TOF (matrix-assisted laser desorption / ionization-
time-of-flight mass spectrometry) and SELDI-TOF (surface enhanced laser desorption / 
ionization time-of-flight mass spectrometry) (56), might overcome all of these drawbacks. 
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These technologies are designed to provide a characteristic mass spectral fingerprint based 
on desorbed ions from the cell surface (57) but the MALDI-TOF can also be applied on other 
protein groups, for instance the cord-factors, of which different patterns already have been 
identified for 12 mycobacterial species (58, 59). Therefore, a total protein profile can be 
obtained from isolates. The methods are applicable on cultured cells without extraction, can 
be fully automated, and do not need prior information of sequences or proteins. Mass 
spectrometry has recently been described for the differentiation of 37 mycobacterial species 
and strains (57, 58, 60, 61). The technology is suitable for both intact and disrupted cells and 
recent studies have suggested it to be suitable for sub-typing in other bacterial species like 
Aeromonas and Staphylococcus (62, 63). While perhaps already very useful for typing 
purposes, the methods require an extensive database with protein profiles of species and 
strains, before it will be fully operational in mycobacterial species identification and of course 





Application of the ITS real-time PCR assay on patient materials enables rapid diagnosis of 
NTM disease. The technique was extremely useful for the rapid detection of the slow- 
growing Mycobacterium species and was successfully applied as a rapid test for 
the inclusion of patients in a clinical trial. However, sensitivity is limited to 1100 cfu/ml 
purulent lymph node biopsy material and contamination with saprophytic mycobacterial DNA 
is problematic for the current genus-specific detection in clinical materials. Therefore, special 
attention should be given to appropriate controls.  Mycobacterial RNA detection might 
overcome these bottlenecks of PCR techniques. 
 
Addition of species-specific probes to the ITS assay, identified M. haemophilum to be 
present in previously undiagnosed skin inflammation and resulted in the recognition of M. 
haemophilum as the second most common mycobacterial species causing lymphadenitis. 
Subsequent Amplified Fragment Length Polymorphism (AFLP) analysis of M. haemophilum 
isolates showed this species to posses an extremely low mutation rate. Also, M. 
haemophilum lymphadenitis cases are suspected to have a common source, most likely 
piped water, in contrast to M. avium infections, which appear to originate from variable 
environmental sources. 
 
Future efforts to shorten and structure mycobacterial diagnostics might be directed towards 
sensitive molecular detection directly in clinical materials and application of, for instance, the 
MALDI-TOF methodology, which enables the combined species identification and subtyping 
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Samenvatting: Diagnostiek van niet-tuberculeuze mycobacteriën. 
 
 
Het genus Mycobacterium bestond in november 2007 uit 127 species waarvan 121 species 
behoren tot de niet-tuberculeuze mycobacteriën (NTM). Van 1990 tot 2000 werden 28 
nieuwe species geïdentificeerd, van 2000 tot september 2007 kwamen er 41 bij. De 
ontdekking en identificatie van nieuwe species heeft nog steeds een continu voortgaande 
snelheid. Ongeveer tweederde van het aantal NTM species is initieel gevonden als infectieus 
agens bij mensen en al deze, met uitzondering van Mycobacterium leprae en M. ulcerans, 
worden beschouwd als opportunistisch pathogeen. 
Klinisch kunnen deze NTM verantwoordelijk zijn voor ondermeer huidinfecties, longinfecties, 
gedissemineerde infecties, lymphadenitis, osteoperose en keratitis. NTM infecties worden 
voornamelijk aangetoond in immuun gecompromitteerde patiënten, maar zijn ook niet zelden 
gevonden in immuun competente patiënten. Vooral lymphadenitis is een veel voorkomende 
klinische NTM manifestatie bij “gezonde” kinderen. 
 
De grote aantallen species en de grote verscheidenheid in klinisch beeld maken van de 
mycobacteriële diagnostiek een ingewikkeld stukje microbiologie. 
Conventionele mycobacteriologie bestaat voornamelijk uit langdurige kweek, microscopische 
kleuringen en resistentiebepalingen in een aanvullende kweekperiode, eventueel aangevuld 
met of vervangen door immunologische of histopathologische methoden. Vanwege 
veiligheidsvoorschriften is er voor de conventionele mycobacteriologische diagnostiek een 
gespecialiseerd laboratorium vereist dat voldoet aan de normen voor bio-safety-level 3. De 
afwezigheid van een specialistisch laboratorium, alsmede de aspecificiteit van kleuringen èn 
de langdurige kweekperiode, resulteren in een groeiende behoefte aan moleculaire detectie- 
en identificatiemethoden. 
 
Moleculaire technieken worden inmiddels als gouden standaard beschouwd bij de 
identificatie van positieve kweken, maar worden voor de detectie van NTM in klinische 
materialen nog maar mondjesmaat toegepast. Meestal bestaan deze methoden dan uit 
conventionele PCR, soms multiplex- of nested-, met additionele analysestappen, welke niet 
als optimaal gelden voor het hedendaagse microbiologische laboratorium. Vanwege de 
verschillende stappen zijn ze vaak contaminatiegevoelig, vereisen een variatie aan 
apparatuur en over het algemeen missen ze een hoge sensitiviteit. Real-time PCR is in 
theorie hiervoor een goede vervanging, maar vooralsnog was een genus-specifieke test 
moeilijk te realiseren wegens de grote variatie binnen de NTM groep. 
 
Hoofdstuk 3 beschrijft het ontwerp van een genus-specifieke real-time PCR, die bij 
toepassing op lymfeklier-biopties, een NTM infectie kon aantonen binnen slechts 2 dagen. Bij 
vergelijking van de real-time PCR met conventionele diagnostische methoden, bereikte de 
PCR een sensitiviteit van 72% vergeleken met 42% voor de kweek. Door de toevoeging van 
een M. avium-specifieke probe werd de aanwezigheid van deze species direct herkend bij 38 
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van de 67 NTM positieve lymphadenitis-patiënten. De toepassing van deze diagnostische 
test resulteerde in de mogelijkheid binnen enkele dagen een gerichte behandeling te starten 
zonder de kweekresultaten af te wachten. 
 
In Hoofdstuk 4 is dezelfde real-time PCR uitgebreid met een M. haemophilum-specifieke 
probe. Deze species werd bij diverse patiënten aangetoond na sequencing van PCR 
producten met enkel een positief signaal in de genus-specifieke real-time PCR zoals 
beschreven in hoofdstuk 3. De toevoeging van de M. haemophilum-specifieke probe 
resulteerde in de ontdekking van 16 M. haemophilum-positieve lymphadenitis-patiënten. 
Omdat initieel niet aan de specifieke kweekvoorwaarden voor deze species werd voldaan, 
waren deze diagnoses niet gesteld zonder de toepassing van de real-time PCR. Hieruit 
volgde de vraag hoeveel mogelijke NTM infecties in het verleden gemist zouden zijn (!) 
 
Hoofdstuk 5 beschrijft daarom de toepassing van de genus- en species-specifieke real-time 
PCR detectie in paraffine-ingebedde huidbiopties. Van de 30 biopties, verzameld tussen 
1982 en 2004, bleken 13 materialen positief voor mycobacteriën. In 7 materialen werd M. 
haemophilum geïdentificeerd. Ten tijde van de afname van de klinische materialen waren 
maar in 5 van de 13 NTM-positieve biopties mycobacteriën aangetoond. 
 
Hoofdstuk 6 omvat de genotypering van een collectie M. haemophilum stammen. Van de in 
totaal 32 M. haemophilum stammen, die aangetoond werden bij kinderen met lymphadenitis, 
bleken er 30 uit de regio Amsterdam afkomstig te zijn. Om hiervan aan te tonen dat deze 
stammen aan elkaar verwant waren, is een genotypering uitgevoerd. Slechts twee keer 
eerder waren genotyperings-studies uitgevoerd, beide op een kleine collectie stammen. 128 
stammen werden verzameld vanuit verschillende continenten en klinische manifestaties om 
te vergelijken in AFLP. De methode had een goed onderscheidend vermogen en was in staat 
grote variabiliteit in genotypen te herkennen. Niet alleen de stammen uit Amsterdam bleken 
identieke patronen te vormen (en bewezen daarmee verwant te zijn), maar infecties met de 
species kwamen vaker geclusterd voor. Twee clusters uit Australië en een cluster uit New-
York werden aangetoond. De identieke patronen bleven langdurig stabiel; ze bleven tot 18 
jaar lang onveranderd. 
 
In hoofdstuk 7 is de genotypering van M. avium stammen beschreven. Lymphadenitis bij 
kinderen wordt vaak “vogeltjes-tbc” genoemd, naar de species M. avium. Tegenwoordig is 
een typeringstechniek beschikbaar die het onderscheid kan maken tussen het vogel-type M. 
avium, en humane typen. Deze methode is in hoofdstuk 7 toegepast om aan te tonen welke 
subspecies M. avium lymphadenitis veroorzaakt en hoe groot de genetische variabiliteit 
tussen stammen is. In tegenstelling tot de clustering van M. haemophilum stammen in 
hoofdstuk 6, werd tussen de M. avium stammen een grote variatie aangetoond. Geen enkele 





In hoofdstuk 8 van dit proefschrift worden zes gen-targets vergeleken voor de identificatie 
van zes verschillende NTM species. De meest gebruikte identificatiemethode voor NTM 
species is direct sequencing van gen-targets na een positieve kweek. Er zijn verschillende 
sequentie targets bekend die geschikt zouden zijn voor dit doel, maar een vergelijking van de 
functionaliteit is nauwelijks uitgevoerd. Een geschikte target dient voldoende variabel te zijn, 
maar evengoed geconserveerd voor de toepassing van genus-specifieke primers. In de 
vergelijking beschreven in hoofdstuk 8 bleek dat de verschillende gen-targets een 
verschillend niveau van differentiatie bieden. De bekendste, het 16S rRNA-gen, biedt enkel 
differentiatie tot op het niveau van speciesgroepen, maar is zeer betrouwbaar. Daarentegen 
zijn de ITS, en het rpoB- en het hsp65-gen in staat tot op sub-species niveau te 
differentiëren. Het nadeel van deze drie genoemde targets is dat de variatie zo groot kan 
zijn, dat de genus-specifieke amplificatie niet gegarandeerd kan worden. De nieuwste 
targets: sodA en secA1 lijken een gemiddeld differentiatieniveau te bieden. Helaas zijn van 
beide genen te weinig sequenties bekend om alle species te herkennen. Waarschijnlijk is de 
beste wijze van identificatie het gebruik van twee gentargets tegelijk, zoals bijvoorbeeld de 
combinatie van 16S en ITS sequenties.  
 
Doordat het genus Mycobacterium zeer gevarieerd is en er onvoldoende kennis bestaat over 
de genetische opbouw van dit genus, is het tot nu toe niet geheel gelukt een moleculaire 
assay te ontwikkelen die zonder beperkingen toegepast kan worden ter vervanging van de 
huidige kweekmethoden. De algemene aanwezigheid van vervuilend mycobacterieel DNA in 
reagentia en het ontbreken van een “Multi-copy” target voor detectie, bemoeilijken het 
gebruik van real-time PCR in de directe detectie van NTM. Mogelijk kunnen RNA- 
detectiemethoden hier een oplossing vormen. 
In toekomstig onderzoek naar de verbetering van de NTM diagnostiek zou de verdere 
ontwikkeling van een sensitieve en specifieke moleculaire test voor de detectie van NTM in 
klinische materialen centraal moeten staan. Voor meer kennis over de epidemiologische 
eigenschappen en klinische relevantie van NTM infecties, zal het gebruik van identificatie- en 
typeringstechnieken een belangrijke rol kunnen spelen en zouden toepassingen hiervan, 
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